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Abstract 
 
Eukaryotic chromatin is organised into a hierarchy of topologically constrained loop 
structures. Matrix Attachment Regions (MARs) are genomic sequences that mediate the 
anchoring of chromatin to the insoluble proteinaceous fraction of the nucleus known as 
the nuclear matrix. Since only a few MARs have been characterised so far, their role in 
genomic structure and function is not well understood.  
 
The aim of this thesis is to use the human Major Histocompatibility Complex (MHC) as 
model region to provide novel insights into the relationship between chromatin folding 
mediated by MARs and gene expression. This large locus contains critical genes for 
immunity and is associated with more diseases than any other genomic region. Classical 
MHC genes are expressed in a cell type specific pattern, and can be induced by 
cytokines such as IFN-γ.  
 
MARs were identified across the entire MHC in uninduced fibroblasts, IFN-γ induced 
fibroblasts and B lymphoblastoid cells. Expression array analysis showed that these cell 
types exhibit different MHC expression profiles. MARs were first isolated treating 
nuclei with hypertonic buffers followed by nuclease digestion and then mapped by 
hybridizing them onto a novel tiling path array for the MHC. The suitability of this 
array platform to study DNA-protein interactions was verified using hybridisations of 
CIITA-enriched DNA and DNA enriched in H3-K9/K14 acetylation.  
 
The findings reveal that MARs are unevenly distributed across the MHC, and that they 
can be classified into three classes: constitutive, cell type specific and transcription-
dependent. These sequences are mainly positioned in intergenic regions and in close 
proximity to the MHC class boundaries, subdividing the locus into physical domains. 
By comparing the position of MARs in uninduced fibroblasts, IFN-γ induced 
fibroblasts and B lymphoblastoid cells, transcriptional activation of the MHC was found 
to be associated with a reconfiguration of chromatin architecture resulting from the 
formation of additional genomic anchors. These results suggest that the dynamic 
tethering of chromatin is linked to transcriptional regulation. 
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1 Introduction 
 
A newly formed international consortium has recently announced the ‘1000 Genomes 
Project’, an ambitious effort which involves the sequencing of at least a thousand 
people from around the world. Although there is no doubt that sequencing projects have 
been and will continue to be critical for our understanding of genome function, the 
linear sequence of nucleotide bases does not provide the complete description of the 
genome as genetic information exists in a dynamic and three-dimensional complex of 
DNA with proteins. A central question in biology is how the genetic information is 
packaged into the nucleus so that it can be accessed by nuclear regulatory machineries 
during cellular differentiation and responses to environmental stimuli. Through 
hierarchical levels of folding, DNA molecules are packaged with specific proteins into 
chromosomes, which are compartmentalised into discrete domains called chromosome 
territories. The degree of chromatin condensation and the attachment of DNA to the 
nuclear periphery have been shown to contribute to chromosome architecture. Three-
dimensional chromosomal structure is also driven by other properties including the 
affinity of chromatin for nuclear components such as nucleoli and splicing speckles. 
However, the determinants of chromatin organisation are still largely unknown. The 
aim of my thesis is to improve our understanding of the relationship between chromatin 
architecture and gene expression in a model genomic region, the human Major 
Histocompatibility Complex (MHC). 
 
1.1 The complex architecture of the human genome 
 
A typical nucleus of a human cell is about 5 µm in diameter and contains approximately 
2 metres of DNA. This tight packaging is achieved through a complex series of folding 
levels. 
 
1.1.1 DNA organisation in chromosomes 
 
The DNA of the human genome contains approximately 3.2x109 nucleotides distributed 
over 24 chromosomes (Makalowski, 2001). With the exception of germ-line cells and 
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specialised cell types lacking DNA, such as red blood cells, each human cell contains 
46 chromosomes, of which 22 pairs are autosomes and 1 pair are sex chromosomes. 
 
Each chromosome is characterised by a centromere and two telomeres. The centromere 
divides the chromosome into the short and long arms designated as p-arm and q-arm, 
respectively. By interacting with spindle microtubules, the centromere ensures correct 
segregation during mitosis and meiosis. The telomeres are located at the termini of each 
chromosome and protect chromosomes from progressive shortening after each mitotic 
cycle.  
 
The chromosomes of the human genome differ significantly with respect to size. 
Chromosome 1 is the largest of the human chromosomes and is approximately six times 
longer than chromosome 21, 22 and Y, which are the three smallest human 
chromosomes (Gregory et al., 2006). The shape of each chromosome, which depends on 
the position of its centromere, is also variable. 
 
The structure of human chromosomes undergoes major changes during the cell cycle. 
At G1-phase, each chromosome is relatively decondensed and is not visible under the 
light microscope. During S-phase, the DNA molecules are replicated. At G2-phase, 
each chromosome consists of two sister chromatids attached at the centromere. As the 
cell progresses into M-phase, the DNA molecules become more highly condensed and 
form mitotic chromosomes, which are readily visible under the light microscope. Upon 
completion of mitosis and segregation of the chromatids to each daughter nucleus, each 
chromosome is progressively decondensed. 
 
By applying specific chemical treatments, each metaphase chromosome can be 
characterised by a unique band pattern. One of the most common treatments for 
visualising chromosome bands involves the use of trypsin and the Giemsa dye, which 
stains bands with different regional genomic features. Giemsa-dark bands (G-bands) are 
associated with relatively low GC content and gene density, they replicate late in the 
cell cycle and are often highly condensed during both interphase and metaphase 
(Niimura and Gojobori, 2002). In contrast, Giemsa-light bands (R-bands) are associated 
with relative high GC content and gene density, they replicate early in the cell cycle and 
are less condensed than Giemsa-dark bands (Niimura and Gojobori, 2002). This finding 
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has revolutionised the identification of chromosomes and the detection of abnormalities 
that characterise genetic diseases. 
 
1.1.2 Nucleosomal DNA 
 
Within the nucleus, the DNA double helix does not exist as a naked molecule, but rather 
as a complex with histone (H) and non-histone proteins to form chromatin, which is the 
substrate of enzymatic machineries involved in critical nuclear processes including 
DNA replication, transcription and repair. The basic unit of chromatin is the 
nucleosome, which is formed by DNA wrapped around a disc-shaped structure 
consisting of highly conserved histone proteins. The individual nucleosome core 
particle (NCP) consists of an octameric histone structure comprising two copies each of 
the core nucleosomal histones H2A, H2B, H3 and H4 and 146 nucleotide pairs of 
double-stranded DNA, which forms 1.7 turns of a left-handed coil (Ramakrishnan, 
1997). Nucleosomes are separated by linker DNA of length ranging from a few 
nucleotide pairs to up to about 80, and can be visualised under the electron microscope 
as ‘beads on a string’ structures, which are about 11 nm wide (Khorasanizadeh, 2004; 
Luger et al., 1997).  
 
The nucleosomal fibre becomes condensed into a 30 nm wide fibre to further compact 
the DNA. This structure consists of several nucleosomes tightly linked together by the 
non-nucleosomal H1 histone, a polypeptide characterised by a globular domain that 
interacts with linker DNA (Ramakrishnan, 1997). The two major models that have been 
proposed to describe the 30 nm fibre are the solenoid and the zigzag models (Fig 1.1). 
According to the solenoid model, consecutive nucleosomes are arranged into a simple 
one-start helix (Finch and Klug, 1976). In the alternative model, the packing of 
nucleosomes creates a double helical structure (a two-start helix), which twists to 
produce a zigzag pattern (Bednar et al., 1998). 
 
Higher organisms have genes encoding histone variants that contribute to distinct 
nucleosomal architectures and confer unique functions to nucleosomes (Brown, 2001). 
For example the centromere protein A (CENPA), an H3 histone variant, is required for 
the assembly of centromeric nucleosomes and might function as a centromere mark for 
kinetochore assembly (Brown, 2001; Howman et al., 2000). While expression of 
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histone proteins takes place predominantly during S-phase, the synthesis of histone 
variants occurs throughout the different phases of the cell cycle (Khorasanizadeh, 
2004). 
 
Histones and histone variants are characterised by N-terminal and C-terminal tails 
which extend out from the DNA histone core (Khorasanizadeh, 2004; Ramakrishnan, 
1997). These tails are subject to covalent modifications (discussed below), which 
regulate different aspects of genomic structure and function. 
 
 
 
 
 
Figure 1.1 Models of the 30 nm chromatin fibre.  
(Left) In the solenoid model, the consecutive arrangement of nucleosomes forms an 
interdigitated one-start helix. Alternative helical gyres are coloured blue and magenta. 
The linker DNA has not been modelled. (Right) In the zigzag model, the alternating 
pattern of adjacent nucleosomes generates a two-start helix. Alternative gyres are 
coloured blue and orange (Tremethick, 2007). 
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1.1.3 Histone modifications 
 
Histone residues are subject to different covalent modifications. So far, 8 types of 
modifications have been identified on over 60 histone residues, acetylation, 
methylation, phosphorylation, ubiquitylation, sumoylation, ADP ribosylation, 
deimination and proline isomerisation (Kouzarides, 2007). Individual histone 
modifications and their combinations can change the structure of each nucleosome in 
many different ways and have the potential to fine-tune mechanisms regulating genomic 
function.  
 
Histone modifications are catalysed by chromatin remodelling enzymes and can both 
alter chromatin architecture and recruit specific proteins (Kurdistani and Grunstein, 
2003). Genome-wide studies have suggested that these modifications are not evenly 
distributed across the genome (Kurdistani et al., 2004; Quina et al., 2006). Furthermore, 
they can dynamically appear and disappear on the nucleosomes depending on the 
presence or absence of environmental stimuli at the cell surface (Li et al., 2007; Quina 
et al., 2006). The role of the different modifications is being unveiled by examining 
their associations with different nuclear processes (Kouzarides, 2007). The most 
common histone modifications, acetylation, methylation and phosphorylation, which 
are also the most well characterised, are discussed below. The target residues of each 
modification type and their relative functions are summarised in Table 1.1. 
 
Histone acetylation is believed to facilitate transcription since it is frequently associated 
with promoters and coding regions of transcriptionally active genes (Grunstein, 1997; 
Kurdistani et al., 2004). Acetylation of specific residues on newly synthesised histones 
at S-phase persists throughout G2-phase if the DNA is damaged, but disappears if the 
DNA is undamaged, suggesting that this modification could be involved in DNA repair 
(Celic et al., 2006; Maas et al., 2006). There is also evidence showing that histone 
acetylation is required for S-phase initiation and chromatin decondensation (Aggarwal 
and Calvi, 2004; Iizuka et al., 2006; Shogren-Knaak et al., 2006). 
 
Histone methylation can either activate or repress transcription depending on which 
histone residue is modified. Specific methylated residues at the 5’ end and 3’ ends of 
active genes recruit the initiating and the elongating form of RNA polymerase (Pol) II, 
respectively, and correlate with transcriptional activation (Kouzarides, 2007). 
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Conversely, other methylated residues are associated with the formation of silent 
heterochromatin and the repression of euchromatic genes (Kouzarides, 2007). Recent 
evidence suggests that histone methylation may recruit the cell cycle protein Crb2 to 
sites of DNA damage and trigger the arrest of the cell cycle at G2-/M-phase to allow 
DNA repair (Botuyan et al., 2006). 
 
Histone phosphorylation has been linked to transcriptional activation of specific genes, 
including FOS and JUN (Clayton et al., 2000; Zippo et al., 2007). In addition, histone 
phosphorylation contributes to the recognition of sites where DNA repair needs to take 
place, by marking long stretches of nucleotides around sites of DNA damage 
(Fillingham et al., 2006). Phosphorylation of specific histone residues facilitates the 
removal of H1, indicating that this histone modification might also play a role in the 
accessibility of chromatin (Fischle et al., 2005). 
 
 
 
Chromatin Modification Residue(s) Modified Functions Regulated 
Acetylation Lysine Transcription, Repair, 
Replication, Condensation 
Methylation Lysine, Arginine Transcription, Repair 
Phosphorylation Serine, Threonine Transcription, Repair, 
Condensation 
Ubiquitylation Lysine Transcription, Repair 
Sumoylation Lysine Transcription 
ADP ribosylation Glutamic acid Transcription 
Deimination Arginine Transcription 
Proline Isomerisation Proline Transcription 
 
Table 1.1 Different types of histone modifications. 
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1.1.4 Histone-modifying enzymes 
 
Histone acetylation is catalysed by histone acetyltransferases (HATs), which transfer an 
acetyl group from Acetyl CoA to histone lysine residues. HATs are grouped into three 
main families: GNATs, p300/CBP and MYST depending on their histone lysine 
specificities (Lee and Workman, 2007). HATs frequently exist in multiprotein 
complexes and are able to regulate other histone modifications (Baker and Grant, 2007; 
Lee and Workman, 2007). This can be seen from acetylation of lysine residues, 
preventing their modification by other histone modifying enzymes and vice versa 
(Yamada et al., 2005; Yang and Seto, 2007). HATs can also affect modifications of 
neighboring residues (Ahn et al., 2006; Li et al., 2006). 
 
Histone methyltransferases (HMTs) catalyse histone methylation by transferring one to 
three methyl groups from the cofactor S-adenosyl methionine to lysine or arginine 
residues. They are divided into histone arginine methyltransferases (HRMTs) and 
histone lysine methyltransferases (HKMTs) (Berger and Gaudin, 2003; Kouzarides, 
2007). Specific HMTs can interact with HATs to synergistically augment transcription 
as well as recruit DNA methyltransferase (DNMT) to promote DNA methylation 
(Zhang and Reinberg, 2001). One of the best-characterised HMTs is arginine 
methyltransferase 1 (PRMT1), which is associated with transcriptional activation (Lin 
et al., 1996; Tang et al., 2000; Wang et al., 2001). 
 
Studies with specific MAP kinase inhibitors show that histone phosphorylation is 
mediated by distinct signalling pathways such as the ERK or p38 MAP kinase pathways 
(Kouzarides, 2007; Soloaga et al., 2003). Downstream kinases, including the mitogen-
stress-induced kinases (MSKs), but not the MAP kinases themselves, catalyse the 
addition of a phosphate group to histone residues (Soloaga et al., 2003). By modifying 
histones, MSKs promote transcription and regulate spindle function during mitosis and 
meiosis. The mechanism with which histone modifying kinases catalyse other 
modifications remains to be established (Nowak and Corces, 2004). 
 
The paucity of isolated and characterised enzymes catalysing histone modifications has 
limited our understanding of how they regulate chromatin function and structure. 
(Kouzarides, 2007). While there is evidence linking these enzymes with transcription, 
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replication and DNA repair processes, the molecular mechanisms underlying such 
associations remain unclear. 
 
Most covalent modifications of histone tails are reversible and a number of enzymes 
removing those modifications have been identified (Cheung et al., 2000; Kouzarides, 
2007). Histone deacetylases (HDACs), which can catalyse the cleavage of acetyl groups 
from histone residues, are the best-characterised (Yang and Seto, 2007). Histone 
modifications are thus governed by the interaction between enzymes adding and 
removing functional groups from histone residues, enabling cells to alter the structural 
and functional properties of the genome in response to changing environmental signals. 
 
1.1.5 Heterochromatin and euchromatin 
 
Early microscopic observations revealed two types of chromatin, heterochromatin and 
euchromatin. Heterochromatin was defined as chromatin remaining highly condensed as 
the cell makes the transition from metaphase to interphase, and euchromatin as 
chromatin with a more ‘open’ conformation. Each of these two chromatin states is 
characterised by distinctive biochemical features, most importantly histone 
modifications, which alter the level of chromatin packaging and convert 
heterochromatin into euchromatin and vice versa (Jacobs et al., 2001; Meneghini et al., 
2003; Richards and Elgin, 2002; Schneider and Grosschedl, 2007). 
 
Heterochromatin contains transcriptionally silent DNA and euchromatin contains 
actively transcribing DNA sequences (Schneider and Grosschedl, 2007). While 
heterochromatin is associated with the NCPs, euchromatin is characterised by 
nucleosome-free DNase hypersensitive sites (HSs) (Grewal and Elgin, 2002; Sun et al., 
2001). Typically, if an active gene from a euchromatic region is relocated to a 
heterochromatic domain via chromosome rearrangement or transposition, it is usually 
silenced (Richards and Elgin, 2002). These observations gave rise to the hypothesis that 
highly packaged chromatin would prevent access of DNA to regulatory factors and 
would thus function as a physical barrier for transcriptional activation (Dillon and 
Festenstein, 2002; Misteli, 2007). 
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The view of chromatin folding as a regulator of accessibility has been challenged by 
Gilbert et al. (2004) on the basis that chromatin fibres with a more ‘open’ structure were 
associated with gene-rich regions while more decondensed chromatin fibres were 
associated with gene-poor regions (Gilbert et al., 2004). Surprisingly, their analysis also 
indicated that an ‘open’ chromatin conformation did not correlate with high levels of 
gene expression and that a ‘closed’ conformation could contain active genes. Taken 
together, these findings suggest a relationship between chromatin architecture and gene 
density rather than between chromatin architecture and gene activity. Furthermore, 
Gilbert’s findings were in agreement with studies showing that dextrans and proteins 
with molecular weights of several hundred kilodaltons were able to freely diffuse 
throughout heterochromatic as well as euchromatic domains within the nucleus (Cremer 
and Cremer, 2001; Lukacs et al., 2000; Verschure et al., 2003). From these 
observations, it can be concluded that chromatin condensation does not constitute an 
insurmountable barrier for transcriptional activation (Misteli, 2007). 
 
1.1.6 Models of higher-order chromatin structure 
 
The higher-order three-dimensional architecture of chromatin structure, which includes 
the different levels of DNA organisation beyond the 30 nm chromatin fibre up to 
metaphase chromosomes, is still poorly described. Although numerous models 
describing higher-order chromatin architecture in both interphase and metaphase nuclei 
have been put forward, there is still no conclusive evidence for any of them. 
 
Two key models of interphase higher-order chromatin structure are the random-
walk/giant-loop (RW/GL) and the multi-loop sub-compartment (MLS) models (Fig 1.2) 
(Munkel et al., 1999; Sachs et al., 1995). Both of these models interpreted data obtained 
by employing fluorescence in vitro hybridisation (FISH) to visualise distinct chromatin 
sites and analyse their physical distance as a function of genomic distance. In the 
RW/GL model, chromatin loops averaging about 3 Mb are associated at their bases to a 
protein scaffold that extends throughout the nuclear interior. According to this model, 
the giant loops and the protein scaffold are described as random walks. In the MLS 
model, the 30 nm chromatin fibre is folded into loop domains of approximately 100 kb. 
About ten of these loops are spatially arranged in a rosette-like structure forming a sub-
compartment of approximately 1 Mb. At the centre of each rosette, the bases of the 
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loops are held together by a ‘loop base spring’, which simulates the anchoring function 
of the nuclear scaffold postulated by the RW/GL model. Multiple consecutive rosettes 
are interconnected by stretches of 30 nm chromatin fibre and are backfolded to form 
interphase chromosomes. The MLS model is compatible with studies on DNA 
replication showing that 1 Mb chromatin domains are visible throughout subsequent 
cell cycles. 
 
A third model, the chromonema model, was proposed by Belmont et al. (1994) 
following a study using both light and electron microscopy (EM). Here, the 30 nm 
chromatin fibre is folded onto itself to form supercoiled, highly condensed structures 
called chromonema fibres (Fig 1.2) (Belmont and Bruce, 1994). The observed diameters 
of chromonema fibres are predominantly 60-80 nm in late G1- and early S-phase and 
100-130 nm in early G1-phase. Interphase nuclei also have local segments of more 
highly compacted chromatin measuring 200-400 nm in diameter, as well as more local 
decondensed chromatin corresponding to more loosely folded chromonema fibres and 
extended 30 nm chromatin fibres. The folding of the 30 nm chromatin fibre is proposed 
to be mediated by proteins of a nuclear scaffolding or non-specific inter-fibre 
interactions at multiple sites and not necessarily at the bases of the loops. 
 
An earlier model, the radial loop model was proposed for mitotic chromosome 
architecture based on the visualisation of EM micrographs of thin sections containing 
swollen metaphase chromosomes isolated using different ionic conditions (Marsden and 
Laemmli, 1979; Paulson and Laemmli, 1977). Here, highly condensed chromatin loops 
are arranged in a radial fashion with their bases anchored to a central axis extending 
along most of the length of the chromatid. Recent studies have indicated that the 
metaphase chromosome axis is constituted of structural proteins which are physically 
disconnected from one another to form a discontinuous network (Kireeva et al., 2004; 
Marko, 2008). However, the validity of the radial loop model has been questioned by 
concerns that the structure of mitotic chromosomes visualised using non-physiological 
ionic conditions might not reflect their true structure in vivo. 
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Figure 1.2 Models of higher-order chromatin architecture in interphase cells.  
A) The random-walk/giant-loop model proposes that 3 Mb loops are attached to a non-
DNA scaffold. B) The multiloop sub-compartment model proposes a structure of 
multiple rosettes containing loops of approximately 100 kb each. C) The chromonema 
model proposes hierarchical levels of chromatin folding back on itself to form fibres 
with diameters of 60-80 and 100-130 nm, depending on the compaction. 
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1.1.7 Organisation of chromosomes in the nucleus 
 
It was long assumed that, when cells are not dividing, chromatin exists as long thin 
tangled threads randomly arranged within the nucleus. Now there is solid evidence that 
interphase chromosomes display a high degree of organisation (Bolzer et al., 2005; 
Branco and Pombo, 2007; Cremer and Cremer, 2006; Cremer et al., 2004; Spector, 
2003). Groundbreaking experiments by Cremer et al. (1982) using UV microirradiation 
on defined areas of interphase nuclei in living cells revealed that only a small number of 
chromosomes were damaged. This indicated that the genome is compartmentalised 
during interphase (Cremer et al., 1982). The subsequent development of FISH using 
probes specific for entire chromosomes allowed the visualisation of interphase 
chromosomes in situ and demonstrated that each chromosome occupies a distinct 
physical domain within the nucleus called a chromosome territory (CT) (Fig 1.3) 
(Bolzer et al., 2005; Cremer and Cremer, 2006). 
 
Microscopic analysis has provided evidence that CTs are not solid structures but rather 
are porous entities with invaginations of non-chromatin spaces extending from their 
peripheries throughout their interiors (Cremer and Cremer, 2001; Misteli, 2005; 
Verschure et al., 1999; Visser et al., 2000). These spaces might facilitate access of 
regulatory protein complexes to DNA sequences located within the interior of the CT. 
Visualisation of chromatin with H2B tagged with green fluorescent protein (GFP) has 
enabled the identification of interchromatin channels, now called the interchromatin 
compartment (IC) or interchromatin domain (ICD), starting from nuclear pores, 
expanding between CTs and into their interior (Cremer and Cremer, 2001; Kanda et al., 
1998). 
 
The positioning of CTs is cell type specific. In several human cell types including 
lymphocytes and lymphoblastoid cell lines, gene-rich chromosomes are situated in the 
nuclear interior and gene-poor chromosomes in the periphery of the nucleus (Boyle et 
al., 2001; Cremer et al., 2001; Croft et al., 1999). Gene-dense regions are typically 
transcriptionally active and replicate early. However, it is still not clear whether in these 
cell types CT position is shaped by either gene density per se, replication timing, 
transcriptional activity or different combinations of these related parameters (Cremer 
and Cremer, 2006). In contrast, chromosome size appears to be the major determinant 
of CT positioning in human fibroblasts since, independent of gene density, larger 
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chromosomes are preferentially located towards the nuclear periphery and smaller 
chromosomes towards the nuclear interior (Bolzer et al., 2005). 
 
Branco and Pombo (2006) developed a novel FISH procedure (cryo-FISH), which 
provides high-resolution images of chromosomes while preserving chromosomal 
architecture (Branco and Pombo, 2006). The findings revealed that CTs are not entirely 
physically separated by the IC as they show extensive levels of intermingling mostly at 
their boundaries. From these data, it was estimated that approximately 20% of the 
nuclear volume is occupied by intermingling chromosomes. Furthermore, it was shown 
that in human lymphocytes, the degree of intermingling between specific chromosome 
pairs is positively correlated with the frequency of chromosomal translocations in the 
same cell type (Branco and Pombo, 2006; Branco and Pombo, 2007). CT intermingling 
might thus facilitate interchromosomal interactions and have a direct impact on the 
formation of chromosomal aberrations. 
 
 
 
 
 
Figure 1.3 Organisation of chromosomes in a human fibroblast nucleus at 
interphase. 
The chromosomes occupy discrete domains called chromosomal territories, which are 
represented here by different colours (Bolzer et al., 2005). 
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1.1.8 The nuclear position of genes  
 
The architecture of the nucleus is highly complex since it comprises a nuclear envelope, 
distinct higher-order chromatin domains such as heterochromatin and euchromatin, and 
various proteinaceous structures including the nucleolus and small nuclear bodies. As 
the position of genes relative to these different nuclear landmarks as well as to each 
other is non-random, it is essential to understand how the spatial organisation of genes 
affects their function (Misteli, 2005; Parada et al., 2004; Wang et al., 2004).  
 
One of the difficulties in designing experiments to understand nuclear organisation is 
that there are currently few options for defining a nuclear address. One approach is to 
determine the radial distance of the gene from the geometrical centre of the nucleus 
(Lukasova et al., 1997). Another method is to determine the position of the gene within 
one of the concentric ‘shells’ of the nucleus of equal radius or volume (Murmann et al., 
2005). A novel approach was taken by Wang et al. (2004) who determined the 
proximity of genes to promyelocytic leukaemia (PML) nuclear bodies (Wang et al., 
2004). 
 
The nuclear periphery contains significant amounts of heterochromatin, and therefore it 
is traditionally regarded as a transcriptionally repressive environment (Misteli, 2004). 
The repositioning of the murine IgH and Igκ loci from the nuclear periphery to the 
nuclear interior following their activation during lymphocyte development supports this 
view (Kosak et al., 2002). However, recent observations suggest that the role of the 
nuclear periphery is more complex than originally thought. Experimental positioning of 
human chromosomes to the nuclear periphery by tethering them to a protein of the inner 
nuclear membrane was shown to have a silencing effect on many, but not all active 
genes (Finlan et al., 2008). Furthermore, in budding yeast boundary activities that 
protect the expression status of active genes, are achieved by binding of active 
chromatin to nuclear pore complexes (NPCs) (Ishii et al., 2002). Thus, the nuclear 
periphery is not simply a transcriptionally repressive zone but a heterogeneous nuclear 
microenvironment regulating gene activation and repression. 
 
The proximity of loci to particular nuclear structures is also of functional significance. 
Actively transcribed genes frequently colocalise with nuclear structures called 
interchromatin granule clusters (IGCs), which contain splicing components such as 
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small nuclear ribonucleoprotein particle (snRNP) and SR proteins (Lamond and 
Spector, 2003). This has led to the idea that the localisation of active genes near ICGs 
facilitates transcription by providing relatively high concentrations of splicing 
components (Kosak and Groudine, 2004). Similarly, the frequent association of a subset 
of active genes with Cajal bodies, which contain snRNPs, has suggested that this 
colocalisation is linked to mRNA processing (Gall, 2000; Ogg and Lamond, 2002).  
 
The formation of spatial gene clusters indicates that certain gene loci are non-randomly 
positioned relative to each other. In a typical mammalian nucleus, 50-100 ribosomal 
genes located on 2-4 different chromosomes coalesce in the nucleolus where they are 
brought into physical proximity (Olson et al., 2000). A similar phenomenon was 
observed for tRNA genes in Saccharomyces cerevisiae where over 50 genes from 16 
chromosomes are clustered near the nucleolus (Thompson et al., 2003). Studies in 
erythroid cells showed that certain co-ordinately regulated genes are relocated at shared 
sites of ongoing transcription upon activation (Osborne et al., 2004). Although these 
associations could have a regulatory function, it remains to be established whether they 
are a general feature for other co-regulated genes. The extent to which the physical 
proximity of particular genes facilitates co-ordinate regulation remains to be 
established. 
 
In addition to playing a role in gene expression, non-random gene positioning may be 
involved in the formation of chromosomal abnormalities such as chromosomal 
translocations (Misteli, 2005). There are strong indications that the positions of genes 
relative to each other determine their probability of undergoing translocations. The loci 
involved in translocations in promyelocytic leukaemia, acute myelocytic leukaemia, 
Burkitt’s lymphoma and thyroid lymphoma are observed in closer spatial proximities 
than non-translocating regions in the corresponding normal cells (Misteli, 2004; Neves 
et al., 1999; Parada et al., 2004; Roix et al., 2003). These findings are also supported by 
studies in human lymphocytes showing that the degree of chromosomal intermingling 
between certain chromosomes correlates with the frequencies of chromosomal 
translocations (Branco and Pombo, 2006).  
 
Studies carried out so far have investigated the nuclear positions of relatively small 
genomic regions in a limited number of cell types. The use of high-throughput imaging 
methods and pattern recognition tools are likely to overcome this limitation and extend 
 30 
our understanding of the relationship between gene positioning and function (Misteli, 
2004). 
 
1.1.9 Chromatin loop structures 
 
Higher-order chromatin architecture is derived from hierarchical loop configurations, 
which are thought to be of fundamental importance for the regulation of gene 
expression. Within a eukaryotic cell, the size of these chromatin loops is reported to 
vary extensively. Local chromatin loops arise from short-range chromatin interactions 
and can be analysed using biochemical approaches, such as the chromosome 
conformation capture (3C). Giant chromatin loops can be identified by FISH. 
 
In order to understand the function of chromatin loop domains, it is critical to know 
how they are formed and determine whether they are either static or dynamic. The 
development of the 3C technique has provided significant insights into the role of local 
chromatin loops. This assay involves formaldehyde fixation of cells followed by 
restriction enzyme digestion, ligation and polymerase chain reaction (PCR) analysis to 
quantify the frequency of ligated DNA products (Cullen et al., 1993; Dekker et al., 
2002). As two restriction fragments in close physical proximity will have a higher 
ligation frequency than two other restriction fragments located further apart from one 
another, the in vivo 3-D organisation of chromatin can be examined. 
 
These studies have identified interactions of locus control regions (LCRs) or enhancers 
with their relative promoters and genes to promote gene expression. A classical 
example is found at the murine β-globin locus where the promoter and the LCR, which 
is located several kb upstream, are brought into physical proximity by a local 
rearrangement of the chromatin at the onset of transcriptional activation (Apostolou and 
Thanos, 2008; Vakoc et al., 2005). The tethering of the loop at its base requires the 
recruitment of haematopoietic transcription factor GATA1 and its co-factor FOG1, 
indicating that expression of the locus is associated with loop formation (Vakoc et al., 
2005). 
 
Local loops are also formed by the transcription-dependent interaction between 
promoter and terminator regions of individual genes. Activation of several loci in 
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Saccharomyces cerevisiae and in humans, is dependent on the folding back of genes 
onto themselves to juxtapose their 5’ and 3’ end sequences (Ansari and Hampsey, 2005; 
O'Sullivan et al., 2004). Physical interactions have also been observed between the 3’ 
end processing complexes and transcription initiation factors (Bentley, 2005; Misteli, 
2007). These loops facilitate a single RNA Pol II molecule re-initiating transcription, 
which would not be possible with a linear configuration since de novo recruitment of 
RNA Pol II molecules would be required for consecutive rounds of transcription 
(Ansari and Hampsey, 2005). 
 
The physical interaction between insulator DNA sequences which shield genes from 
stimulatory and repressive effects arising from flanking regions, can also produce local 
loop structures. In Drosophila melanogaster, for instance, the insulators scs and scs’ 
which are located about 15 kb apart from each other are brought into close proximity by 
the interaction between scs and scs’ insulator proteins, Zw5 and BEAF, respectively 
(Blanton et al., 2003). The topological constraints of the loops are thought to establish 
chromatin domains characterised by unique properties. In Schizosaccharomyces pombe, 
the tethering of insulators with the transcription factor TFIIC at the nuclear periphery 
mediates the formation of loops containing active sequences which protrude into the 
nuclear interior (Noma et al., 2006). Here, the loops appear to function as physical 
barriers separating active euchromatic domains from repressive heterochromatic 
regions. 
 
Giant chromatin loops have been observed at certain genomic regions with high gene 
density. This phenomenon was first discovered for the 4 Mb major histocompatibility 
complex (MHC), which was shown to escape from the borders of the FISH-painted 
chromosome 6 domain by forming a giant chromatin loop extruding typically about 1 or 
2 µm into the surrounding nucleoplasm (Volpi et al., 2000). Upon transcriptional up-
regulation of the MHC, the frequency with which the MHC was located on a giant loop 
increased (Christova et al., 2007; Volpi et al., 2000). Similar higher-order chromatin 
configurations were subsequently observed in co-ordinately regulated and other gene-
rich regions of the genome, such as the human epidermal differentiation complex and 
the mouse Hox gene clusters (Chambeyron and Bickmore, 2004; Sproul et al., 2005; 
Williams et al., 2002). Although the molecular basis underlying the formation of these 
loops and their functional significance are still not clear, it was recently found that the 
MHC loops represent regions of decondensed chromatin conformation which might 
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facilitate the binding of transcription factors and promote up-regulation of gene 
expression (Christova et al., 2007). 
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1.2 Matrix attachment regions 
 
It has long been hypothesised that the major determinants of chromosomal architecture 
are found in the fraction of the nucleus termed the nuclear matrix. These determinants 
are thought to interact with genomic sequences called matrix attachment regions 
(MARs), located at the bases of chromatin loops, thus organising the genome into loop 
domains. Although the nuclear matrix is almost certainly not a discrete entity, there is 
increasing evidence showing that its components are required to establish the three-
dimensional structure of chromosomes, organise the nucleus into different functional 
compartments and regulate fundamental nuclear processes including transcription and 
DNA replication. 
 
1.2.1 The nuclear matrix 
 
The nuclear matrix is the insoluble fraction that remains after the nucleus is treated with 
high-strength ionic buffers and nucleases to remove soluble proteins and chromatin. It 
was first observed approximately 40 years ago where it was described as a residual 
nuclear protein fraction (Wang, 1966). Although the terms ‘nuclear scaffold’ and 
‘nucleoskeleton’ are sometimes employed to describe this fraction, the term that is most 
widely used is nuclear matrix, which was coined by Berezney and Coffey in 1974 
(Berezney and Coffey, 1974). 
 
Electron micrographs of the nuclear matrix indicate that it has a fibrogranular 
organisation extending from the nuclear envelope throughout the nuclear volume (Fig 
1.4) (Jackson, 2003; Nickerson, 2001). This structure has been identified in different 
eukaryotes ranging from yeasts to mammals. It is composed of hundreds of different 
proteins and RNA and can be divided into two main regions: the nuclear lamina and the 
internal nuclear matrix that is connected to the lamina and fills the nuclear interior  
(Berezney and Coffey, 1977).  The internal nuclear matrix consists of an intricate 
ribonucleoprotein (RNP) network of highly branched 10 nm filaments, which are 
preserved through the matrix isolation procedure (Jackson, 2003). Structural remnants 
of nucleoli can be observed in this network. 
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The most common experimental procedures for isolating nuclear matrices are extraction 
with buffers containing 25 mM lithium di-iodosalicylic acid (LIS), 2 M NaCl or 0.65 M 
(NH2)2SO4 (Donev et al., 2002). The LIS and ammonium sulphate extraction conditions 
are relatively mild and more physiological compared to the 2 M NaCl procedure 
(Donev, 2000). However, these and other similar procedures generate underlying 
networks of core filaments with remarkably similar ultrastructural features (Nickerson, 
2001). 
 
Upon treatment with high-salt buffers, soluble proteins including histones are released 
from the nucleus causing the DNA to unfold and loop out far beyond the nuclear lamina 
(Vogelstein et al., 1980). These preparations can be observed under fluorescent light 
microscopy by staining with 4’,6-diamidino-2-phenylindole (DAPI), which fluoresces 
brightly when it forms complexes with the minor groove of double-stranded DNA. 
Multiple DNA loops, which can be seen as circular ‘halos’ around the nuclei, remain 
attached to the insoluble intranuclear structure suggesting that the core filaments of the 
nuclear matrix are bound to chromatin (Heng et al., 2004; Jackson, 2003). 
 
Whether the nuclear matrix is a continuous network of fibres is still under debate. GFP 
tagging of Drosophila nuclear matrix proteins CP60 and CP190 shows that they form 
filaments throughout the nucleus in vivo (Oegema et al., 1997). In mammalian cells, 
immunostaining of proteins that resist high-salt extraction has allowed the visualisation 
of networks of filaments at the nuclear periphery as well as ‘cage-like’ structures 
throughout the nucleus (Cai et al., 2003; Dechat et al., 2008). However, most of the 
characterised nuclear matrix proteins have not been demonstrated to form core filaments 
in living cells (Jackson et al., 2003; Pederson, 2000). 
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Figure 1.4 The nuclear matrix in a mammalian cell. 
This electron micrograph of a HeLa cell shows the nucleus demarcated by a dense 
nuclear lamina (L) and a heavily stained nucleolus (No).  Prior to this micrograph being 
taken, the cell was treated with nucleases to remove approximately 90% of its DNA.  
The nuclear matrix is seen here as an intricate network of filaments extending 
throughout the nucleus (Jackson et al., 2003). 
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1.2.2 Proteins of the nuclear matrix 
 
The composition of the nuclear matrix can vary depending on the cell type and 
organism. In matrices prepared from different human cell lines and tissues, 
approximately 200-300 proteins are seen on two-dimensional gels (Fey and Penman, 
1988; Gerner et al., 1998). Many matrix proteins are common to different cell types, 
including lamins, scaffold attachment factor A (SAFA), scaffold attachment factor B1 
(SAFB1), and topoisomerase II (Fey and Penman, 1988; Mattern et al., 1997; Stuurman 
et al., 1990). 
 
Lamins provide shape and stability to the nucleus and contribute to a wide range of 
nuclear functions. They are composed of a long α-helical rod flanked by globular N-
terminal and C-terminal domains, and have the capacity to self-assemble into higher-
order structures (Herrmann and Foisner, 2003; Stuurman et al., 1998). Lamins form 
type V intermediate filaments, which are the main constituents of the nuclear lamina, 
but they are also found in a diffused form throughout the nuclear interior (Dechat et al., 
2008; Goldman et al., 2002). Most insights into the function of lamins have been 
obtained by studying cells and organisms with mutated lamin genes. While there is firm 
evidence that lamins are important in the regulation of transcription, DNA replication 
and repair, their precise roles in these processes remain to be elucidated (Kennedy et al., 
2000; Liu et al., 2005; Moir et al., 1994; Spann et al., 2002). Cells with mutated lamins 
usually have irregularly shaped nuclei and abnormal positions of CTs. Furthermore, 
heterochromatin appears to be displaced from the nuclear periphery. Therefore, lamins 
are likely to maintain the integrity of nuclear architecture (Meaburn et al., 2007; Muchir 
et al., 2003; Nikolova et al., 2004; Sullivan et al., 1999). In humans, mutations in lamin 
genes cause a group of disorders called laminopathies, which include severe diseases 
such as Emery-Dreifuss muscular dystrophy, dilated cardiomyopathy, premature aging 
and progeroid syndromes (Bonne et al., 1999; Dechat et al., 2008; Worman and Bonne, 
2007). 
 
The nuclear matrix proteins SAFA and SAFB1 are associated with transcription. Both 
proteins contain the highly conserved SAF-box, a homodomain-like motif, which can 
interact with DNA sequences (Kipp et al., 2000; Oesterreich, 2003). Chromatin 
immunoprecitation experiments indicate that SAFA binds to DNA and recruits the 
transcriptional co-activator, p300 (Martens et al., 2002). This interaction is 
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accompanied by local histone acetylation, suggesting that SAFA might poise genes for 
transcription. By binding to DNA as well as the C-terminal of RNA Pol II and RNA 
processing factors, SAFB1 is thought to co-ordinate transcription by bringing these 
complexes into physical proximity (Nayler et al., 1998; Oesterreich, 2003; Weighardt et 
al., 1999). SAFB1 knockout mice show high pre-neonatal and neonatal lethality while 
their embryonic fibroblasts fail to undergo senescence and exhibit spontaneous 
immortalisation, highlighting the importance of this protein in development and cellular 
growth (Dobrzycka et al., 2006; Ivanova et al., 2005).  
 
Topoisomerases alter the topological status of DNA to ensure correct progression of 
transcription, DNA replication, recombination and condensation. Topoisomerase II is 
one of the abundant components of the nuclear matrix (Berrios et al., 1985). In 
metaphase cells, it is mainly concentrated along the longitudinal axis spanning the 
chromatid, while at interphase it is diffused throughout the nuclear interior (Earnshaw et 
al., 1985). By catalysing the decatenation of DNA by an ATP-dependent mechanism, 
which cleaves and rejoins single- or double-stranded DNA, topoisomerase II relieves 
the torsional stress due to DNA supercoiling (Martins and Krawetz, 2007; Wang, 2002). 
Althought the role of topoisomerase II in nuclear structure is still uncertain, its 
interaction with chromatin at the bases of chromatin loops may play an important role in 
maintaining the integrity of chromosome architecture (Adachi et al., 1989; Earnshaw et 
al., 1985).  
 
Other molecules identified in the nuclear matrix include components of the 
transcriptional machinery such as the phosphorylated form of RNA Pol II, HATs, 
HDACs, chromatin remodelling factors and numerous general transcription factors 
(Boulikas, 1995; Davie and Hendzel, 1994; Nayler et al., 1998; Patturajan et al., 1998; 
Reyes et al., 1997). The nuclear matrix also harbours molecules involved in mRNA 
processing including splicing factors and the ubiquitous heterogeneous nuclear 
ribonucleoproteins (hnRNPs), which are important in RNA biogenesis (Blencowe et al., 
1994; Gerner et al., 1998; Mattern et al., 1996; Nayler et al., 1998). Furthermore, active 
DNA polymerase, primer recognition proteins (PRPs) and a number of other critical 
proteins involved in DNA replication are retained in the nuclear matrix (Collins and 
Chu, 1987; Jackson and Cook, 1986; Vishwanatha et al., 1992). The nuclear matrix is 
thus associated with fundamental nuclear processes. 
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1.2.3 The function of the nuclear matrix 
 
The nuclear matrix has been hypothesised to determine the spatial arrangement of 
transcription and DNA replication by providing the structural framework for these 
processes (Berezney, 2002). Transcription and replication are highly compartmentalised 
in the nucleus (Fig 1.5). By incorporating bromo-UTPs to newly transcribed mRNA, 
Jackson et al. (1993) showed that RNA synthesis occurs at a few hundred foci termed 
transcription factories (Jackson et al., 1993). Subsequent studies showed that each 
factory was a transcription ‘hot spot’ containing transcription factors and several active 
forms of RNA Pol which are involved in transcription initiation and elongation (Cook, 
1999; Grande et al., 1997; Iborra et al., 1996; Pombo et al., 1999). Distinct 
transcriptional microenvironments are created in transcription factories that contain 
different sets of transcription factors and transcribe certain sets of genes (Xu and Cook, 
2008). This organisation is likely to ensure effective interactions between components 
of the transcription machinery (Misteli, 2007). Furthermore, sharing a transcription 
factory could facilitate the co-ordinate transcription of commonly regulated genes. 
 
There are several lines of evidence suggesting that transcription factories are attached to 
the nuclear matrix. Treatments of nuclei with hypertonic solutions show that as well as 
the main components of the transcriptional machinery, the nuclear matrix retains 
nascent RNA transcripts (Cook, 1999). As transcription factories are formed prior to 
transcription, they are likely to exist as independent sub-nuclear compartments 
(Osborne et al., 2007). Furthermore, the movement of molecules visualised during 
transcription reveals that upon activation, genes migrate to pre-existing relatively 
immobile transcription factories (Mitchell and Fraser, 2008). 
 
As found for transcription, DNA replication is clustered at discrete sites known as 
replication factories, which can be visualised by incorporation of dUTP into newly 
replicating DNA (Cook, 2002). These foci contain the entire replication machinery, 
multiple replication origins as well as factors involved in chromatin assembly (Cook, 
1999). 
 
The binding of replication factories to the nuclear matrix is more controversial than for 
transcription factories. The nuclear matrix contains nascent DNA fragments, DNA Pol 
and other factors involved in replication (Cook, 1999). Furthermore, replication sites 
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coincide with intranuclear lamin structures, and initiation of replication is impaired 
when lamins are disrupted (Kennedy et al., 2000). However, replication factories are not 
formed prior to replication and appear to be maintained by the process of active DNA 
replication, suggesting that they are not independent sub-nuclear compartments 
(Kitamura et al., 2006). 
 
A different view is that the global organisation of nuclear architecture, and therefore 
also of these essential nuclear processes, is not determined by the nuclear matrix but 
rather by the self-organising properties of the nuclear components (Misteli, 2005). In 
this model, the ongoing nuclear processes and the various affinities of chromatin for 
nuclear regulatory components are the major factors responsible for shaping the nuclear 
compartments (Cook, 2002; Misteli, 2001; Pombo and Branco, 2007). The global 
changes observed in nuclear architecture upon interference with transcription and 
replication support the self-organising nature of the nucleus (Lamond and Spector, 
2003). 
 
The major impediment in experimental testing of self-organising systems is the 
difficulty in separating structure from function. Computer simulations, which are based 
on a combination of data including the movement and the affinities of different nuclear 
components, are being developed to construct detailed models and make testable 
predictions (Misteli, 2007). The self-organising model does not exclude the existence of 
an underlying nuclear structure such as the nuclear matrix, as nuclear machineries can 
still be formed on a stable scaffold functioning as a landing platform (Gorski and 
Misteli, 2005; Misteli, 2007). 
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Figure 1.5 Distribution of transcription and replication factories throughout the 
nuclear interior.  
A) Transcription sites were visualised by extending nascent transcripts in the presence 
of bromo-UTPs. Newly made RNA (red) is concentrated in discrete foci, called 
transcription factories. B) Replication sites were visualised by growing cells in the 
presence of bromo-dUTPs. Newly synthesised DNA (green) is clustered at sites known 
as replication factories (Misteli, 2007). 
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1.2.4 The controversy of the nuclear matrix 
 
Despite evidence of an association between the nuclear matrix, nuclear architecture and 
different nuclear processes, the existence of a nuclear matrix as a separate nuclear entity 
remains controversial (Jackson, 2003; Pederson, 2000). Opponents of the nuclear matrix 
consider it to be an aggregation phenomenon generated by the preparative procedures, 
which can alter the structure of chromatin as well as the global nuclear environment. 
The removal of nucleic acids from the nucleus could disrupt DNA-protein interactions 
and allow the cationic sites of proteins previously bound to DNA to interact with other 
proteins (Pederson, 1998). Furthermore, different ionic conditions affect van der Waals’ 
forces which in turn influence interactions between proteins, and could lead to the 
formation of artifactual protein complexes (Pederson, 1998). 
 
On the other hand, the existence of a nuclear matrix is supported by the preservation of 
the functional domains of the nucleus such as splicing sites, PML bodies, CTs as well as 
replication and transcription factories within the nuclear matrix (Berezney, 2002). Since 
it is difficult to predict the changes caused by hypertonic buffers, methodologies have 
been developed to isolate the nuclear matrix in more physiological conditions (Jackson 
and Cook, 1986; Jackson et al., 1990; Mirkovitch et al., 1984). For example, cells can 
be encapsulated in agarose spheres and, after treating them with detergents and 
restriction enzymes, the chromatin and the soluble products is electro-eluted rather than 
removed with high-salt buffers (Jackson and Cook, 1986). Subsequent observations 
revealed that the ultrastructural features of these matrix preparations were similar to 
those obtained from extraction with high-salt buffers (Capco et al., 1982; Jackson and 
Cook, 1988). However a comprehensive analysis of the proteins constituting nuclear 
matrices isolated using different extraction methods is still lacking. 
 
Based on the findings that nuclear matrix proteins such as special AT-rich sequence 
binding protein 1 (SATB1) are able to form intranuclear networks in vivo, there is now 
a growing recognition of the nuclear matrix as a fraction containing functional 
components of the eukaryotic nucleus that are necessary for the organisation of 
chromatin domains and the maintenance of sub-nuclear compartments (Cai et al., 2003; 
Oegema et al., 1997). 
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1.2.5 Features of matrix attachment regions 
 
MARs, also described as genomic anchors, are short DNA sequences of approximately 
100-2000 bp that tether chromatin loops to the nuclear matrix (Bode et al., 2003; Frisch 
et al., 2002; Ottaviani et al., 2008b; Singh et al., 1997). The strong interaction of MARs 
with the insoluble proteins of the nuclear matrix protects these sequences from nuclease 
digestion and treatments with high-strength ionic buffers (Heng et al., 2004). 
Subsequent digestion with proteases and RNase A followed by DNA extraction 
protocols allows MARs to be isolated and characterised. 
 
MARs are ubiquitous features of eukaryotes since they organise the genome into 
hierarchical series of loop domains (Farache et al., 1990). The human genome has been 
estimated to contain between 30,000 and 80,000 MARs (Linnemann et al., 2007). So 
far, only a few hundred MAR sequences have been described. The best-characterised 
are those at the chicken lysozyme and α-globin, and the human β-globin and protamine 
loci (Farache et al., 1990; Girod et al., 2005; Martins and Krawetz, 2007; Ostermeier et 
al., 2003; Phi-van et al., 1998). 
 
Although a consensus sequence has not yet been identified, MARs are rich in AT and 
repetitive sequences, and map to regions where the DNA is intrinsically curved or 
kinked and has a propensity for base unpairing (Bode et al., 1992; Fiorini et al., 2006; 
Kohwi-Shigematsu and Kohwi, 1990; von Kries et al., 1990). They are associated with 
topoisomerase I and II binding and cleavage sites, replication origins, transcription 
factor binding sites, nucleosome-free stretches, and DNase I cleavage sites, one of the 
hallmarks of ‘open’ chromatin (Boulikas, 1993; Glazko et al., 2003; Singh et al., 1997). 
 
MARs are bound to the nuclear matrix either constitutively or transiently (Jackson et 
al., 1996; Kieffer et al., 2002; Liebich et al., 2002). Constitutive MARs are likely to 
maintain the higher-order chromatin structure of interphase and metaphase 
chromosomes (Glazko et al., 2003; Rollini et al., 1999). The transient, more dynamic 
associations are instead dependent on the transcription/replication status of the genomic 
domain, indicating a regulatory role (Heng et al., 2004). 
 
MARs are often referred to as a distinct class of cis-acting elements as there is strong 
evidence linking them with the spatial and temporal regulation of gene expression and 
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DNA replication as discussed below. Furthermore, by dynamically organising 
chromatin in three-dimensional space, these genomic anchors play a prominent role in 
cellular development and disease (Cai et al., 2006; Iarovaia et al., 2004; Petrov et al., 
2006). 
 
1.2.6 Matrix attachment regions and transcription 
 
The tethering of DNA to the nuclear matrix plays a vital role in transcription (Eivazova 
et al., 2007; Geyer, 1997; Heng et al., 2004). Using T cell differentiation as an example, 
the facilitation of transcription by MARs and their shaping of chromatin architecture to 
insulate chromatin domains from the effects of flanking chromatin will be described. 
 
Upon stimulation by antigen, naive CD4+ helper T cells differentiate into effector Th1 
and Th2 cells. In mice, Ifng (the gene for the cytokine IFN-γ) is silenced in naive T cells 
but transcribed in activated Th1 cells. The architecture of the Ifng locus has been 
analysed in these two cell types by a combination of 3C (see Section 1.1.9) and 
microarray technology (Eivazova et al., 2007). In naive T cells, Ifng was found to exist 
in a linear conformation, but in Th1 cells it is present in a chromatin loop, due to 
tethering of DNA to the nuclear matrix by MARs 7 kb upstream and 14 kb downstream 
of the locus. The absence of this selective DNA attachment to the nuclear matrix in 
naive T cells suggests that dynamic DNA anchors mediate the formation of the looped 
structure and the expression of the Ifng locus (Eivazova et al., 2007). 
 
The molecular mechanisms by which MARs reorganise higher-order chromatin 
structure have been investigated in detail at the mouse Th2 cytokine locus, which 
contains a cluster of co-ordinately regulated genes, Il4, Il13 and Il5, in a region of about 
120 kb (Loots et al., 2000). These genes are silent in naive T cells but expressed in Th2 
cells. Following activation of Th2 cells, expression of the nuclear matrix protein 
SATB1 is rapidly induced, and MARs within the locus mediate the formation of small 
loops by anchoring the loops onto a common protein core associated with SATB1 (Cai 
et al., 2006). Down-regulation of SATB1 expression by RNA interference prevents both 
the formation of this looped structure and transcriptional activation of the locus (Cai et 
al., 2006). In SATB1-null thymocytes the expression of many genes is spatially and 
temporally misregulated, and T cell development in SATB1-deficient mice is 
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prematurely blocked. These findings indicate that the binding of SATB1 at MARs 
regulates the expression of T cell differentiation genes by reorganising higher-order 
chromatin architecture (Alvarez et al., 2000; Cai et al., 2003). A similar MAR-mediated 
loop-formation mechanism regulates expression of the human β-globin gene cluster 
(Ostermeier et al., 2003; Wen et al., 2005). 
 
Cai et al. (2003) reported that, at MARs, SATB1 recruits chromatin remodelling 
enzymes, which are able to either activate or repress the expression of adjacent 
sequences (Cai et al., 2003). Other studies have shown that MARs interact dynamically 
with basal components of the transcription machinery and with splicing factors (Donev 
et al., 2002; Rajaiya et al., 2006). As MARs associate with components of transcription 
factories as well as the nuclear matrix, it is tempting to speculate that their dynamic 
interactions with the matrix bring together proximal and distal regulatory DNA 
sequences and localise them close to transcription factories, thus promoting efficient 
regulation of gene expression (Fig 1.6). 
 
Many genes are shielded by so-called 'insulator' elements from stimulatory or repressive 
transcriptional effects attributable to the chromatin state and regulatory elements in 
flanking regions. MARs commonly map to sequences flanking genes, and co-localise 
with some of the most extensively analysed insulator elements, including the gypsy 
retrotransposon in Drosophila melanogaster, suggesting that MARs have an insulator 
function (Nabirochkin et al., 1998). In Drosophila melanogaster, the nuclear matrix 
protein Su(Hw) binds to gypsy, creating chromatin loops (Byrd and Corces, 2003). 
Certain mutations in Su(Hw) that disrupt the loop structures render the insulator non-
functional (Byrd and Corces, 2003; Valenzuela and Kamakaka, 2006). This suggests 
that the tethering of MARs to the nuclear matrix topologically constrains the DNA into 
looped structures, protecting the intervening DNA from the influence of cis-regulatory 
elements outside the loop. In vertebrates, CTCF, a ubiquitous nuclear matrix protein 
that binds to insulators, has also been shown to interact with MARs (Yusufzai and 
Felsenfeld, 2004). Experiments in a wide variety of higher eukaryotes have shown that 
in stably transfected cells, MAR-containing transgenes were expressed at higher levels 
compared with transgenes lacking MARs, indicating that the MARs shield the 
transgenes from the effects of the neighbouring chromatin regions (Girod et al., 2007; 
Halweg et al., 2005). 
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Figure 1.6 A simplified model depicting the function of matrix attachment regions 
(MARs) in gene regulation. 
Activation of transcription is accompanied by the anchoring of MARs to the nuclear 
matrix. This results in the formation of an anchored chromatin loop that is insulated 
from the stimulatory or repressive effects of the flanking chromatin. The transcription 
machinery is assembled at the site of the MAR-nuclear matrix attachments. Interaction 
of MARs with the nuclear matrix brings together gene coding sequences, regulatory 
DNA elements and the transcription machinery, thus enabling specific genes to be co-
ordinately regulated. 
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1.2.7 Matrix attachment regions and replication 
 
To ensure that the genome is copied accurately, and only once per cell cycle, eukaryotes 
have evolved intricate mechanisms to regulate DNA replication. Some of the best-
characterised origins of replication (ORIs) have been mapped to AT-rich genomic 
regions with base-unpairing elements. Futhermore, sequences at or near the ORIs for 
the human lamin B2 gene, the chinese hamster dihydrofolate reductase-β and -β' genes, 
the human β-globin gene, the chicken α-globin and lysozyme genes, and the Xenopus 
and mouse c-myc genes, function as dynamic MARs during the cell cycle (Djeliova et 
al., 2001a; Djeliova et al., 2001b; Girard-Reydet et al., 2004; Lagarkova et al., 1998; 
Mesner et al., 2003; Phi-van et al., 1998; Razin et al., 1991). 
 
DNA replication is temporally and spatially ordered in the nucleus so that series of 
replicons are co-ordinately replicated at foci in the S-phase nucleus (Jackson and 
Pombo, 1998; Ma et al., 1998). Evidence that replication foci are associated with the 
nuclear matrix came first from EM (Hozak et al., 1993). Further support came from a 
study of nuclear matrix structures where DNA synthesis occurred at replication sites 
that were indistinguishable from those found in intact cells (Nakayasu and Berezney, 
1989). In another study, DNA replication was found to be initiated at discrete 
chromosomal sites attached to the nuclear matrix (Radichev et al., 2005). 
 
At replication foci, the nuclear matrix houses factors necessary for DNA replication, 
such as DNA Pol, the sliding clamp (PCNA) and single-strand binding protein (RPA), 
and provides structural support throughout the replication process. Wu and Gilbert 
(1996) proposed that origins are selected and replicon size determined in early G1-
phase of the cell cycle (Wu and Gilbert, 1996). Using an in vitro system, it was 
subsequently shown that MCM2, a component of the pre-replicative complex, is loaded 
onto chromatin gradually and cumulatively throughout G1-phase, but is rapidly 
excluded from active replication foci in S-phase (Dimitrova et al., 1999). Tatsumi et al. 
(2003) reported a similar cycle of events for ORC1, a component of the replication 
initiation complex at ORIs (Tatsumi et al., 2003). This coincides with the recruitment of 
the chromatin-bound ORC2-5 complex to a structure likely to be the nuclear matrix, 
suggesting a link between the accumulation of ORC1 and the assembly of the 
replication complex in human nuclei (Ohta et al., 2003). 
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These observations fit a model in which MARs stably anchor the replicon ends and, 
during G1-phase, small-scale sub-chromosomal chromatin refolding recruits ORIs to 
the nuclear matrix, where factors accumulate to form the pre-replicative complexes (Fig 
1.7). Subsequently, as ORIs begin to replicate in S-phase, certain protein factors 
dissociate from the chromatin and undergo proteolysis as part of a control mechanism to 
prevent re-replication, thus releasing the ORIs from the nuclear matrix. In the 
meantime, replication continues at the initial location as DNA is reeled through the 
replication machinery or replication factory (Hozak et al., 1993). At the ends of 
replicons, stable MARs could act as barriers to prevent the accumulation of supercoiled 
DNA structures, while providing binding sites for topoisomerase II to resolve 
replication intermediates. 
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Figure 1.7 DNA replication is organised at the nuclear matrix.  
(a) Replicons are defined in early G1-phase of the cell cycle by attachment of MARs to 
the nuclear matrix. (b) In late G1-phase, origins of replication (ORIs) are recruited to 
the nuclear matrix and replication factors assemble at these sites, licensing the 
chromatin for replication. (c) Once the appropriate mitogenic stimuli have been 
received, cells enter S-phase, at which ORIs become activated. Following initiation of 
replication at a particular locus, the two identical newly replicated ORIs probably 
dissociate from the nuclear matrix. Two loops of replicated DNA gradually emerge 
(shown in blue), while the yet-to-be replicated DNA of the replicon moves through the 
replication factory. (d) At the end of S-phase, the replication machinery is dismantled. 
Adapted from (Anachkova et al., 2005), (Ottaviani et al., 2008b). 
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1.2.8 Matrix attachment regions and disease 
 
Integration of retroviral DNA into the host genome is essential for viral replication. 
Although retroviral integration sites lack a consensus sequence, they are often AT-rich 
and have base unpairing and DNA-bending and unwinding elements (Rampalli et al., 
2003; Shera et al., 2001). DNA sequence analysis indicates that both DNA tumuor 
viruses and retroviruses integrate within or close to MARs (Fig 1.8) (Johnson and Levy, 
2005; Kulkarni et al., 2004). Furthermore, the efficiency of transcription of the 
retrovirus HIV-1 is determined by the proximity of its integration to MARs (Rampalli et 
al., 2003). As SATB1 binds to MARs flanking HIV-1 integration sites and silencing of 
SATB1 gene expression alters the pattern of integration sites, it has been suggested that 
retroviruses use MARs to form viral pre-integration complexes (Kumar et al., 2007b). 
 
MARs also appear to play a role in the development of some cancers. Chromosome 
rearrangements are hallmarks of certain malignancies and inherited genetic disorders. 
The breakpoints of recurrent translocations in leukaemia as well as deletions involving 
the breast-cancer susceptibility genes BRCA1 and BRCA2 occur at MARs, indicating 
that the bringing together of these sequences at the nuclear matrix facilitates their 
illegitimate recombination (Iarovaia et al., 2004; Welcsh and King, 2001). Patients who 
develop leukaemia following treatment of a primary tumour with inhibitors of 
topoisomerase II often have specific chromosome translocations in their cancer cells 
whose breakpoints contain MARs, emphasising the importance of the chromatin 
environment in the generation of chromosome aberrations (Strick et al., 2006). 
 
Fragile sites are hypervariable regions that generate genomic instability in tumours. 
Certain fragile sites contain long AT-rich minisatellites, called AT-islands, which 
function as MARs (Jackson et al., 2003). AT-islands are susceptible to considerable 
repeat expansion, which, in the fragile site FRA16B associated with leukaemia, appears 
to strengthen their attachment to the nuclear matrix (Jackson et al., 2003). The presence 
of abnormal transcripts of the tumour suppressor gene WWOX (which spans FRA16B) 
in the absence of detectable mutations or deletions may be caused by aberrant chromatin 
architecture due to enhanced MAR anchoring by expanded AT-islands (Woynarowski, 
2004). 
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The identification of AT-islands has led to the emergence of a new class of drugs that 
specifically alkylate them (Woynarowski, 2004). These drugs exhibit an extraordinary 
cytotoxicity, which is likely to be due to their disruption of replication and transcription, 
the two essential nuclear processes organised at MARs (Fig 1.9). One of these drugs, 
bizelesin, binds specifically to the minor groove of DNA at AT-rich regions and 
generates interstrand cross-links. It has high cytotoxic activity in vitro towards a broad 
spectrum of human cancer cell lines and, more importantly, high activity against various 
tumours engrafted in mice (Alley et al., 2004; Carter et al., 1996). While extensive 
development will be needed to make these compounds safe anti-cancer drugs for 
clinical use, their DNA sequence-specificity might offer a novel approach for targeting 
tumour cells containing expanded AT-repeat sequences. 
 
 
 
 
 
Figure 1.8 Schematic representation of viral genome integration.  
Tumour viruses and HIV-1 integrate near MARs attached to the nuclear matrix, where 
the transcription and DNA replication machinery is assembled. The viral genome is thus 
integrated near the machinery required for its transcription and replication. Adapted 
from (Shera et al., 2001), (Ottaviani et al., 2008b). 
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Figure 1.9 Proposed mechanism for the cytotoxic action of AT-specific drugs.  
The drugs bind to AT-rich MARs in chromatin, cross-linking the two strands of the 
DNA. This leads to the disruption of processes such as transcription and DNA 
replication that are initiated at or in the vicinity of MARs (Ottaviani et al., 2008b). 
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1.3 The major histocompatibility complex 
 
The human major histocompatibility complex (MHC) is one of the most important 
regions of the genome with respect to immunity to pathogens, autoimmunity and 
transplantation. It contains clusters of genes that are critical for innate and adaptive 
immune function, including antigen processing and presentation as well as the 
complement system. MHC genes are under tight regulatory control and mis-regulation 
of their expression gives rise to a range of diseases. 
 
1.3.1 Overview 
 
The human major histocompatibility complex (MHC) is one of the most extensively 
studied regions of the genome. In humans, it extends over approximately 4 Mb on the 
short arm of chromosome 6. The mouse MHC, called H2, was first identified and 
associated with immunity about 60 years ago by George Snell (Fernando et al., 2008). 
The locus was recognised in humans a few years afterwards where it was termed the 
MHC or human leukocyte antigen (HLA) region since MHC molecules were found to 
be present on the surface of leukocytes cells (Dausset, 1958; Payne et al., 1964). 
 
The classical MHC is divided into 3 sub-regions, class II (centromeric), class III, and 
class I (telomeric) (Fig 1.10). Relative to other parts of the genome, the MHC is 
extremely gene-rich and highly polymorphic. The identification of MHC related genes 
beyond the boundaries of the classically defined MHC locus, has led to the description 
of the extended MHC, (xMHC). The xMHC spans about 7.6 Mb and includes the 
extended class I sub-region, located upstream of the MHC class I and the extended class 
II sub-region, located downstream of the MHC class II (Horton et al., 2004). 
 
The genes contained in each class of the MHC have related functions and are subject to 
co-ordinate regulation. The products of the classical MHC class I and II genes are 
involved in antigen processing and presentation to T cells, while genes in the class III 
region encode complement components which are involved in the induction of 
inflammatory responses and damages to pathogens via proteolytic cleavages of 
glycoproteins. 
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Approximately 40% of the 224 loci identified within the MHC play a role in the 
immune system. HLA genes, which encode cell-surface antigen-presenting molecules, 
are the most polymorphic in the entire genome, some having over 200 alleles. HLA 
genes are closely linked and the entire MHC is inherited as a haplotype from each 
parent. Combinations of different HLA alleles give rise to an extremely large number of 
haplotypes, but in a population certain haplotypes occur more frequently than expected 
by chance (Choo, 2007). This phenomenon, which defines the non-random association 
between alleles at adjacent loci is known as linkage disequilibrium (LD). The high LD 
characterising the MHC could favour the persistence of favourable haplotypes in the 
population. Each person is heterozygous for HLA genes as the genome contains a 
paternal and maternal haplotype, which are co-dominantly expressed. This generates an 
extremely high level of genetic variation, which is required to mount an effective 
immune response against a wide range of evolving pathogens. 
 
The MHC is associated with more diseases than any other region of the human genome 
(Price et al., 1999). These include autoimmune diseases such as multiple sclerosis, type 
1 diabetes, systemic lupus, ulcerative colitis and rheumatoid arthritis (Fernando et al., 
2008; Rubio et al., 2004; Thorsby, 1997). Although the exact mechanisms underlying 
the role of the MHC in these diseases are still unclear, association studies indicate that 
specific HLA haplotypes are related to autoimmune disease susceptibility (Fernando et 
al., 2008). As the MHC is critical in combating pathogens, MHC variants can confer 
susceptibility to infectious diseases such as malaria and HIV (Carrington et al., 1999; 
Hill et al., 1991). Furthermore, HLA molecules are important in transplantation, since 
they are recognised on the organ graft by host T cells causing graft rejection. 
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Figure 1.10 Gene map of the human MHC.  
The human MHC spans approximately 4 Mb on the short arm of chromosome 6. Gene 
annotation is according to the RefSeq database (http://genome.ucsc.edu, May 2004 
Assembly). The different classes of the MHC are highlighted in different colours: 
classical class I – red; classical class III – blue; classical class II – yellow; and extended 
class II – green. 
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1.3.2 MHC class I genes 
 
The MHC class I region contains the classical HLA-A, HLA-B and HLA-C genes, which 
encode the α-chain (also called heavy chain) of the class I molecule. The β2-
microglobulin protein, encoded by a gene on chromosome 15, is non-covalently bound 
to the α-chain to form the complete heterodimeric structure of the class I molecule (Fig 
1.11) (Bjorkman and Parham, 1990). The α-chain contains three extracellular domains 
(α-1, α-2 and α-3), a hydrophobic transmembrane domain and a cytoplasmic tail 
(Bjorkman et al., 1987). The α-1 and α-2 domains, constituted by variable amino acid 
sequences, form a unique groove accommodating the processed peptide antigen, which 
is typically 8-10 residues long (Choo, 2007). 
 
The classical class I genes are expressed on all nucleated cells of the body and bind to 
fragments of peptides derived from intracellular parasites such as viruses or proteins 
normally synthesised by the cell (self-molecules). These peptides are degraded by the 
proteasome complex in the cytosol and then are actively translocated into the lumen of 
the endoplasmic reticulum (ER) by the membrane transporter TAP, a heterodimer 
constituted by the TAP1 and TAP2 subunits (Gromme et al., 1999; Kloetzel and 
Ossendorp, 2004; Powis et al., 1992; Powis et al., 1993; Shepherd et al., 1993). Once in 
the ER, these peptides are loaded onto the fully folded classical class I molecules and 
then transported via the secretory pathway to the cell surface where they interact with 
CD8+ cytotoxic T lymphocytes (CTLs) (Kloetzel and Ossendorp, 2004). 
 
The MHC also contains the non-classical class I molecules, encoded by the HLA-E, 
HLA-F and HLA-G genes, which are evolutionary and structurally related to the 
classical class I molecules. The non-classical class I molecules also play a role in 
antigen presentation but are less polymorphic and exhibit a more restricted expression 
pattern than the classical class I molecules (Gobin and van den Elsen, 2000). While 
expression of HLA-E is ubiquitous, expression of HLA-F and HLA-G is mainly confined 
to B lymphocytes and extravillous cytotrophoblast cells, respectively (Gobin and van 
den Elsen, 2000). In addition to presenting peptides derived from the signal sequence of 
classical class I molecules to natural killer (NK) cells, it is emerging that HLA-E might 
also mediate CTL responses (Hoare et al., 2006). HLA-F has been undetected at the cell 
surface, however, structural predictions in combination with biochemical studies 
suggest it might be able to reach the cell surface by binding cell type specific peptides 
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and interact with immunoglobulin-like receptors ILT2 and ILT4 (Lepin et al., 2000). 
Although the function of HLA-G is unknown, there is evidence suggesting it can inhibit 
NK and T cell mediated cell-lysis and contribute to the normal progression of 
pregnancy and growth of the developing foetus (Hviid, 2006). 
 
Additional genes with immune-related functions contained in the MHC class I region 
are MICA and MICB which encode membrane bound polypeptides different from the 
HLA class I proteins (Stephens, 2001). The MIC molecules do not associate with the β2-
microglobulin and the reduced sized of their groove cannot accommodate peptides for 
presentation to T cells (Stastny, 2006). Several studies indicate that MICA and MICB 
function as ligands for the receptor NKG2D, which is found on NK cells as well as 
different types of T cells. This interaction seems to calibrate the cytotoxic activity of 
these cells and may play a role in eliminating infected and tumour cells (Schrambach et 
al., 2007). 
 
 
 
 
 
Figure 1.11 Diagram of the HLA-A, HLA-B or HLA-C molecule.  
The α-chain has three extracellular domains, α1, α2 and α3. It is non-covalently 
associated with the smaller polypeptide, β2-microglobulin. The α3-domain and β2-
microglobulin are Ig-like. While β2-microglobulin is invariant, the α-chain is extremely 
polymorphic, mainly in the α1-and α2-domains, which form the peptide-binding site 
(Alberts et al., 1994). 
 57 
1.3.3 MHC class II genes 
 
The MHC class II region contains the classical HLA-DP, HLA-DR and HLA-DQ loci, 
which encode transmembrane proteins, each constituted by two non-covalently bound 
polypeptide chains: the α-chain and the β-chain (Fig 1.12). Each polypeptide chain has 
two extracellular domains (α-1, α-2; β-1, β-2), a single transmembrane and an 
intracytoplasmic domain (Jones et al., 2006). The N-terminal α-1 and β-1 domains form 
a groove, the peptide-binding domain, which binds to fragments of processed 
polypeptides. The α-2 and β-2 domains form an immunoglobulin-like domain (Stern et 
al., 1994). 
 
The classical class II molecules are expressed by antigen presenting cells (APCs) such 
as dentritic cells, macrophages and B cells, but their expression can be induced in many 
cell types by cytokines including interferon-γ (IFN-γ). The antigens presented by the 
classical class II molecules are derived from peptides that are translocated from the 
extracellular space into the cytosol via micropinocytosis, phagocytosis or receptor-
mediated uptake (Kumanovics et al., 2003). 
 
Synthesis of the classical class II molecules takes place in the ER where they bind to the 
invariant chain (Ii) molecule at the peptide-binding domain. Ii molecules act as 
chaperones directing the classical class II molecules to the endocytic pathway and 
prevent the peptide grooves from binding with self-molecules (Cresswell, 1996). In the 
endocytic pathway, increasingly acidic endosome compartments degrade the 
internalised peptides to about 13-18 amino acids and the Ii molecule is gradually 
degraded to a small fragment known as class II associated invariant chain peptide 
(CLIP), which serve to stabilise the folded classical class II molecule (Bakke and 
Dobberstein, 1990). The non-classical class II molecules HLA-DM and HLA-DO 
mediate the removal of CLIP and the loading of the antigens onto the groove of the 
classical class II molecule, which is then transferred to the cell surface where it interacts 
with CD4+ T cells to regulate the adaptive immune responses against invading 
pathogens (Kumanovics et al., 2003). 
 
Other genes in the MHC class II region encode molecules which participate in the class 
I antigen presentation pathway (Kumanovics et al., 2003). These include the transporter 
genes TAP1 and TAP2 (see Section 1.3.2) as well as the proteasome genes PSMB9 and 
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PSMB8, which collectively form a gene cluster. Within the MHC, there are genes that 
are not related to antigen processing and presentation but seem to be involved in other 
aspects of the immune response. An example is DAXX, which encodes a molecule 
involved in growth arrest and/or apoptosis of auto-reactive lymphocytes (Kiriakidou et 
al., 1997; Muromoto et al., 2004). 
 
 
 
 
 
Figure 1.12 Diagram of the HLA-DP, HLA-DR or HLA-DQ molecule.  
The α-chains and β-chains are polymorphic, mainly in the α1- and β1-domains, which 
interact to form a groove that binds peptide fragments. The α2- and β2-domains are Ig-
like (Alberts et al., 1994).  
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1.3.4 MHC class III genes 
 
Compared to the class I and II regions, which are characterised by numerous genes 
involved in antigen processing and presentation pathways, the class III region harbours 
a more heterogeneous collection of genes. These genes encode proteins that are crucial 
for various aspects of immunity including activation of the complement system, 
hormone synthesis, inflammation and cell stress, synthesis of lymphotoxins and heat 
shock proteins (Hauptmann and Bahram, 2004). 
 
The complement system is a major effector of innate immunity and also interacts with 
the cells of the adaptive immune system to influence adaptive immune responses 
(Morgan and Harris, 2003). The molecules constituting the complement system include 
approximately 25 soluble proteins existing in the serum as inactive pro-enzymes 
(zymogens), which can be activated to augment antibody responses, lyse foreign cells 
and promote the clearing of immune complexes and apoptotic cells (Sim and 
Tsiftsoglou, 2004). The complement system can be activated by three different 
pathways known as the classical, lectin and alternative pathways. 
 
The MHC class III region contains genes encoding two critical pro-enzymes, C4 and 
C2. The trigger of the ‘classical pathway’ is the binding of antibodies with their antigen 
(Sim and Tsiftsoglou, 2004). This interaction activates a component of the complement 
system C1, which cleaves C4 into the sub-components C4a and C4b, and C2 into the 
sub-components C2a and C2b (Sim and Tsiftsoglou, 2004). The binding of C4b to C2a 
forms the C3 convertase complex, a protease that initiates a cascade culminating in the 
formation of the membrane attack complex (MAC), which creates a transmembrane 
pore on the target cell leading to its lysis (Law and Dodds, 1997). 
 
The C4 and C2 molecules are also involved in the ‘lectin’ pathway, which is activated 
by the binding of mannose-binding lectin to mannose residues on the surface of 
pathogens. This interaction activates the serine proteases MASP-1 and MASP-2, which 
in turn induces the cleavage of C4 and C2 into their active sub-components leading to 
pathogen elimination via the same steps described for the classical pathway (Holmskov 
et al., 2003). 
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The MHC class III region encodes an additional important pro-enzyme, the B-factor 
that activates the complement system through the ‘alternative’ pathway. This cascade is 
initiated by the spontaneous hydrolysis of C3, which then forms a complex with the B-
factor. This process leads to the cleavage of the B-factor by the D protease and the 
formation of the C3bBb complex, which is analogous to the C3 convertase of the 
classical and lectin pathways (Sim and Tsiftsoglou, 2004). Once formed, the alternative 
pathway C3 convertase interacts with other proteins, including factor I and H, to 
regulate opsonisation. 
 
The MHC class III region contains immune-related loci that are not part of the 
complement system. These include the tumour necrosis factor (TNF), lymphotoxin-α 
(LTA) and lymphotoxin-β (LTB) genes, which encode cytokine precursors involved in 
the signalling networks mediating innate and adaptive immune responses (Deakin et al., 
2006). Disruption of these signalling pathways reduces inflammation as well as 
resistance to selected pathogens (Ware, 2005). Additional class III genes with important 
functions in immunity are AIF1, LST1 and NCR3 that play a role in inflammation, 
lymphocyte development and NK activation, respectively (Deininger et al., 2002; Pende 
et al., 1999; Rollinger-Holzinger et al., 2000). 
 
1.3.5 Transcriptional co-regulation of MHC genes 
 
The expression of classical MHC genes, as well as those involved in antigen processing 
and presentation, is subject to co-ordinate regulation. This provides cells with an 
effective system to orchestrate the interaction of functionally linked MHC molecules at 
the appropriate time and place. The co-regulation of MHC genes is complex and 
involves the activity of conserved genomic regulatory elements as well as epigenetic 
mechanisms. 
 
The classical and non-classical MHC class I genes, with the exception of HLA-G, share 
three major regulatory elements: enhancer A, IFN-stimulated response element (ISRE) 
and the SXY module (Fig 1.13)(van den Elsen et al., 1998; van den Elsen et al., 2004). 
These sequences are localised within about 200 nucleotides upstream of the 
transcription start site and are part of the 5’ promoter region (van den Elsen et al., 
2004). Enhancer A contains binding sites for the nuclear transcription factor kB (NF-
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kB), while ISRE interacts with the IFN regulatory factors 1 (IRF-1) and 2 (IRF-2) 
(Gobin et al., 1998; Gobin et al., 1999). The synthesis of these molecules, which 
modulate the induction and suppression of these class I genes, is regulated by cytokines 
including TNF and IFNs (van den Elsen et al., 2004). The SXY module, which contain 
the S, X (comprising X1 and X2 sequences) and Y motifs, binds to a multiprotein 
complex constituted by regulatory factor X (RFX), activating transcription factor 
(ATF), cAMP response element binding protein (CREB) and the nuclear factor Y 
(NFY) (van den Elsen et al., 2004). This complex forms a landing platform for the 
crucial transcription factor, class II Transactivator (CIITA), to up-regulate the 
transcription of classical and non-classical MHC class I genes (Krawczyk et al., 2008). 
 
The SXY module is also part of the promoter region of the classical and non-classical 
MHC class II genes (Fig 1.14). In contrast to the class I genes, the class II genes do not 
have the enhancer A and ISRE sequences in their promoter regions. The absence of 
these cis-regulatory sequences could contribute to the differences in expression between 
class I and II genes observed in different cell types. Studies on cell lines with mutated 
forms of CIITA and RFX show that they are essential for the expression of class II 
genes and also contribute, albeit to a lesser extent, to transcription of class I genes 
(Krawczyk et al., 2008). Mutations in the CIITA or RFX genes are responsible for a 
severe hereditary immunodeficiency disease, the bare lymphocyte syndrome (BLS), 
which is characterised by lack of expression of the class II genes and down-regulation 
of class I genes (Reith and Mach, 2001). The residual expression of class I genes is due 
to their additional upstream regulatory elements which can partially compensate for the 
absence of functional RFX or CIITA. The expression of classical class II genes is also 
modulated by conserved S’-Y’ modules, which function as transcriptional enhancers 
(Krawczyk et al., 2004). These motifs contain the binding sites for CIITA and RFX and 
are localised several hundred base pairs upstream of the CIITA transcription initiation 
sites (Krawczyk et al., 2004). 
 
CIITA activates and regulates gene expression, not only by interacting with several 
transcription factors at the SXY and S’-Y’ modules, but also by binding to chromatin 
remodelling enzymes (Zika and Ting, 2005). Several studies have shown that CIITA is 
responsible for recruiting HATs, HMTs, and the ATP-dependent remodelling factor 
Brahma-related gene 1 (BRG1) at selected promoter regions (Mudhasani and Fontes, 
2002; Wright and Ting, 2006; Zika and Ting, 2005). 
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Expression of MHC class II genes in APCs is due to their constitutive expression of 
CIITA. The expression of class II can be activated in many other cell types by inducing 
the synthesis of CIITA with IFN-γ via the JAK-STAT signalling pathway (Darnell et 
al., 1994). The pathway starts with the binding of IFN-γ to specific receptors on the cell 
surface, which are associated with protein kinases belonging to the Janus kinase (JAK) 
family (Darnell et al., 1994; Hibino et al., 1992).  Ligand attachment leads to the 
phosphorylation of JAKs, which can than activate latent cytoplasmic signal transducers 
and activators of transcription (STAT) proteins through phosphorylation (Lee and 
Benveniste, 1996).  Subsequently, the activated STATs dimerise and rapidly translocate 
into the nucleus where they binding the IFN-γ activation sequence (GAS) elements 
present in the promoters of IFN-γ inducible genes, including CIITA (Fig 1.15) (Darnell 
et al., 1994). 
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Figure 1.13 The conserved regulatory elements of the classical and non-classical 
class I HLA genes.  
The SXY module is bound by RFX, ATF/CREB and NFY. CIITA exerts its activity 
primarily through the SXY module and its binding proteins. The enhancer (enhA) and 
ISRE are bound by NF-kB and IRF-1/2 factors, respectively. The protein binding the S 
module has not been identified. 
 
 
 
 
 
 
Figure 1.14 The conserved regulatory elements of the classical and non-classical 
class II HLA genes.  
The SXY module is bound by RFX, ATF/CREB and NFY. CIITA exerts its activity 
through the SXY and S’-Y’ modules.  
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Figure 1.15 The JAK/STAT signalling pathway.  
(1) Binding of IFN-γ to specific receptors on the cell surface activate protein kinases 
belonging to the JAK family. (2) The activated JAKs interact with latent cytoplasmic 
proteins termed STATs and activate them through phosphorylation. (3) Subsequently, 
the activated STATs dimerise and (4) translocate into the nucleus where they induce 
transcription of certain genes by binding to specific sequences. 
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1.4 Aims of this thesis 
 
Matrix Attachment Regions (MARs) are genomic sequences that mediate the anchoring 
of chromatin into loop domains. Although there is evidence implicating MARs in 
different aspects of genomic function, comprehensive knowledge of their function is 
still lacking since small-scale methods have limited their identification to very few 
regions of the genome. Are MARs characterised by a unique sequence consensus motif? 
How are they distributed across the genome? Are they static or dynamic elements of the 
genome? What role do they play in transcriptional regulation? 
 
I have approached these questions by examining the tethering of a large locus, the 
human Major Histocompatibility Complex (MHC) in cell types exhibiting different 
patterns of MHC expression. Thus, the overall aim of this thesis is to improve our 
understanding of the relationship between chromatin anchors, or MARs and gene 
expression in the MHC. To this end: 
 
1. The utility of a novel MHC tiling path array for mapping MARs was determined 
– Chapter 3. 
 
2. MARs were mapped and characterised across the MHC locus in human 
fibroblasts – Chapter 4. 
 
3. MARs were mapped and characterised across the MHC locus in IFN-γ treated 
human fibroblasts and B lymphoblastoid cells – Chapter 5. 
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2 Materials and Methods 
 
2.1  Cell culture 
 
Cells were grown on 75 cm2 plastic culture flasks in incubators maintaining a 
temperature of 37 °C and a humidified atmosphere supplemented with 5% CO2. Cell 
lines, growth media and other cell culture reagents were supplied by Cancer Research 
UK Cell Services (Clare Hall). 
 
MRC5 cells are human lung fibroblasts derived from a male embryo (ECACC 
97112601). They were cultured as monolayers in RPMI-1640 media supplemented with 
10% foetal calf serum (FCS), 2mM L-glutamine, 100 units/ml penicillin V and 0.1 
mg/ml streptomycin.  MRC5 cells were passaged when they reached confluence, 
usually every 3-4 days. They were washed with phosphate-buffered saline (PBS) and 
detached by incubating them for 5 min with 3 ml of a solution containing porcine 
trypsin and EDTA per culture flask. The trypsin digestion was then blocked by the 
addition of an excess culture medium containing FCS. Cells were reseeded in two or 
three flasks at 30-50% confluence. Cell-surface expression of HLA molecules in MRC5 
cells was induced by adding 200 IU/ml of human IFN-γ (recombinant Human IFN-γ 
R&D Systems) to the culture medium for 24 h (Darley et al., 1993). 
 
HT1080 is a human fibrosarcoma cell line derived from a female (ECACC 85111505). 
HT1080 cells were cultured as monolayers in Dulbecco’s Modified Eagle’s Medium 
(DMEM) and supplemented with 5% FCS, 2mM L-glutamine, 100 units/ml penicillin V 
and 0.1 mg/ml streptomycin. They were usually passaged every 2-3 days as described 
for MRC5 cells. 
 
PGF is a human EBV-transformed B lymphoblastoid cell line derived from a 
consanguineous male and is homozygous for the MHC (ECACC 9405342). PGF cells 
were grown in suspension in RPMI-1640 supplemented as described for MRC5 cells, 
and maintained at exponential growth by addition of fresh media every 2-3 days so that 
their concentration would not exceed 106 cells/ml. 
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Raji is a B lymphoblastoid cell line established from a Burkitt’s lymphoma of a human 
male (ECACC 85011429). RJ2.2.5 is a CIITA-deficient mutant derived from the human 
Raji cell line (ICLC HTL02002). Both cell lines were grown in suspension using the 
same conditions described for PGF cells by the Immunopathology Laboratory at 
Geneva University. 
 
2.2 Isolation of matrix attachment region and halo DNA fractions 
 
The optimal time for nuclear protein extraction was resolved as described previously 
(Krawetz et al., 2005). PGF and MRC5 cells +/- IFN-γ were washed in PBS 
supplemented with 1 mg/ml bovine serum albumin (BSA) and Complete Protease 
Inhibitor (CPI) (Roche). The cells were re-suspended in PBS supplemented with CPI 
and lysed on ice for 15 min following addition of Nuclear Buffer (10mM Tris, pH 7.7, 
100mM NaCl, 300mM sucrose, 3mM MgCl2, 0.5% Triton-X 100 and CPI). The 
concentration of nuclei was adjusted to 1.5 x 105 /ml with PBS supplemented with CPI 
and 1.25 x 104 nuclei were attached to slides using a Shandon Cytospin 2 cytofuge 
(Thermo Shandon).  
 
Halo Buffer (10mM Tris, pH 7.7, 10mM EDTA, 2M NaCl, 1mM dithiothreitol and 
CPI) was placed on the nuclei and incubated for varying times ranging from 0 to 15 
min. The reaction was stopped by washing the slide for 1 min in a graded series of PBS 
washing solutions, and then the cells were dehydrated using a series of graded ice-cold 
ethanol washes. Each slide was then baked for 2 h at 72 °C. The nuclei were stained 
with DAPI and viewed using a Zeiss Axiophot microscope, equipped with a CCD-
camera (Photometrics), which was used to obtain images.  
 
For each cell type, the size of the halo structures at each time point was determined by 
measuring the average distance between the perimeter of the halo and the edge of the 
nuclear matrix of 30 cells in 3 biologically independent experiments. The minimum 
time required to reach maximum average distance between the edge of the nuclear 
matrix and the perimeter of the extracted DNA was considered optimal. 
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The isolation of MAR and halo DNA fractions was repeated five times for each cell line 
to obtain a total of five biological replicates. Two of these replicates were used for array 
hybridisations, and the other three for real-time PCR.  
 
PGF and MRC5 cells +/- IFN-γ  were washed in PBS supplemented with 1 mg/ml BSA 
and CPI. The cells were then re-suspended in 125 µl of PBS and 125 µl of 2x Nuclear 
Buffer and lysed on ice for 15 min. The nuclei were collected by centrifugation and 
incubated in 250 µl of 2x Halo Buffer on ice. The incubation time with 2x Halo Buffer 
was 12 min for nuclei from MRC5 cells +/- IFN-γ, while it was 9 min for nuclei from 
PGF. The reaction was then stopped with the addition of 9.5 ml Restriction Buffer (50 
mM Tris, pH 8.0 and 10 mM MgCl2) supplemented with 100 U of EcoRI and HindIII 
(Sigma). The DNA was digested at 37 °C for 4 h.  
 
Following centrifugation at 16,000 g, the supernatant containing the halo fraction and 
the pellet containing the MAR-enriched fraction were placed in separate tubes. The 
MAR-enriched sample was washed three times with Restriction Buffer. Both samples 
were digested with 120 µg of proteinase K (Roche) in Protease K Buffer (50 mM Tris, 
pH 8.0, 50 mM NaCl, 25 mM EDTA and 0.5% w/v SDS) overnight at 55 °C.  
 
The DNA of both fractions was purified using a commercial purification kit (QIAmp 
DNA blood kit) and their concentration determined by using a NanoDrop ND-1000 
which can quantify DNA in 1 ul samples without performing dilutions or washing 
cuvettes. 
 
2.3  Chromatin immunoprecipitation 
 
Chromatin immunoprecipitation (ChIP) was carried out using HT1080 cells following 
the method described in (Christova and Oelgeschlager, 2002) with minor amendments. 
Approximately 5 x 106 cells were cross-linked with 1% v/v formaldehyde at room 
temperature for 15 min under constant agitation. To stop the cross-linking reaction, 
glycine was added to a final concentration of 125 mM. 
 
Cells were washed twice in ice-cold PBS and re-suspended in Lysis Buffer (50 mM 
HEPES, pH 7.9, 10 mM EDTA, pH 8.0 and 1% w/v SDS) supplemented with CPI. 
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They were then sonicated on ice using a sonicator mounted with a 2 mm diameter probe 
(Sonics) until cross-linked chromatin was sheared to an average DNA fragment length 
of 1−2 kb. The length of the DNA fragments was monitored by agarose gel 
electrophoresis. 
 
After removing cell debris by centrifugation, the soluble cross-linked chromatin was 
diluted 1:10 in Immunoprecipitation (IP) Buffer (10 mM HEPES, pH 7.9, 1% Triton X-
100 and 150 mM NaCl) supplemented with CPI, divided into aliquots and stored at -80 
°C. Protein A−Sepharose CL4B (Pharmacia) was blocked with 1 mg ml-1 BSA (Roche) 
and 1 mg ml-1 herring-sperm DNA (Sigma) in IP Buffer for 4−6 h at 4 °C and washed 
three times with IP Buffer before use. 
 
In order to pre-clear chromatin, blocked Protein A−Sepharose (50 µl of 50% slurry per 
ml of chromatin) was added to the soluble chromatin preparations for 2 h at 4 °C. The 
Protein A−Sepharose was then removed by centrifugation and the pre-cleared chromatin 
was incubated with antibodies against acetyl-histone H3-K9/K14 (Upstate, catalogue 
number 06-599) for 12−14 h at 4 °C. The immunoprecipitates were incubated with fresh 
blocked Protein A-Sepharose for 2 h at 4 °C and recovered by centrifugation. 
 
The pellets were washed three times with IP Buffer, three times with Washing Buffer 
(10 mM Tris, pH 8.0, 0.25 mM LiCl, 0.5% NP-40, 0.5% sodium deoxycholate and 1 
mM EDTA, pH 8.0) and three times with Tris-EDTA (TE), pH 8.0. The pellets were re-
suspended in TE, pH 8.0 and digested with 50 µg ml-1 RNAse A (Roche) for 30 min at 
37 °C. The immunoprecipitated DNA was mixed with 250 µg ml-1 proteinase K 
(Roche), SDS to 0.25% w/v and incubated for 12 h at 37 °C. The formaldehyde cross-
links were then reversed by incubating the chromatin preparations for 6 h at 65 °C. The 
chromatin was purified using a commercial purification kit (QIAmp DNA blood kit) 
and the DNA concentration determined by using a NanoDrop ND-1000. 
 
2.4  Construction of a MHC tiling path array 
 
The tiling path array of the MHC was constructed and optimised in collaboration with 
the Immunogenomics Group at the Wellcome Trust Sanger Institute (Tomazou et al., 
2008). A total of 1747 overlapping plasmid clones covering the MHC region were used 
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to generate the array. Of those, 1662 clones (average insert size of 2 kb) were picked 
from the HapMap chromosome 6 library at the Wellcome Trust Sanger Institute. The 
remaining 85 clones were generated by cloning gap-spanning PCR amplicons (average 
insert size 332 bp). Across the MHC, about 12 kb of repeat-rich regions were refractory 
to PCR amplification and could not be included in the array. Therefore, the overlapping 
plasmid clones cover 99.67% of the entire MHC region. 
 
Vector-specific PCR was performed using each clone to produce amino-linked 
amplicons. The PCR reactions were carried out in 50 mM KCl, 5 mM Tris, pH 8.5 and  
2.5 mM MgCl2 (10 min at 95 °C followed by 35 cycles of 95 °C for 1 min, 60 °C for 
1.5 min, 72 °C for 7 min and a final extension of 72 °C for 10 min) using the forward 
primer 5'-CCCAGTCACGACGTTGTAAAACG-3' and the reverse primer 5' 
AGCGGATAACAATTTCACACAGG-3'. In order to generate strand-specific array 
probes, two separate PCR reactions were performed for each clone, in one case using a 
5'-amino-linked primer for the forward strand, and in the other case, for the reverse 
strand. 
 
After assessing the products by agarose gel electrophoresis, they were re-suspended in 
Spotting Buffer (250 mM sodium phosphate, pH 8.5, 0.00025% w/v sarkosyl and 0.1% 
sodium azide) and filtered (Multiscreen-GV filter plates, Millipore). The products were 
spotted onto amine binding slides (CodeLink, GE Healthcare) at 20–25 °C, 40–50% 
relative humidity. After incubating the slides overnight in a humid chamber, they were 
treated with 1% ammonium hydroxide for 5 min and then 0.1% SDS w/v for 5 min. 
They were then denatured with 95 °C ddH2O for 2 min, rinsed in ddH2O and dried by 
centrifugation. 
 
Each clone was printed four times across the array to minimize spatial effects.  Test 
sequencing was carried out on 15% of the amplified PCR products.  The results show 
that the sequences of ~97% of the selected PCR products matched the expected regions 
of the MHC.  From this partial analysis, it is possible to extrapolate that ~3% of the 
spots of the MHC tiling path array do not represent the expected MHC sequences. 
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2.5  Random labelling of DNA samples 
 
DNA samples were labelled with Cy3- and Cy5-labelled dCTPs (Amersham 
Biosciences) using a random prime labelling system (Bioprime DNA Labelling System; 
Invitrogen) as described previously (Mulholland et al., 2006).  
 
A pre-mixture was prepared containing between 0.3 and 0.5 µg of DNA, 60 µl of 2.5x 
Random Primer Mix. The volume was made up to 126 µl with distilled water.  After 
denaturing the DNA template for 10 min at 100 °C, the pre-mixture was snap-cooled on 
ice. A solution containing 15 µl of 10x dCTP mix, 6 µl of Cy3- or Cy5-labelled dCTP 
(Perkin Elmer) and 3 µl of Klenow fragment was added to the pre-mixture while on ice 
and the sample was incubated at 37 °C overnight. The reaction was stopped by adding 
15 µl of 0.5 M EDTA.   
 
The labelled samples were purified on Micro-spin G50 columns (Amersham) to remove 
unincorporated nucleotides. Fluorescent dye incorporation was monitored using the 
Nanodrop ND-1000 spectrophotometer. 
 
2.6  Array hybridisation and washes 
 
The Cy3- and Cy5-labelled DNA samples were hybridised onto the MHC tiling path 
array using a procedure previously described in (Fiegler et al., 2003). In one tube, equal 
amounts of Cy3- and Cy5-labelled probe were combined with 100 µg human Cot-1 
DNA (Roche) and precipitated with absolute ethanol precipitation using the standard 
methodology. In a second tube, 300 µg of herring sperm DNA (Sigma) was added to 50 
µg of human Cot-1 DNA and precipitated in a similar manner. 
 
The pellets of the first and second tubes were re-suspended in 60 and 200 µl, 
respectively, of Hybridisation Buffer (50% v/v deionised formamide, 10% w/v dextran 
sulphate, 0.1% v/v Tween 20, 2x SSC, and 10 mM Tris, pH 7.5). In order to re-suspend 
the pellets uniformly, after applying the buffer to each tube, the samples were kept at 80 
oC on a heat block for 10 min with vortexing every 2 min. 
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The content of the second tube was applied to the MHC tiling path array, which was 
placed in a humid chamber saturated with 20% v/v formamide and 2x SSC. The 
chamber was sealed air-tight and placed in a hybridisation oven with gentle rocking for 
1 h at 37 °C. Meanwhile, 40 ng of yeast tRNA (Sigma) was added to the first tube, 
which was then incubated at 37 °C for pre-annealing. Subsequent to array pre-
hybridisation the contents of the first tube was applied to the array and placed in the 
same humid chamber and allowed to hybridise for 48 h at the same conditions as 
described above. 
 
The MHC tiling path array was removed from the chamber and placed in a Coplin jar 
containing 2x SSC and 0.03% w/v SDS to wash off any excess hybridisation solution.  
The slide was then transferred to another Coplin jar and washed in 2x SSC and 0.03% 
w/v SDS for 5 min at 65 °C, three times in 0.2x SSC for 20 min at room temperature 
and in PBS and 0.05% v/v Tween 20 for 10 min at room temperature.  After rinsing in 
distilled water, the slide was spin dried at 1000 rpm for 5 min using a swinging rotor 
and then placed in a dark chamber at room temperature. 
 
2.7  Array scanning and data analysis 
 
Arrays were scanned at 532 nm (Cy3) and 635 nm (Cy5) using the confocal scanner 
ScanArray 4000 (GSI Lumonics).  For each clone, a ratio of Cy5 to Cy3 fluorescent 
intensity was calculated by processing the array images in TIGR Spotfinder 
(http://www.tm4.org/spotfinder.html). The median spot intensities were subtracted from 
the median intensities of each spot for each Cy5 and Cy3 images.  
 
Analysis of the data was carried out with the contribution of Richard Mitter, at the 
Bioinformatics and Biostatistics group, London Research Institute Cancer Research 
UK, using the open-source software Bioconductor (Smyth, 2004).  
 
The Cy5 to Cy3 log2 ratios were normalized by subtracting the weighted median for 
each array. Intensities were normalised between arrays using the “quantile” method of 
“NormaliseBetweenArrays” function from the Bioconductor package limma to ensure 
that the intensities have the same empirical distribution across arrays and across 
channels. For each clone, a mean log2 was calculated using the four replicates within 
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each array. Pearson Correlation Coefficients were calculated between all arrays and 
found to be strongest between duplicates. Summarised log2 ratios were calculated by 
taking a mean across duplicate arrays. 
 
Data points derived from clones constituted entirely of repetitive sequences were 
excluded from the analysis (Appendix I). Repetitive sequences were defined as in the 
‘all repeats’ track in the Ensembl browser (Hubbard et al., 2007). Dye swap 
hybridisation for each pair of arrays was performed to normalise for any dye bias. The 
genomic position of the BACs used to generate the MHC tiling path arrays was 
determined using the NCBI build 34 assembly of the human genome. 
2.8  Real-Time PCR 
 
SYBR Green real-time PCR was used to analyse the process of DNA amplification 
quantitatively throughout the PCR reaction. SYBR is a cyanine dye that binds to the 
minor groove of double-stranded DNA and is fluorescent when bound. 
 
PCR primers were designed using Primer 3 software (http://frodo.wi.mit.edu/cgi-
bin/primer3/primer3_www.cgi). Real-time PCR was performed using SYBR Green 
Jumpstart Taq Ready Mix kit (Sigma Aldrich, Missouri, USA). PCR reactions were 
prepared in 50 µl reaction volume and consisted of 25 µl of SYBR Green Jumpstart Taq 
Ready Mix, 100 ng of DNA template and forward and reverse primer mix at final 
concentration of 500 nM.  
 
The PCR cycling conditions consist of an initial denaturation for 5 min at 95 °C, 40 
cycles of denaturation at 95 °C for 40 sec, annealing at 55 °C for 30 sec and extension 
at 72 °C for 30 sec, followed by a final 5 min extension step at 72 °C. After completion 
of the amplification, a melting curve of each product was obtained by heating the 
samples from 72 °C to 95 °C and monitoring fluorescence every 1 °C increase in 
temperature to determine the specificity of the PCR reaction. These reactions were 
performed using the Opticon2 (MJ Research) thermal cycler.  
 
In order to quantify the target regions in the DNA samples, standard curves were 
produced for each primer pair from PCR reactions with known amounts of genomic 
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DNA. Data analysis was performed using different versions of the Opticon (MJ 
Research) amplification detection software. 
 
2.9 Threshold of array enrichment identifying matrix attachment 
regions 
 
In order to identify MARs based on the array data, a threshold of array enrichment was 
determined by comparing the array enrichment values with the quantitative real-time 
PCR enrichment of selected MHC clones using MAR and halo DNA fractions. 
 
The selected MHC clones were characterised by MAR/halo array enrichments ranging 
from approximately -1 to 1 (log2). Each real-time PCR reaction was carried out as 
described in section 2.9. The experiments were performed three times using MAR and 
halo DNA fractions from three independent populations of untreated MRC5 cells 
(samples 3, 4 and 5). 
 
The data show that the clones having array enrichment values greater than 0.4 (log2), 
are consistently confirmed to be MARs (Table 2.1). Therefore, genomic regions with 
array enrichment greater than 0.4 were thus designated as MARs. 
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MHC region MAR/Halo predicted 
by array enrichment 
Array enrichment 
value MAR/halo (log2) 
RT-PCR enrichment 
MAR/halo (log2) 
30455483-30457800 MAR 0.999 3.234 
31955316-31957399 MAR 0.803 2.526 
32591170-32594283 MAR 0.597 3.624 
29933548-29935949 MAR 0.406 1.902 
29739385-29741249 MAR 0.201 -0.919 
30118308-30120829 MAR 0.008 -1.485 
33051852-33053947 Halo -0.202 -0.823 
32127610-32130779 Halo -0.400 -2.724 
33190199-33192634 Halo -0.602 -1.251 
31236895-31239353 Halo -0.811 -1.923 
31649837-31652271 Halo -1.005 -2.014 
 
Table 2.1 Comparison between real-time PCR (RT-PCR) data and array 
enrichment values. 
 
2.10 Expression Array 
 
The gene expression of PGF and MRC5 cells +/- IFN-γ was determined using 
Affymetrix U133 plus 2.0 GeneChips  (Affymetrix, Santa Clara, CA). Total RNA was 
extracted using the Qiagen  RNeasy Mini Kit following the manufacturer’s protocol. 
Briefly, 5 x 106 cells were lysed and homogenised in the presence of a highly 
denaturing guanidine-thiocyanate–containing buffer, which inactivates RNases to 
ensure purification of intact RNA. 70% ethanol was then added to the lysate to promote 
selective binding of RNA to the membranes of the RNeasy Mini spin columns. A series 
of washes with RNeasy washing buffers was then performed to remove contaminants 
before eluting the total RNA from the RNeasy mini columns with 60 µl of RNase-free 
water. The bind, wash and elution steps were performed by centrifugation. The amount 
of RNA was measured using the Nanodrop ND-1000 spectrophotometer and the RNA 
quality assessed using the Agilent 2100 Bioanalyser.   
 
The samples were prepared and hybridised to the microarrays according to the 
Affymetrix Technical Manual (www.affymetrix.com/support/technical/manual/ 
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expression_manual.affx). Briefly, total RNA (10 µg) was converted into double-
stranded cDNA using the reverse transcriptase and oligo-dT primers of the One-Cycle 
cDNA Synthesis Kit. In vitro transcription of biotin-labelled antisense RNA (cRNA) 
was carried out using the cDNA as a template. Prior to hybridisation, the cRNA was 
fragmented in Affymetrix Fragmentation Buffer at 94 °C for 35 min to produce 25-200 
bp fragments. Approximately 15 µg of labelled, fragmented cRNA was added to a 
hybridisation cocktail, which was then hybridised to U133 Plus 2.0 GeneChips for 16 h 
at 45 °C with gentle rocking. GeneChips were washed with a series of non-stringent and 
stringent solutions containing variable amounts of morpholino ethane sulfonic acid, 
Tween 20, sodium chloride, sodium phosphate and EDTA. The microarrays were then 
stained with streptavidin phycoerythrin, and the fluorescent signal was amplified using a 
biotinylated antibody solution. Fluorescent images were detected using a GeneChip 
Scanner 3000, and expression data extracted using the GeneChip Operating System v 
1.1 (Affymetrix). 
 
Statistical analysis was performed using the open source statistical  environment R 
(www.r-project.org) and Bioconductor packages (Smyth, 2004). Probe set expression 
measures were calculated using the “Affy” package's Robust Multi-chip Average 
(RMA) default method. Probe sets exhibiting a  >2 fold change were called 
differentially expressed. Where multiple probe sets mapped to the same gene, a mean 
fold change was taken. All expression data were deposited in NCBI Gene 
Expression Omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo/) and are accessible 
through  GEO Series accession number GSE10880. 
 
2.11 FISH and image analysis 
 
FISH was performed on PGF and MRC5 cells +/- IFN-γ to examine the higher-order 
chromatin architecture of the MHC. The PAC RP1-172K2 probe was selected for the 
MHC class II gene HLA-DRA and obtained from the Wellcome Trust Sanger Institute, 
UK. Probe DNA was labelled with digoxigenin-11-dUTP (Roche) by nick-translation 
using the enzyme mix from BioNick kit (Invitrogen) and a digoxigenin labeling mixture 
replacing biotin 14-dATP (Roche Diagnostics). A solution containing 5 µl of 
digoxigenin labelling mixture, 5 µl of 10x enzyme mixture, 1 µg of probe DNA and 
made up to 40 µl with water was incubated at 16 °C for approximately 85 min to 
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produce 500 bp fragments. The size of the fragments was examined by agarose gel 
electrophoresis. In order to inactivate the enzymes, 5 µl of EDTA was then added and 
the mixture heated to 60 °C for 5 min. 
 
PGF and MRC5 cells +/- IFN-γ were fixed in a methanol acetic acid (3:1) solution and 
placed on glass microscope slides. Prior to hybridisation, the chromosomes on each 
slide were aged with microwave irradiation for 2.5 min using a microwave (Sharp 
Carousel II) set at medium/high power. To denature the chromosomes, 90 µl of 
denaturation mixture (70% v/v formamide, 2x SSC) was placed on the slide under a 22 
x 50 mm coverslip and the slide heated on a hot plate at 73 °C for 3 min. The slide was 
then washed with 2x SSC and dehydrated in alcohol. 
 
Labelled DNA (300 ng) was precipitated with human Cot-1 DNA, salmon sperm DNA, 
NaAc and absolute alcohol and then re-suspended in hybridisation mixture (50% 
formamide, 2x SSC and 10% w/v dextrane sulphate). The probe was denatured on a 
heating block at 85 °C for 5 min and incubated at 37 °C for 30 min. The slide was then 
pre-warmed on a heating block at 37 °C, the denatured probe applied to the slide with 
FITC-labelled chromosome 6 paint (Cambio) and the slide placed in a moist chamber at 
37 °C overnight. 
 
The slide was washed three times in 50% v/v formamide, 2x SSC at 42 °C and then 
three times in 1x SSC at 60 °C. The hybridisation area was then blocked in 90 µl of 
blocking solution (4x SSC, 0.1% v/v Tween 20 and 5% w/v skimmed milk powder 
(Marvel)) and incubated at 37 °C for 25 min. The blocking solution was drained from 
the slide and the detection antibody applied and covered with a coverslip (22 x 50 mm).  
 
Anti-avidin-FITC 1:300 and anti-digoxigenin-rhodamine 1:100 antibodies were used for 
detection by incubation at 37 °C for 45 min followed by three washes with 4x SSC and 
0.1% v/v Tween 20 at 42 °C. The chromosomes were then counterstained with DAPI 
(200 ng/ml) in Citifluor antifade solution and stored at 4 °C in the dark. Slides were 
examined with a Zeiss Axiophot epifluorescence microscope. 
 
Separate grey-scale images were recorded with a cooled CCD-camera (Hamamatsu). 
They were then pseudocoloured and merged using SmartCapture X software (Digital 
Scientific, Cambridge). The position of signal from the HLA-DRA probe was analysed 
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in relation to the domain defined by the chromosome 6-specific paint. Each 
chromosome homologue was counted separately and a score derived for the percentage 
of loci that were located on an external chromatin loop. Experiments were repeated 
twice on cells from independent cultures. 
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3 Validation of a tiling path array for the MHC 
 
3.1  Introduction 
 
The MHC is one of the most important genomic regions for protection of the organism 
against diseases. While much effort has been made to understand the genetics of this 
locus, contributing greatly to our knowledge on the regulation of MHC genes, further 
studies are necessary to elucidate the relationship between the three-dimensional 
properties of the MHC and its function. This region constitutes an ideal model to 
investigate chromatin organisation as it contains genes that are constitutively expressed, 
tissue-specific or inducible (Boehm et al., 1997; Rohn et al., 1996). Furthermore the 
MHC has distinct structural configurations dependent on its transcriptional status 
(Christova et al., 2007; Volpi et al., 2000). 
 
The development of assays using DNA microarrays and high-throughput sequencing 
and their application in combination with other techniques, including ChIP, has allowed 
the study of chromatin structure on a genome-wide scale. These technologies are 
applicable to properties of chromatin such as nucleosome positioning, DNA 
methylation, chromatin-modifying enzymes, histone and non-histone structural proteins 
(Schones and Zhao, 2008). In addition, high-throughput approaches can be used to 
study higher-order chromatin architecture. For instance, the chromosome conformation 
capture approach allows the identification of multiple long-range DNA interactions 
(Simonis et al., 2006; Zhao et al., 2006). Analysis of cells at different stages of 
differentiation or exhibiting different transcription and replication profiles enables the 
role of chromosome architecture in genomic function to be determined.  
 
In order to facilitate the comprehensive study of MHC architecture, I generated a novel 
tiling path array covering the locus, in collaboration with the Immunogenomics Group 
at the Sanger Institute. The array was constructed to determine the DNA-protein 
interactions that contribute to the organisation of the MHC and how the structural 
properties of the MHC affect its function. It was also designed to be compatible with 
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various assays including ChIP, methylated DNA immunoprecipitation (MeDIP) and 
array comparative genomic hybridisation (aCGH). 
The array platform was constructed utilising a public clone resource 
(http://www.hapmap.org) at a fraction of the costs associated with commercially 
available arrays. A study by Tomazou et al. (2008) showed that the MHC array can be 
successfully used for the identification of tissue-specific differentially methylated 
regions (Tomazou et al., 2008). Here, the identification of the Class II Transactivator 
(CIITA) binding sites and the analysis of histone H3-K9/K14 acetylation across the 
MHC were used to validate the array since they are both well described (Krawczyk et 
al., 2004; Krawczyk et al., 2008; Liang et al., 2004; Roh et al., 2005). 
 
CIITA induces transcription of the classical and non-classical class II genes by 
interacting with transcription factors at the conserved proximal-promoter SXY motif 
and the distal enhancer-module S’-Y’(Gobin et al., 1997; Harton and Ting, 2000; 
Krawczyk et al., 2004; Martin et al., 1997). Acetylation of the amino terminal lysines of 
histones H3 is associated with induction of transcription and is thought to disrupt 
condensed chromatin to allow accessibility of transcription factors and RNA 
polymerase (Beresford and Boss, 2001; Grunstein, 1997; Utley et al., 1998). The 
histone H3-K9/K14 acetylation profile of the MHC was tested as it is a feature of 5’ 
regions of transcriptionally active human genes (Liang et al., 2004; Roh et al., 2005). 
 
The validation experiments were performed using the MHC tiling path array in 
combination with ChIP. The data show that the arrays identify previously described 
CIITA-binding sites with high reliability as well as novel putative CIITA-binding sites, 
which are mostly located in the promoter and regulatory region of MHC genes. The 
histone study confirms that the highest levels of H3-K9/K14 acetylation are at the 
promoter regions of constitutively expressed genes. Taken together these experiments 
demonstrate the utility of the arrays for the profiling of DNA-protein interactions and 
the epigenetic status of the region. 
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3.2  Results 
 
3.2.1 MHC tiling path arrays 
 
A tiling array, encompassing almost the entire 4 Mb MHC region (99.67%) at a 
resolution of 2 kb, was constructed. The array contains 7832 probes consisting of two 
replicates of both forward and reverse strands of MHC sequences and appropriate 
controls. Approximately 97% of these probes were estimated to be informative based on 
the quality controls described in Chapter 2. 
 
3.2.2 Analysis of technical variation 
 
Regardless of the experiment performed, the identification of MHC regions that are 
truly enriched for the factor of interest is of critical importance. To distinguish between 
the real enrichment and the background enrichment, which occurs as consequence of 
technical noise, the experimental variation was calculated using a series of self-self 
hybridisations. 
 
The DNA samples used consisted of genomic DNA from human MRC5 fibroblast cells 
sonicated to an average size of 1 kb. These samples were differentially labelled with 
dCTP-Cy3 and dCTP-Cy5 fluorophores and hybridised to the MHC tiling path array. 
The slides were then washed and scanned and acquired images were analysed with an 
imaging software (Spotfinder). This experiment was carried out three times. The 
Cy3/Cy5 ratio of each probe on the array was used as an indication of the representation 
of region covered by the probe in the two samples. The ratios of the fluorescent dyes of 
each locus were log2 transformed, and the combined means calculated and subsequently 
plotted on the UCSC human genome database (http://genome.ucsc.edu, May 2004 
Assembly) (Fig 3.1). Array probes consisting entirely of repetitive sequences, as listed 
in the previous chapter, were excluded from the analyses. 
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Findings are shown as log2 ratios, with a ratio of zero representing no enrichment of 
either sample.  As samples from the same genomic DNA were co-hybridised to the 
MHC tiling path array, the log2 ratios were expected to remain close to 0 and any 
deviations to be attributable to experimental errors. The average log2 ratio was 0.01. 
The graphical representation of the results shows that there are no significant 
enrichments across the MHC locus. The experimental variation was determined by 
calculating the standard deviation of the log2 ratios of the array probes for each 
experiment. The average standard deviation was as low as 0.11.  
 
In order to validate the array results, eight regions across the MHC were randomly 
selected and subjected to independent real-time PCR analysis. The log2 array 
enrichment of the selected MHC regions varied from –0.04 to. 0.10. For all 8 regions, 
the amount of DNA was found to be almost equivalent in both genomic samples. This is 
consistent with the array data suggesting that the MHC tiling path array is suitable for 
the identification of differential DNA enrichment (Fig 3.2). 
 
 
 
 
 
Figure 3.1 MHC plot of self-self experiments. 
The plot was obtained by co-hybridising the two samples of genomic DNA from MRC5 
cells labelled with Cy3 and Cy5 fluorophores onto the MHC tiling path array. The 
experiment was carried out three times. Each bar represents a clone from the MHC 
locus. The height of each bar shows the average log2 enrichment level of each sample at 
a given MHC region. Positive ratios represent enrichments of a given MHC region in 
the Cy5-labelled samples while negative regions represent enrichments of a given MHC 
region in the Cy3-labelled samples. 
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Figure 3.2 Quantitative real-time PCR analysis of eight regions across the MHC 
locus. 
Real-time PCR was performed using two samples of genomic DNA from MRC5 cells 
and primers spanning eight MHC regions exhibiting no significant difference in 
enrichment of Cy5- and Cy3-labelled genomic DNA in the array experiments. Real-
time PCR indicated that the quantity of those amplicons is almost equivalent in both 
Cy5- and Cy3-labelled genomic DNA samples, thus validating the array data. Bars 
represent the mean of two experiments and show the standard deviation. 
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3.2.3 CIITA-binding sites across the MHC 
 
ChIP was performed using polyclonal anti-CIITA in the human Burkitts’ lymphoma 
cell-line Raji and a CIITA-deficient cell-line generated in vitro from Raji, RJ2.2.5.  Raji 
cells express CIITA constitutively and the ChIP samples from these cells were enriched 
in CIITA target sequences. Conversely RJ2.2.5 cells do not synthesise CIITA and the 
resulting ChIP DNA sample was enriched only in non-specific immunoprecipitated 
DNA sequences. The ChIP DNA products from both cell lines were competitively 
hybridised to the MHC tiling path arrays. ChIP assays were carried out by the 
Immunopathology Laboratory at the Geneva University using the method described by 
Masternak et al. (2003) (Masternak et al., 2003).  
 
Due to the small amounts of DNA obtained from this procedure, two rounds of ligation 
mediated PCR were carried out prior to competitive hybridisation.  The ChIP samples 
from Raji and RJ2.2.5 cells were then labelled with Cy3 and Cy5 fluorophores, 
respectively, and co-hybridised to the MHC tiling path array.  A dye swap experiment 
was carried out to control for the efficiency of the labelling. The ratios of the 
fluorescent dyes of each locus were log2 transformed, and the combined mean values 
calculated and plotted on the UCSC human genome database (http://genome.ucsc.edu, 
May 2004 Assembly). The graphical representation of the results shows that, although 
each class of the MHC contains CIITA-binding sites, the highest peaks representing 
CIITA enrichments are present across the MHC class II (Fig 3.3). The DNA regions 
enriched in the ChIP samples from RJ2.2.5 cells are expected to represent enrichment in 
immunoprecipitated DNA sequences derived from the nonspecific binding of the 
antibody and subsequent DNA amplification. 
 
The best-documented targets of CIITA are the regions proximal to the classical and 
non-classical MHC class II genes, which contain the SXY and S’-Y’ modules. These 
sequences were used as positive controls to validate the MHC tiling path arrays. A 
threshold of four standard deviations was used to select CIITA-enriched clones for 
further analysis. The application of this threshold identified 27 CIITA-enriched loci, of 
which 14 overlapped with the SXY and S’-Y’ modules of the MHC class II genes 
(Table 3.1). No data were available for the S’-Y’ module of HLA-DRA since it is a 
region refractory to PCR amplification due to repeats, thus, it could not be included in 
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the tiling path array. The S’-Y’ module of HLA-DQA1 is the only positive control 
represented in the MHC tiling path array, which is not confirmed to be highly enriched 
in CIITA.  
 
Additional positive controls include the SXY and S’-Y’ modules of MHC class I genes. 
The array results revealed that these modules are among the 27 highest CIITA-enriched 
sites across the MHC locus (Table 3.2). This list also includes sequences that were not 
candidate CIITA-binding sites. These regions were designated as novel putative CIITA-
enriched sites (Table 3.3). As these sequences were more CIITA-enriched than positive 
controls, their enrichment is unlikely to be attributable to stochastic differences in the 
competitive hybridisation of targets to the probes on the arrays and technical variation. 
Of these novel putative CIITA-binding sites, four overlapped transcription initiation 
sites and two were located in the intergenic region downstream of the start site. Several 
of the novel putative CIITA-binding sites are either within or proximal to genes that 
contribute to a range of clinical conditions (Aquino-Galvez et al., 2008; Heinzelmann-
Schwarz et al., 2004; Matsuzaka et al., 2002). 
 
 
 
 
 
Figure 3.3 CIITA-binding sites across the MHC. 
The plot was obtained co-hybridising Cy3- and Cy5-labelled ChIP DNA from Raji and 
RJ 2.2.5 to the MHC tiling path array.  The values above 0 represent enrichment in 
ChIP DNA from Raji.  The values below 0 represent enrichment in ChIP DNA from RJ 
2.2.5. The experiment was carried out twice. The height of each bar shows the average 
log2 enrichment. 
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Table 3.1 Positive controls within the MHC class II region identified by the MHC 
tiling path arrays. 
 
 
 
 
 
Table 3.2 Additional positive controls identified by MHC tiling path arrays.  
 
 
 
 
 
Table 3.3 Novel putative CIITA-binding sites identified by ChIP-MHC tiling path 
arrays. 
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3.2.4 Quantitative real-time PCR of ChIP DNA from Raji and RJ2.2.5 cells 
 
In order to confirm the array results, six DNA regions enriched in the ChIP sample from 
Raji cells and six DNA regions enriched in the ChIP sample from RJ2.2.5 cells were 
subjected to independent quantitative real-time PCR analysis. This validation was 
performed using the ChIP DNA samples used for the microarray experiments.  
 
Each amplicon designed across the selected regions was quantified using standard 
curves produced for each primer pair from real-time PCR reactions with known 
amounts of genomic DNA. PCR reactions were performed at the same time using the 
same cycling conditions and with equal amounts of template and master mix in order to 
compare the quantity of each amplicon between the Raji and RJ2.2.5 ChIP samples. 
 
The DNA regions enriched in the ChIP samples from Raji cells, representing sequences 
bound to CIITA, overlapped the SXY module of HLA-DRA, HLA-DMA, HLA-F, HLA-
C and the transcription start site of TAP1 and HLA-G. The DNA regions enriched in the 
ChIP samples from RJ2.2.5 cells, which instead represented enrichment in non-
specifically immunoprecipitated DNA sequences, overlapped the intragenic regions of 
MSH5, CFB, C4B, TNXB, COL11A2 and CSNK2A1. The real-time PCR results were 
consistent with the array data indicating that the MHC tiling path array is suitable for 
the study of DNA-protein interactions (Fig 3.4-3.5). 
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Figure 3.4 Quantitative real-time PCR analysis at CIITA-enriched loci in Raji and 
the derivative CIITA negative cell line RJ2.2.5.  
Real-time PCR was carried out using two samples each of ChIP DNA from Raji and RJ 
2.2.5 cells and primer pairs spanning regions of high CIITA enrichment according to the 
array data. The DNA regions overlapping the SXY modules of HLA-DRA, HLA-DMA, 
HLA-F, HLA-C and the transcription start sites of TAP1 and HLA-G were found to be 
highly enriched in the Raji ChIP samples and thus in CIITA target sequences. Bars 
represent the mean of two experiments and show the standard deviation. 
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Figure 3.5 Quantitative real-time PCR analysis at loci enriched in non-specifically 
immunoprecipitated DNA sequences.  
Real-time PCR was carried out using two samples each of ChIP DNA from Raji and RJ 
2.2.5 cells and primer pairs within regions of no CIITA enrichment according to the 
array data. DNA sequences located in the intragenic region of MSH5, CFB, C4B, TNXB, 
COL11A2 and CSNK2A1 were found to be highly enriched in the RJ2.2.5 ChIP 
samples, which contain non-specifically immunoprecipitated DNA sequences. Bars 
represent the mean of two experiments and show the standard deviation. 
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3.2.5 Histone H3-K9/K14 acetylation across the MHC 
 
In order to profile histone H3-K9/K14 acetylation across the MHC, DNA samples 
enriched in H3-K9/K14 acetylation were obtained by ChIP and then hybridised to the 
MHC tiling path arrays. HT1080 fibroblasts were treated with formaldehyde and 
subjected to standard ChIP with antibodies directed against H3-K9/K14 acetylation. 
ChIP was also performed using non-specific mouse IgG antibodies as a negative 
control. Acetylation of H3-K9/K14 has been previously found at the 5’ regions of 
transcriptionally active human genes (Liang et al., 2004; Roh et al., 2005). To assess the 
quality of the ChIP, H3-K9/K14 acetylation was analysed with quantitative real-time 
PCR at the 5’ regions of HLA-A, HLA-C, HLA-DRA and HLA-DRB1. In HT1080 
fibroblasts, the HLA-A and HLA-C genes are constitutively expressed while HLA-DRA 
and HLA-DRB1 genes are transcriptionally silenced (Rohn et al., 1996; Singer and 
Maguire, 1990). In agreement with previous reports, the PCR data show that HLA-A an 
HLA-C genes are significantly more H3-K9/K14 acetylated compared to HLA-DRA and 
HLA-DRB1 genes confirming that H3-K9/K14 acetylation is associated with active 
transcription of human genes (Fig 3.6) (Agalioti et al., 2002; Liang et al., 2004). 
  
The DNA immunoprecipitates obtained using anti-acetyl H3-K9/K14 and mouse IgG 
antibodies were labelled with Cy5 and Cy3 fluorophores and co-hybridised to the MHC 
tiling path array. A dye swap experiment was carried out to reduce the bias introduced 
by the different fluorescent labelling of the DNA samples. The ratios of the fluorescent 
dyes of each locus were log2 transformed and the combined mean values calculated. An 
arbitrary cut-off of array enrichment was set at 3 standard deviations of the mean to 
identify H3-K9/K14 acetylated MHC regions which were subsequently plotted on the 
UCSC human genome database (Fig 3.7). The results show that 281 regions of the 
MHC, representing 17% of the array probes, are associated with K9/K14 acetylated H3. 
These enriched probes are unevenly distributed across the MHC locus. Over 47% of the 
H3-K9/K14 acetylated regions are contained in the MHC class I, 31% in the MHC class 
III, 8% in the MHC class II and 14% in the extended MHC class II regions. 
 
To determine if the H3-K9/K14 acetylation is biased towards any functional regions in 
the human genome, the MHC was divided into transcription initiation sites, gene body 
regions including introns and exons, and intergenic regions. Approximately 57% of the 
array probes covering the MHC locus contain entirely intergenic regions, 31% contain 
 91 
gene body regions while 12% contain transcription initiation sites (Fig 3.8a). This 
distribution is significantly different from that of the array probes enriched in H3-
K9/K14 acetylation. Of such probes 23% contain intergenic regions, 43% contain gene 
body regions and 34% contain transcription start sites (Fig 3.8b). H3-K9/K14 
acetylation is thus biased towards the transcription sites and gene body regions of the 
genome. The distribution of the 50 array probes most enriched in H3-K9/K14 
acetylation is even more shifted towards the transcription initiation sites (Fig 3.8c). This 
suggests that the 5’ ends of genes are the most highly acetylated regions, as previously 
shown by a genome-wide analysis of H3-K9/K14 acetylation in T cells (Roh et al., 
2005). 
 
In agreement with the real-time PCR results, the array data show that the regions 
overlapping the 5’ region of HLA-A and HLA-C are enriched in H3-K9/K14 acetylated 
DNA while HLA-DRA and HLA-DRB1 are not H3-K9/K14 acetylated. This indicates 
that the arrays are suitable for the profiling of histone modifications across the MHC 
locus. The genes that are H3-K9/K14 acetylated include all the classical MHC class I 
genes but none of the classical MHC class II genes (Table 3.4). While fibroblasts 
constitutively express the classical MHC class I genes, they do not express the classical 
MHC class II genes unless induced with cytokines such as IFN-γ (David-Watine et al., 
1990; Rohn et al., 1996; Singer and Maguire, 1990). These experiments further validate 
the MHC tiling path arrays since they are consistent with previous reports associating 
transcriptionally active genes with H3-K9/K14 acetylation (Agalioti et al., 2002; Liang 
et al., 2004; Roh et al., 2005). 
 
 92 
 
 
Figure 3.6 Quantitative real-time PCR analysis at the 5’ regions of HLA-A, HLA-C, 
HLA-DRA and HLA-DRB1 in HT1080 cells.  
Real-time PCR was carried out using two samples each of ChIP DNA from HT1080 
cells and primer pairs at the 5’ regions of HLA-A, HLA-C, HLA-DRA and HLA-DRB1. 
a) The data indicate that the 5’ regions of HLA-A and HLA-C are enriched in the ChIP 
samples obtained by using anti-acetyl H3-K9/K14 compared to the samples obtained by 
using mouse IgG. b) No significant differences are observed between the two ChIP 
samples relative to the enrichment of the 5’ region of HLA-DRA and HLA-DRB1. Bars 
represent the mean of two experiments and show the standard deviation. 
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Figure 3.7 H3-K9/K14 acetylation profile of the MHC.  
The plot was obtained by co-hybridising to the MHC tiling path array Cy3- and Cy5-
labelled ChIP DNA from HT1080 cells using anti acetyl-histone H3-K9/K14 and mouse 
IgG. The values above 0 represent enrichment in acetyl-H3-K9/K14 ChIP DNA.  The 
values below 0 represent enrichment in mouse IgG ChIP DNA. The experiment was 
carried out twice using ChIP DNA from two biologically independent experiments. The 
height of each bar shows the average log2 enrichment. 
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Figure 3.8 Distribution of H3-K9/K14 acetylated probes across the start sites of 
genes, within genes and intergenic regions of the MHC in HT1080 cells.  
Array probes were divided into three groups: overlapping transcription initiation sites, 
gene body regions including introns and exons and intergenic regions. The pie charts 
show the calculated percentages of each group in a) MHC array probes, b) H3-K9/K14 
acetylated probes and c) the 50 most acetylated H3-K9/K14 probes. 
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Number Gene Chr. co-ordinates Number Gene Chr. co-ordinates 
1 MOG 29732788-29748126 48 BAT4 31737842-31741142 
2 HLA-F 29799096-29803052 49 CSNK2B 31741636-31745822 
3 HLA-G 29902735-29906878 50 LY6G5B 31746707-31748206 
4 HLA-A 30018310-30021632 51 LY6G5C 31794405-31797489 
5 HCG9 30050871-30054148 52 BAT5 31762715-31779067 
6 ZNRD1 30137015-30140665 53 DDAH2 31802797-31806018 
7 PPP1R11 30142911-30146085 54 CLIC1 31806339-31812320 
8 TRIM31 30178655-30188846 55 MSH5 31815753-31838429 
9 TRIM15 30238962-30248452 56 LSM2 31873155-31882722 
10 TRIM26 30260213-30289132 57 HSPA1L 31885375-31890814 
11 TRIM39 30403019-30419484 58 HSPA1A 31891316-31893696 
12 RPP21 30420916-30422611 59 HSPA1B 31903491-31906010 
13 HLA-E 30565250-30569064 60 C6ORF48 31910672-31915518 
14 GNL1 30621675-30632987 61 NEU1 31934932-31938662 
15 PRR3 30632735-30640159 62 SLC44A4 31938949-31954802 
16 ABCF1 30647149-30667286 63 ZBTB12 31975373-31977748 
17 PPP1R10 30676162-30692999 64 CFB 32021752-32027839 
18 MRPS18B 30693465-30702153 65 RDBP 32027844-32034843 
19 C6ORF134 30702592-30720427 66 SKIV2L 32034560-32045511 
20 C6ORF136 30722780-30728961 67 STK19 32047625-32057201 
21 DHX16 30728886-30748736 68 C4A 32090550-32111173 
22 NRM 30763806-30766748 69 TNXB 32116911-32185129 
23 MDC1 30775563-30793437 70 CREBL1 32191023-32203995 
24 TUBB 30796136-30801172 71 FKBPL 32204465-32206045 
25 FLOT1 30803492-30818432 72 PPT2 32229279-32239429 
26 IER3 30818955-30820306 73 AGPAT1 32243968-32253820 
27 DDR1 30959840-30975910 74 AGER 32256724-32260001 
28 GTF2H4 30983956-30989858 75 PBX2 32260488-32265941 
29 VARS2 30989961-31002212 76 GPSM3 32266522-32271278 
30 PSORS1C1 31190602-31215816 77 NOTCH4 32270599-32299822 
31 PSORS1C2 31213290-31215106 78 TAP2 32897588-32914525 
32 CCHCR1 31218195-31233545 79 PSMB8 32916477-32919794 
33 TCF19 31234282-31239970 80 TAP1 32920965-32929726 
34 HCG27 31273578-31279723 81 BRD2 33044415-33057260 
35 HLA-C 31344509-31347834 82 RXRB 33269344-33276410 
36 HLA-B 31429628-31432968 83 SLC39A7 33276581-33280191 
37 MICA 31479350-31491069 84 RING1 33284264-33288476 
38 HCP5 31538938-31541460 85 VPS52 33326028-33347640 
39 MICB 31573834-31586880 86 RPS18 33347830-33352259 
40 BAT1 31605977-31618204 87 PFDN6 33365356-33366689 
41 ATP6V1G2 31620221-31622606 88 RGL2 33367416-33374716 
42 NFKBIL1 31623351-31634584 89 TAPBP 33375452-33389967 
43 LTB 31656317-31658181 90 DAXX 33394379-33398682 
44 LST1 31661950-31664664 91 KIFC1 33467291-33485677 
45 BAT2 31696429-31713533 92 PHF1 33486772-33492191 
46 BAT3 31714784-31728456 93 CUTA 33492297-33494043 
47 C6ORF47 31734054-31736528 94 SYNGAP1 33495825-33529443 
 
Table 3.4 H3-K9/K14 acetylated genes across the MHC in HT1080 cells identified 
by ChIP assays coupled with MHC tiling path arrays. The H3-K9/K14 acetylated 
genes were identified setting an array enrichment cut-off of 3 standard deviations of the 
mean. 
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3.3  Discussion 
 
The MHC tiling path arrays were validated using three strategies: 1) self-self DNA 
hybridisations 2) hybridisations of CIITA-enriched DNA 3) hybridisations of DNA 
enriched in H3-K9/K14 acetylation. Self-self hybridisations indicated that the array 
probes exhibited a high degree of hybridisation uniformity. Hybridisations of DNA 
enriched in CIITA and H3-K9/K14 acetylation showed that specific DNA-protein 
interactions at previously characterised MHC sites could be detected with high 
reliability. For each set of experiments, findings compared well with quantitative real-
time PCR. Taken together, these results demonstrate the utility of the tiling path array in 
profiling DNA-protein interactions across the MHC locus.  
 
In contrast to most commercial arrays, these MHC array platforms include repetitive 
sequences, which were blocked in each experiment using Cot1 DNA. Control 
hybridisations were performed with the MHC tiling path arrays, with and without Cot1 
DNA (Tomazou et al., 2008). These experiments showed that when using Cot1 DNA, 
the intensities of repeat-containing probes are similar to those detected for repeat free 
probes. This suggests that unwanted signals derived from repetitive elements can be 
efficiently suppressed and that the unique regions of repeat containing probes are 
informative and can be used for further analysis (Tomazou et al., 2008). The array 
probes constituted entirely of repetitive sequences were removed from further analyses 
since hybridisation to those sequences would be non-specific.  
 
Control self-self hybridisations were carried out to identify any array probes that failed 
to give the expected ratios of fluorescent dyes and to determine the experimental 
variation. In these experiments, the log2 ratio for each probe was expected to be close to 
zero. The results did not reveal any probe with a ratio deviating significantly from the 
expected values. The experimental variation, defined as the technical background 
signal, was determined by calculating the standard deviation of the array probes. This 
was extremely low in each hybridisation indicating that the results were consistent and 
reproducible. The results of the self-self experiments were then validated using an 
independent method. Quantitative real-time PCR was carried out across six randomly 
selected regions, indicating that there were no significant enrichments of either DNA 
sample, thus further confirming the array data. 
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Array hybridisations with ChIP DNA samples obtained using antibodies against CIITA 
identified 27 CIITA-enriched loci. These sequences include 12 proximal-promoter 
regulatory modules, SXY, and 2 distal regulatory modules, S’-Y’, of the classical and 
non-classical MHC class II genes. The MHC class II contains a total of 12 proximal-
promoter regulatory modules, SXY, and 4 distal regulatory modules, S’-Y’, for a total 
of 16 characterised CIITA target sites (Krawczyk et al., 2004). The S’-Y’ module from 
HLA-DRA was not represented on the arrays since it was refractory to PCR 
amplification. Thus, out of the 15 CIITA target sites spotted onto the arrays, only one 
S’-Y’ module was not detected. This indicates that the MHC tiling path array is suitable 
for mapping DNA-protein interactions with high sensitivity. 
 
These SXY and S’-Y’ modules bind to RFX, CREB and NF-Y to form a landing 
platform that recruits CIITA (Krawczyk et al., 2004; Louis-Plence et al., 1997; 
Masternak et al., 2000). These proximal-promoter modules have been shown to be 
essential for the expression of the classical and non-classical MHC class II molecules 
(Reith and Mach, 2001). The promoters of the genes coding for the classical and non-
classical MHC class I molecules are also characterised by the SXY module (Gobin and 
van den Elsen, 2000; Krawczyk et al., 2008; van den Elsen et al., 2004). Although 
CIITA is involved in the basal and induced transcriptional activation of these MHC 
class I genes, its binding to their regulatory sequences has not been yet shown (van den 
Elsen et al., 2004). The MHC tiling path arrays coupled with the ChIP assay indicated 
that the array probes overlapping the SXY modules of several genes of the MHC class I 
are associated with CIITA. This suggests that CIITA might play a role in the expression 
of classical and non-classical MHC class I molecules by interacting at conserved 
binding sites. 
 
Six novel potential CIITA-binding sites were identified. These either overlap or are 
proximal to genes which have been implicated in a wide range of human diseases. 
TRIM14 encodes a member of the tripartite motif (TRIM) family of ubiquitin ligases 
(Meroni and Diez-Roux, 2005). By promoting the ubiquitination of substrate proteins, 
members of this family can alter their cellular location or function as well as regulating 
their degradation via the proteosome (Krawczyk et al., 2008). Krawczyk et al. (2008) 
suggested that an altered expression of TRIM proteins could potentially contribute to 
the development of tumours (Krawczyk et al., 2008). MICA encodes a transmembrane 
glycoprotein that functions as a ligand for NK cells (Zou et al., 2005). The expression of 
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MICA has been associated with a risk of developing several autoimmune and immune-
mediated diseases (Gambelunghe et al., 2005). DPCR1 synthesises a multiple-domain 
transmembrane protein which has been linked with diffuse panbronchiolitis (Matsuzaka 
et al., 2002). HLA-G is an HLA class I heavy chain paralogue. Its expression is confined 
to extravillous cytotrophoblast cells and has been proposed to play a role in materno-
fetal tolerance (Gobin and van den Elsen, 1999). Previous studies suggest that HLA-G 
transcription is not responsive to CIITA mediated pathways, however, the implication 
of CIITA in the regulation of HLA-G cannot be conclusively excluded at present (Gobin 
and van den Elsen, 1999). TUBB synthesises β-tubulin, a GTPase. Mutations in the 
TUBB gene were shown to be a good predictor of chemotherapy responses in non-small 
cell lung cancer (Monzo et al., 1999). TAP1 encodes a membrane-associated protein 
that is involved in the processing of endogenous peptides that bind to MHC class I 
molecules (Alvarado-Guerri et al., 2005). This protein is associated with susceptibility 
to coeliac disease and insulin-dependent diabetes mellitus (Colonna et al., 1992).  
 
A recent microarray study by Krawczyk et al. (2008) did not identify these six potential 
CIITA target sites. This work was carried out with a microarray carrying only the 
promoter regions of 27434 human genes (Krawczyk et al., 2008). Thus the novel 
putative CIITA-binding sites identified in TUBB and MICA could have not been 
identified as they are located away from their promoter regions. The remaining four 
potential CIITA target sites could have been missed since Krawczyk et al. (2008) used a 
different microarray platform (NimblGen) and analysed the data using a software 
(SignalMap, NimblGen) which identified positive peaks using a 500 bp sliding window 
containing five consecutive peaks. It is also possible that these novel potential CIITA-
bindings sites are false positives generated during the amplification step that I used to 
generate sufficient quantities of DNA for microarray analysis. The DNA was amplified 
using ligation-mediated PCR, an approach which could introduce sequence-dependent 
and length-dependent biases due to the ligation efficiency and kinetics of the PCR 
reaction. Furthermore, the amplification of low abundance species can be highly 
variable. One way to validate the CIITA target sites identified with the microarrays 
would be to identify them with PCR using ChIP DNA products which have not been 
subjected to amplification. Due to the amplification step, the quantitative real-time PCR 
could not conclusively confirm the novel CIITA target sites, however, it was successful 
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in validating the array results demonstrating that the MHC tiling path array can be used 
to screen DNA-protein interactions.  
 
To further validate the array platform we used ChIP in combination with the MHC 
tiling path arrays to profile histone H3-K9/K14 acetylation. This histone modification is 
a hallmark of transcriptional activation and has been previously reported to be 
associated with the 5’ ends of active human genes (Kurdistani et al., 2004; Liang et al., 
2004; Pokholok et al., 2005; Roh et al., 2005). The array results have shown that the 5’ 
ends of the constitutively active classical MHC class I genes are highly acetylated while 
the 5’ ends of the transcriptionally silent classical MHC class II genes do not exhibit 
high levels of acetylation. This experiment did not require an amplification step since 
the DNA quantities obtained from ChIP using antibodies against acetylated H3-K9/K14 
were suitable to carry out array hybridisations. Quantitative real-time PCR confirmed 
the array results demonstrating that the MHC tiling path array is a powerful tool for the 
study of the histone modifications characterising the MHC locus. Major advances in our 
understanding of the role of histone acetylation in regulating gene expression comes 
from studies in yeast where the genome has high levels of acetylation, largely localised 
at the promoter as well as the coding regions of active genes (Bernstein et al., 2002; 
Kurdistani et al., 2004). Recent studies in human cells, however, have suggested that 
H3-K9/K14 acetylation occurs predominantly at the beginning of transcriptionally 
active genes (Liang et al., 2004; Litt et al., 2001; Roh et al., 2005). This is in agreement 
with the MHC array data, which indicate that acetylation is highest at the 5’ ends of 
constitutively expressed MHC genes and decreases downstream of their start sites. 
 
A recent study has shown that the MHC tiling path array is suitable for the profiling of 
DNA methylation across the MHC of different cell types (Tomazou et al., 2008). This 
investigation, in combination with the study of H3-K9/K14 acetylation of the MHC, 
strongly suggests that this array platform can facilitate comprehensive epigenetic 
analyses of this region. In addition, the experiments identifying CIITA target sites 
indicate that these arrays can be also used to map MHC regions interacting with 
proteins involved in the regulation of MHC genes. Based on the design of these arrays 
we also expect them to be compatible with additional assays including array 
comparative genomic hybridisation (aCGH), expression profiling and the biochemical 
extraction of MARs. 
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4 Genomic anchors in MRC5 fibroblasts 
 
4.1 Introduction 
 
MARs have been implicated in numerous aspects of gene regulation (Berezney et al., 
1995; Singh et al., 1997). They can recruit chromatin remodelling enzymes, histone 
modifying enzymes, and transcription factors, including SATB1 and SAFB1, and can 
increase transgene expression by shielding the transgene from the silencing effects of 
neighbouring chromosomal regions (Cai et al., 2006; Girod et al., 2007; Oesterreich, 
2003). However, before this study was performed only a few MARs were identified, 
limiting our understanding of how they function (Linnemann et al., 2007).  
 
Individual MARs were identified previously by quantitative real-time PCR and in vitro 
binding affinity of genomic sequences to the nuclear matrix. The need to identify MARs 
on a genome-wide scale has led to the development of algorithms for their prediction 
based on the sequence patterns associated with experimentally defined MARs. 
However, the predicted sequences are not always in agreement with experimental data 
(Linnemann et al., 2007).  Such inconsistencies could be due to our current incomplete 
understanding of MAR sequences and/or to the fact that a significant proportion bind to 
the nuclear matrix in a cell and stage-specific manner (Heng et al., 2004; Linnemann et 
al., 2007; Ostermeier et al., 2003). 
 
The development of high-throughput technologies presents the opportunity to construct 
detailed genome-wide maps of MARs. Ioudinkova et al. (2005), working on the 40 kb 
domain at the α-globin gene domain, were the first to show that MARs could be 
successfully identified by hybridising them onto oligonucleotide arrays of a specific 
genomic region (Ioudinkova et al., 2005). Taking a different approach, Linnemann et al. 
(2008) identified MARs on human chromosome 16 by competitively hybridising MAR 
and halo DNA onto genomic microarrays (Linnemann et al., 2008). The positions of 
MAR and halo DNA sequences, which were previously differentially labelled with 
fluorochromes, were then determined by calculating the ratio of fluorochrome 
intensities at each microarray probe.  
 
Since the primary sequence and linear organisation of the MHC have been extensively 
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characterised, it provides an ideal model region to investigate the structural and 
functional role of MARs. In this chapter, MARs were mapped across the MHC of 
human fibroblasts using the biochemical isolation of MAR and halo DNA fractions 
followed by their co-hybridisation to the tiling path array covering the MHC locus. 
 
MARs were found to be non-randomly distributed across the MHC, since most were 
located in the class I and II regions. Furthermore, they mainly had intergenic positions, 
closely flanking several class I and II genes as well as the MHC class boundaries. These 
data suggest that MARs define chromatin domains and contribute to the class-specific 
regulation of the locus. Sequence analysis of MARs did not reveal a unique consensus 
but established significant correlations between MARs and particular genomic features, 
reinforcing the view that the DNA binding ability to the nuclear matrix might depend on 
DNA sequence context rather than on a unique primary sequence. Finally, validation of 
the microarray data by real-time PCR indicates that the array platform can reliably 
identify interactions of MHC sequences with the nuclear matrix and can thus be used to 
characterise the dynamics of MARs in cells exhibiting different MHC expression 
profiles. The findings in this Chapter and Chapter 5 are included in a paper in press 
(Ottaviani et al., 2008a). 
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4.2  Results 
 
4.2.1 Biochemical isolation of matrix attachment regions from MRC5 
fibroblasts 
 
MARs were isolated by treating nuclei from MRC5 fibroblasts with 2 M NaCl followed 
by nuclease digestion. The hypertonic treatment removed the soluble proteins, including 
histones, causing the DNA to loop out of the nuclei (Cai and Kohwi-Shigematsu, 1999; 
Kramer and Krawetz, 1996). This resulted in the formation of histone-depleted halo 
structures consisting of extruded ‘loop’ DNA. Within the residual nucleus, the DNA is 
anchored to the nuclear matrix through MARs (Gerdes et al., 1994; Kramer and 
Krawetz, 1996). After digesting these structures with restriction enzymes, sedimentation 
was used to separate the MARs from the halo DNA (Ostermeier et al., 2003). 
 
To allow the full extraction of soluble proteins from nuclei and obtain reproducible 
results, the time of incubation with 2 M NaCl had to be optimised. The optimal time, 
defined as the minimum incubation time required to reach the maximum halo size, was 
previously shown to vary according to the cell type (Martins and Krawetz, 2007; 
Ostermeier et al., 2003).  
 
Nuclear preparations were made from MRC5 cells, placed onto microscope slides and 
incubated in 2 M NaCl for varying times ranging from 0 to 15 min. The nuclei were 
then stained with DAPI and visualised under a Zeiss Axiophot microscope equipped for 
epifluorescence. The average size of the halo structures was determined by measuring 
the distance between the perimeter of the halo and the edge of the residual nuclear 
border of 30 cells in 3 biologically independent experiments. The optimal incubation 
time for MRC5 nuclei was found to be 12 min as this produced the largest circular halo 
structures (Fig 4.1, Fig 4.2). The nuclei not incubated with 2 M NaCl, which were used 
as negative controls, did not form halo structures. Incubation times shorter than the 
optimal time restricted the extraction of soluble nuclear proteins and led to the 
formation of small circular nuclear halo structures. Incubation times longer than optimal 
generated halo structures of highly variable shapes and sizes. 
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Figure 4.1 Relationship between halo size and incubation time of MRC5 nuclei 
with 2 M NaCl.  
The size of halo structures at each time point was determined by averaging the distance 
of the perimeter of the halo structure from the edge of the residual nuclear border in 30 
nuclei. An increase in halo size between 0 and 12 min of incubation time is followed by 
a slight decrease at 15 min. The optimal incubation time, defined as the minimum 
incubation time producing the largest circular halo structures, was 12 min. Boxplots 
show the interquartile range of the data, with the horizontal black lines running through 
each boxplot representing the median values of three independent biological 
experiments. The whiskers extend as far as 1.5 times the interquartile range. 
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Figure 4.2 Visualisation of nuclear halo structures in nuclei of MRC5 cells.  
DAPI-stained nuclei after different incubation times in 2 M NaCl (time shown for each 
panel). a) Halo structures were not seen in untreated nuclei. b) Incubation of nuclei with 
2 M NaCl for times shorter than optimal generated circular halo structures with a width 
ranging from 0 to 5 µm. c) The optimal incubation time formed circular halo structures 
with a width ranging from 2 to 7 µm. d) Incubations longer than the optimal time 
produced halo structures of highly variable shapes, with widths ranging from 0.5 to 6.5 
µm. The scale bar is 20 µm. 
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Following optimal extraction of nuclei with 2 M NaCl, EcoRI and HindIII restriction 
enzymes were added to the extracted nuclei to digest the DNA into short fragments of 
approximately 1.5-2.5 kb. MARs were protected from digestion by their strong 
interaction with nuclear matrix proteins and were selectively retained in nuclear 
matrices, enabling their separation from the dissociated halo DNA. After isolating these 
two fractions by high-speed centrifugation, their DNA was purified and quantified. The 
biochemical isolation of MARs was performed five times starting from different MRC5 
populations to obtain five independent biological replicates. In all samples, more than 
70% of the DNA was found to be in the halo fraction (Table 4.1). 
 
 
 
 
 
Table 4.1 Percentage of DNA in the MAR and halo fractions of MRC5 samples. 
Over 70% of the DNA was consistently found in the halo fraction, assuming 100% 
when the MAR and halo fractions were combined. 
 
 
 
To confirm that the isolation procedure was performed accurately and consistently, 
quantitative real-time PCR was performed using the purified MAR and halo fractions to 
interrogate previously characterised MARs and non-MARs sequences. Each amplicon 
was quantified using standard curves produced for each primer pair from real-time PCR 
reactions with known amounts of genomic DNA. To compare the quantity of each 
amplicon in the MAR and the halo fractions, PCR reactions were carried out with equal 
 6 min 
15 min 
 6 min 
15 min 
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amounts of template and equal amounts of master-mix. For each amplicon, PCR 
reactions were performed at the same time using the same cycling conditions. 
 
The amplicons PRM2 and F, which map to intragenic regions of the protamine 2 and 
the δ-globin gene respectively, were used as non-MAR controls since they are 
sequences consistently enriched in the halo fraction of several somatic cells (Kramer 
and Krawetz, 1996; Kramer and Krawetz, 1997; Ostermeier et al., 2003). The 
amplicons HS3 and rep30, which are located within the β-globin LCR and upstream of 
the γ-globin gene respectively, were used as controls for MARs since they are well 
characterised in human fibroblasts (Ostermeier et al., 2003). The results show 
significant enrichment of PRM2 and F in the halo fractions and of HS3 and rep30 in the 
MAR fractions (Fig 4.3). The proportion of each amplicon in the MAR and halo 
fractions was calculated by assuming 100% when the average of the MAR and halo 
fractions were combined. The MAR fractions contained 75% and 72% of the HS3 and 
rep30 amplicons, respectively, while the halo fractions contained 81% and 83% of the 
PRM2 and F amplicons, respectively. These findings indicate that the isolation of MAR 
and halo fractions was consistent, and therefore, these samples could be used for further 
analysis. 
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Figure 4.3 Enrichment of MAR and non-MAR amplicons in MAR and halo 
fractions of MRC5 cells.  
Quantitative real-time PCR was performed using matrix and halo DNA samples from 
five biologically independent experiments and primer pairs spanning known MAR (HS3 
and rep30) and non-MAR (PRM2 and F) sequences. Bars represent the mean of five 
experiments, and show the standard deviation. 
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4.2.2 Hybridisation of matrix attachment regions and halo DNA onto MHC 
tiling path arrays 
 
A procedure combining the traditional biochemical isolation of matrix attached DNA 
with microarray technology was then used to identify MARs across the MHC of MRC5 
cells. Equal amounts of MAR and halo DNA from each sample were differentially 
labelled by random priming with Cy-5 and Cy-3 fluorophores and competitively 
hybridised onto the genomic MHC tiling path array. The labelled DNA fragments 
identified the sequences corresponding to MAR and halo DNA in the MHC by binding 
to matching sequences on the array.  
 
Array hybridisations were carried out with MAR and halo DNA from samples 1 and 2. 
Both experiments included a dye swap to correct the bias introduced by the different 
properties of the fluorescent dyes. The relative intensity of the fluorescent dyes across 
each locus was calculated and log2 transformed. Each locus was represented four times 
in the MHC platform. Since two experiments were performed, a total of eight data 
points were obtained for each locus. Subsequently, the combined mean values for each 
locus were calculated and plotted on the UCSC human genome database 
(http://genome.ucsc.edu, May 2004 Assembly) (Fig 4.4). 
 
The graphical representation of the results indicates that MAR and halo DNA sequences 
are not evenly distributed across the MHC of MRC5 cells. The class I region contains 
approximately equal amounts of MAR and halo DNA, the class II region contains 
mainly MAR DNA, and the class III and the extended class II regions consist mainly of 
halo DNA. The overwhelming majority of MAR DNA is contained across the classical 
class I and II regions. Visual examination of the results suggests that the halo DNA has 
a high GC content and is enriched in gene-dense and conserved regions while MARs 
correlate positively with high AT content and gene-poor regions. 
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Figure 4.4 Competitive hybridisation of differentially labelled MAR and halo DNA 
fractions on MHC tiling path arrays.  
MAR and halo DNA fractions were differentially labelled with Cy3 and Cy5 
fluorophores and competitively hybridised onto the MHC microarray platform. The 
log2 ratios of MAR/halo DNA were calculated and plotted on the UCSC genome 
database (http://genome.ucsc.edu/). Positive values represent MARs while negative 
values represent halo DNA (mean ratios of two independent experiments). The GC 
content, positions of RefSeq genes and human mRNAs from GeneBank, regions of 
conservation between 17 vertebrate species and the repetitive sequences LINE, SINE 
and LTR across the MHC are shown below the array data. The different regions of the 
MHC are highlighted in different colours: classical class I – red; classical class III – 
blue; classical class II – yellow; and extended class II – green. 
 110 
4.2.3 Quantitative real-time PCR analysis of matrix attachment regions 
and halo DNA 
 
In order to validate the array results, twenty regions across the MHC were subjected to 
independent quantitative real-time PCR using MAR and halo DNA fractions from 
samples 3, 4 and 5. Eight regions were enriched in halo DNA, according to the 
microarray data, while the remaining twelve were MAR-enriched. These test regions 
were selected within or near genes critical for the functioning of the immune system, 
genes not directly involved in immunity, as well as boundaries separating the MHC 
classes.  
 
The eight regions enriched in the halo DNA according to the microarray data were 
situated within HLA-G, HLA-DRB5, HLA-C, TAP1, HLA-E, LY6G5C, HLA-DRA and 
upstream of TRIM15. Real-time PCR confirmed high enrichment in the halo fraction for 
the regions overlapping HLA-G, HLA-DRB5, HLA-C, TAP1, HLA-E, LY6G5C, and 
upstream of TRIM39 and no significant enrichment in the halo fraction for the region 
overlapping HLA-DRA (Fig 4.5). These regions had array ratios equal to or lower than -
0.003 (log2). 
 
Of the twelve regions enriched in the MAR fraction according to the microarray data, 
eight were successfully validated with quantitative real-time PCR (Fig 4.6). These 
regions, which were located upstream of NOTCH4, HLA-C, ZBTB2 and HLA-A, 
downstream of HLA-DOB, PRRT1 and HLA-DPB1, and overlapping TRIM15, had array 
ratios equal to or higher than 0.52 (log2). The remaining four regions, upstream of 
C6orf10, HLA-B, MICA and HLA-F, were not validated since HLA-B, C6orf10 and 
MICA were highly enriched in the halo fraction and HLA-F showed low enrichment in 
the halo fraction according to real-time PCR (Fig 4.7). These regions had array ratios 
equal to or lower than 0.32 (log2). 
 
Further analysis of these results revealed a relationship between high array ratios 
indicating enrichment in the MAR fraction and successful real-time PCR validation 
(Table 4.2). In order to exclude false positive MARs, a threshold was empirically 
determined using a series of real-time PCR as described in Chapter 2. MHC regions 
having array enrichments equal to or higher than 0.4 (log2) were defined as MARs since 
they were consistently confirmed with real-time PCR. MHC regions having array 
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enrichments lower than 0.4 (log2) were defined as non-MARs as real-time PCR showed 
that they were either not significantly MAR-enriched or halo-enriched. 
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Figure 4.5 Quantitative real-time PCR analysis of halo-enriched loci in MRC5 
cells.  
Real-time PCR was carried out with primer pairs spanning eight loci, which were 
enriched in the halo fraction according to the results of array experiments. The loci 
HLA-G, HLA-DRB5, HLA-C, TAP1, HLA-E, LY6G5C and the upstream region of 
TRIM39 were confirmed to be highly enriched in the halo fraction while significant 
enrichment in the halo fraction was not confirmed for the amplicon overlapping HLA-
DRA. Bars represent the mean of three biologically independent experiments, and show 
the standard deviation. 
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Figure 4.6 Quantitative real-time PCR analysis of loci showing high MAR 
enrichment in MRC5 cells. 
Real-time PCR was carried out with primers pair spanning eight loci, which were found 
to be highly enriched in the MAR fraction in the array experiments. The regions 
upstream of NOTCH4, HLA-C, ZBTB12, HLA-A, downstream of HLA-DOB, PRRT1, 
HLA-DPB1 and overlapping TRIM15 were confirmed to be highly enriched in the MAR 
fraction. Bars represent the mean of three biologically independent experiments, and 
show the standard deviation. 
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Figure 4.7 Quantitative real-time PCR analysis of loci showing low MAR 
enrichment in MRC5 cells.  
Real-time PCR was carried out with primer pairs spanning within regions of low MAR 
enrichment according to the array data. The regions upstream of HLA-B, MICA and 
C6orf10 were confirmed to be highly enriched in the halo fraction while significant 
enrichment in either the halo or MAR fraction was not observed for the region upstream 
of HLA-F. Bars represent the mean of three biologically independent experiments, and 
show the standard deviation. 
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Number MHC region Array 
enrichment value 
(log2) 
Expected 
enrichment based 
on array data 
Observed 
enrichment by 
real-time PCR 
1 HLA-A 1.606 MAR MAR 
2 TRIM15 1.104 MAR MAR 
3 HLA-DPB1 1.008 MAR MAR 
4 PRRT1 0.702 MAR MAR 
5 NOTCH4 0.625 MAR MAR 
6 ZBTB2 0.575 MAR MAR 
7 HLA-C 0.522 MAR MAR 
8 HLA-DOB 0.501 MAR MAR 
9 MICA 0.326 MAR Halo 
10 HLA-B 0.29 MAR Halo 
11 C6orf10 0.118 MAR Halo 
12 HLA-F 0.105 MAR No enrichment 
13 HLA-DRB5 -0.003 Halo Halo 
14 TRIM39 -0.1 Halo Halo 
15 TAP1 -0.102 Halo Halo 
16 HLA-E -0.189 Halo Halo 
17 HLA-DRA -0.201 Halo No enrichment 
18 HLA-C -0.202 Halo Halo 
19 HLA-G -0.27 Halo Halo 
20 LY6G5C -0.301 Halo Halo 
 
Table 4.2 Loci analysed by real-time PCR.  
(1-8) Regions enriched in the MAR fraction based on the array data and successfully 
validated with real-time PCR have array ratios ranging from 0.501 to 1.606 (log2). (9-
12) Regions enriched in the MAR fraction based on the array data but not able to be 
validated with real-time PCR have array ratios ranging from 0.326 to 0.105 (log2). (12-
20) Regions enriched in the halo fraction according to the array data and successfully 
validated with real-time PCR have array ratios ranging from -0.003 to -0.301 (log2). The 
HLA-DRA and HLA-F regions were not found to be enriched in either the MAR or 
halo fractions by real-time PCR. 
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4.2.4 Position of matrix attachment regions across the MHC of MRC5 
fibroblasts 
 
To gain a better insight into the distribution of MARs relative to structural and 
functional characteristics of the MHC locus, a detailed map was constructed for MRC5 
cells using the array threshold of 0.4 (log2) (Fig 4.8).   
 
The graphical representation of the results confirms several trends observed earlier by 
plotting MAR and halo DNA. MARs are not evenly distributed across the MHC and are 
largely positioned within poorly conserved regions. The largest clusters of MARs are 
found within the class I and II regions, while the longest DNA regions lacking MARs 
are located in the class III and extended class II of the MHC suggesting that MAR 
position and gene density across the MHC are inversely correlated, as found in AoAF 
fibroblasts and the HeLa cell line (Linnemann, A. K., personal communication).  
 
Using the criteria described above, MARs were identified on average every 33 kb, 
consistent with a study on the 16q22 locus in HeLa cells (Shaposhnikov et al., 2007). A 
total of 117 MARs were identified across the MHC and subdivided as follows: 64 in the 
class I, 5 in the class III, 43 in the class II and 5 in the extended class II regions of the 
MHC. The class I, III, II and extended class II regions have, on average, one MAR per 
29, 144, 20 and 72 kb, respectively.  
 
Of the 117 MARs detected, 97 are intergenic whereas 19 are intragenic. Using a chi-
squared test, it was found that the bias of MARs to intergenic regions was statistically 
significant (p-value <0.0002; for all statistics a threshold p-value <0.01 was considered 
significant). Of these, 5 are within introns, 10 overlap introns and exons and 4 map to 
regions overlapping introns, exons and intergenic DNA (Table 4.3). Due to technical 
limitations including array resolution and the size of the DNA fragments generated by 
the biochemical isolation procedure, it was not possible to map these MARs more 
precisely. 
 
In this study, MARs are identified at the boundaries of the MHC class III and class II 
regions and the MHC class II and extended class II regions, and 30 kb away from the 
boundary of the MHC class I and class III regions (Fig 4.9). MARs have also been 
identified in regions flanking several genes that have critical roles in the adaptive 
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immune response such as HLA-A, HLA-C, HLA-E, HLA-G, HLA-DRA, HLA-DRB1, 
HLA-DRB5, HLA-DPA1, HLA-DPB1, HLA-DQA1 and HLA-DQB1 (Fig 4.10) (van den 
Elsen et al., 1998). These findings are consistent with previous studies showing that 
MARs can function as boundary elements (McKnight et al., 1992; Namciu et al., 1998). 
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Figure 4.8 MAR profile of MRC5 fibroblasts across the MHC.  
The mean value for two array hybridisations was calculated for each fragment 
represented in the MHC tiling path array. Regions enriched in the MAR fraction with 
mean ratios equal to or higher than 0.4 (log2) were plotted on the UCSC genome 
browser (http://genome.ucsc.edu/) and represented on the top row by black vertical 
lines. Below the array data are shown the GC content, the positions of RefSeq genes 
and human mRNAs from GeneBank, regions of conservation between 17 vertebrate 
species and the repetitive sequences LINE, SINE and LTR. The different regions of the 
MHC are highlighted in different colours: classical class I – red; classical class III – 
blue; classical class II – yellow; and extended class II – green. 
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MAR position (bp) Gene Organisation 
29802604-29804427 HLA-F 1 Exon/1 Intron/Intergenic region 
30146157-30148833 RNF39 1-2 Exons/1-2 Introns 
30231506-30234359 TRIM10 4 Exons/3 Introns 
30238940-30240972 TRIM15 1 Exon/1 Intron 
30698815-30701782 MRPS18B 2 Exons/2 Introns 
30731648-30734384 DHX16 4 Exons/5 Introns 
31865033-31867206 VARS 1 Intron 
31955316-31957399 EHMT2 3 Exons/3 Introns/Intergenic region 
32387922-32390488 C6ORF10 1 Intron 
32390209-32393140 C6ORF10 1 Intron 
32395956 32398655 C6ORF10 1 Exon/2 Introns 
32425489-32427795 C6ORF10 1 Exon/1 Intron 
32434975-32437634 C6ORF10 1 Intron 
32471036-32473567 BTNL2 1 Exon/2 Introns 
32904298-32906120 TAP2 3-4 Exons/3 Introns 
32931156-32933975 PMSB9 4 Exons/3 Introns 
33027231-33028946 HLA-DMA 1 Exon/1 Intron/Intergenic Region 
33283836-33286387 RING1 4 Exons/4 Introns/Intergenic Region 
33501985-33503886 SYNGAP1 1 Intron 
 
Table 4.3 Base pair (bp) position, gene name and DNA organisation of intragenic 
MARs across the MHC in MRC5 cells.  
Out of a total of 19 MARs, 5 are situated within individual introns, 10 are located 
within regions containing introns and exons and 4 MARs map to regions containing 
introns, exons and intergenic DNA.  
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Figure 4.9 Distribution of MARs at MHC class boundaries.  
The boundaries separating the MHC into different sub-regions are highlighted in grey. 
(A) The nearest MAR to the boundary separating class I from class III is approximately 
30 kb away from it. (B-C) The boundaries separating class III from class II and class II 
from extended class II contain 3 and 5 MARs, respectively.  
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Figure 4.10 Schematic representation of MARs flanking class I and II genes in 
MRC5 cells.  
MARs are represented by vertical black bars. (a-d) Class I genes HLA-A, HLA-C, HLA-
E and HLA-G. (e-i) Class II genes HLA-DRB5, HLA-DRA, HLA-DRB1, HLA-DQA1, 
HLA-DQB1, HLA-DPA1 and HLA-DPB1. 
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4.2.5 Sequence analysis of matrix attachment regions 
 
Several genomic features including conservation, AT content, gene and repetitive 
sequences density of MAR and non-MARs within the MHC were analysed using public 
databases and the sequence analysis tools provided by the UCSC Genome Project 
(http://genome.ucsc.edu/). 
 
The AT content of the MARs ranged from 39 to 67% with an average value of 58% 
while that of the non-MARs ranged from 32 to 72% with an average value of 53% 
confirming the previous reports that MARs are generally AT-rich DNA sequences (Fig 
4.11a) (Purbowasito et al., 2004; Shaposhnikov et al., 2007). Using a χ2 test, we found 
that the difference in AT content between MAR and non-MAR sequences was 
statistically significant (P-value of 0). Comparative analysis of AT-rich tracts in MARs 
failed to reveal a precise organisation of AT motifs. 
 
The proportion of intragenic sequences is under-represented by almost twofold among 
MARs relative to non-MARs (P-value < 0.0002) (Fig 4.11b). This is consistent with the 
graphical evaluation of the results showing that most MARs identified within the MHC 
are intergenic and are positioned in relatively gene-poor regions, while non-MARs 
extend intragenically and contain most gene-rich regions. 
 
According to multiple whole-genome alignments of 17 vertebrates including 
mammalian, amphibian, bird, and fish species, non-MARs are more conserved than 
MARs (P-value < 0.008). These findings agree with other studies showing that the 
primary sequence of MARs is not conserved across species despite the fact that their 
functions are evolutionary conserved (Fig 4.11c) (Glazko et al., 2003). 
 
The average content of repetitive sequences of MARs is 63%, while that of non-MARs 
is 45% (P-value of 0) (Fig 4.12a). A detailed analysis of different classes of repetitive 
sequences revealed that MAR and non-MAR DNA sequences do not differ significantly 
in relation to LTR content (P-value of 1) (Fig 4.12b), that non-MARs have a larger 
proportion of SINEs compared to MARs (P-value < 0.006) (Fig 4.12c), and that LINEs 
are over-represented by almost three-fold among MARs relative to their overall 
abundance in non-MARs (P-value < 0.002) (Fig 4.12d). 
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Figure 4.11 Sequence analysis of MARs and non-MARs in relation to different 
genomic features.  
a) The AT content (P-value of 0) b) the proportion of coding region (P-value < 0.0002) 
c) and the degree of conservation were calculated for MARs and non-MARs sequences 
(P-value < 0.008). The conservation score was used as a measure of evolutionary 
conservation and was calculated using the conservation track of the UCSC Genome 
Project (http://genome.ucsc.edu/), which describes the multiple alignment of 17 
vertebrate species. The bars represent the mean values of two biologically independent 
experiments and show the standard deviation. 
 
 124 
 
 
Figure 4.12 Sequence analysis of MARs and non-MARs in relation to different 
classes of repetitive sequences.  
a) The average repetitive content (P-value of 1), b) the LTR (P-value of 1), c) the SINE 
(P-value < 0.006) and d) the LINE abundance were calculated for MARs and non-
MARs (P-value < 0.002). The bars represent the mean values of two biologically 
independent experiments and show the standard deviation.   
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4.2.6 Comparison between matrix attachment regions identified 
experimentally and in silico 
 
Several computer programmes have been developed to predict the positions of MARs. 
Each of these recognises a unique set of motifs associated with MARs. SIDD identifies 
regions with a tendency for base-unpairing (Benham et al., 1997). MARScan identifies 
a bipartite sequence common to a large number of eukaryotic MARs (van Drunen et al., 
1999). ChrClass identifies sequences that associate with different components of the 
nuclear matrix including lamins A, B and C (Glazko et al., 2001). Here, the 
performance of these, SIDD, MARScan and ChrClass, was assessed by comparing in 
silico predictions with the experimental data. 
 
The three programmes predicted different numbers of MARs for the MHC ranging from 
187 to 617. The total number of predicted MARs matching (true positives) or not 
matching (false positives) the experimentally defined MARs in MRC5 fibroblasts is 
shown in Table 4.4. As expected for such heterogeneous sequences the number of false 
positives is high. ChrClass predicted most true and false positives while MARScan 
predicted the fewest.  
 
The accuracy of each computer programme is also expressed using specificity and 
sensitivity scores (Table 4.4). The specificity is defined by the formula: (number of true 
positives)/(total number of predictions) while the sensitivity is defined by the formula: 
(number of true positives)/(total number of expected MARs). The highest sensitivity 
was shown by ChrClass and the lowest by MARScan. A low specificity was found for 
all three programmes. Overall the programme with the best performance in terms of 
sensitivity and specificity was ChrClass. 
 
Of the 117 predicted experimentally identified MARs, 18 were not predicted by any of 
the three programmes, suggesting that additional features should be considered to 
develop more accurate MAR prediction programmes.  
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 ChrClass SIDD MARScan 
Total Predicted 617 543 187 
True Positive 97 63 27 
False Positive 520 480 160 
False Negative 27 61 97 
Specificity 0.16 0.12 0.14 
Sensitivity 0.83 0.54 0.23 
 
Table 4.4 Comparison between different MAR predicting algorithms.  
True positives are predictions coinciding with the experimentally defined MARs in 
MRC5 fibroblasts. False positives are predictions that do not coincide with 
experimentally identified MARs. False negatives are the experimentally identified 
MARs that are not predicted by each programme. The specificity is given by the total 
number of true positives divided by total number of predictions. The sensitivity is 
determined by the number of true positives divided by the total number of 
experimentally identified MARs. 
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4.3  Discussion 
 
In this chapter, MARs were identified across the MHC in human MRC5 fibroblasts 
using MHC tiling path arrays. The key finding is that MARs are non-randomly 
distributed across the MHC as they cluster at specific locations. Although a unique 
sequence consensus was not identified, the sequence context of MARs was defined. 
MARs reside within DNA regions of high AT and repetitive sequences content and low 
gene density. Most of the MARs identified are situated within intergenic domains of the 
MHC class I and II regions, closely flanking several genes that are critical for 
immunity, as well as at the boundaries of the MHC sub-regions. This suggests that the 
folding of the MHC might contribute to transcriptional regulation by defining distinct 
chromatin domains. 
 
The 117 MARs identified in the MHC divide the locus into loop domains averaging 35 
kb in size. This is similar to the 36 kb loop size estimated for human chromosome band 
16q22.1, but smaller than the 50-200 kb predicted by the ‘multi-loop sub-compartment 
model’ which appears to be the model most compatible with recent experimental 
findings (Munkel et al., 1999; Ottaviani et al., 2008b; Shaposhnikov et al., 2007). It is 
important to note that the frequency of MARs has been shown to vary greatly across the 
human genome. For example, telomeres have one MAR per kb, while the 19q13.12 
band has one MAR every 88 kb (Chernov et al., 2002; Luderus et al., 1996). A 
substantial variation in MAR density is present between the MHC sub-regions. More 
than 90% of the MARs identified are in the class I and II regions, which have loop sizes 
averaging 37 kb and 18 kb respectively. The MHC class III and extended class II 
regions contain less than 10% of the MARs and have larger loop sizes of 147 kb and 72 
kb, respectively.  
 
The class I and II regions are characterised by a higher AT content and repetitive 
sequences, lower gene density and lower overall conservation compared to the class III 
and extended class II regions. Computer-assisted analysis was used to define the 
characteristics of MAR sequences. A positive correlation was found between MARs 
and LINEs. This finding is in agreement with a study of experimentally identified 
sequences collected in the MAR transaction database 
(http://transfac.gbf.de/SMARtDB/) (Jordan et al., 2003). The study revealed that LINEs 
are over-represented by more than twofold in human MARs relative to their overall 
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density in the human genome (Jordan et al., 2003). Analysis of the 1 Mb imprinted 
domain on mouse chromosome 7 also showed a similar LINE enrichment in MAR 
sequences (Purbowasito et al., 2004). Another positive correlation was found between 
MARs and high AT content. The AT content of MAR sequences ranged from 39% to 
67% with an average of 58%, which is higher than that of surrounding regions, which is 
53%. This is compatible with studies in mice and humans, which showed that the AT 
content of MARs is often only slightly higher than that of their whole genomes 
(Purbowasito et al., 2004; Shaposhnikov et al., 2007). One of the best-characterised 
MARs, located in the FRA1B fragile site of CEM leukaemic cells, is almost entirely 
constituted of AT-rich minisatellites that appear to strengthen its attachment to the 
nuclear matrix (Jackson et al., 2003). Nevertheless, a large body of evidence suggests 
that high AT content alone is not sufficient to ensure binding to the nuclear matrix 
(Bickmore and Oghene, 1996; Das et al., 1993; von Kries, 1991). 
 
In this chapter, the relationship between MAR sequences and other genomic features 
including gene density, coding or non-coding DNA and evolutionary conservation were 
examined. There is a negative correlation between MARs and gene density. This 
relationship is most clearly seen in the classical class III region, which has the highest 
gene density in the whole genome and the lowest MAR frequency among the MHC sub-
regions. Similar results were observed by a recent study analysing MARs in 
chromosome 16 in AoAf and HeLa cells, suggesting that gene-rich regions are 
generally less topologically constrained than gene-poor regions (Linnemann et al., 
2008). My findings show that MARs are frequently located within intergenic sequences.  
 
Clusters of MARs were mapped near the boundaries separating the MHC sub-regions 
and flanking a significant number of classical class I and II genes including HLA-F, 
HLA-G, HLA-C and HLA-DRA. This indicates that the interaction between the nuclear 
matrix and MARs could define chromatin domains, in agreement with several reports 
suggesting that MARs could function as boundary elements by topologically 
constraining the DNA into loops or by forming a physical barrier that blocks 
interactions between promoters and unrelated enhancers (Dunn et al., 2003; 
Nabirochkin et al., 1998).  
 
Sequence analysis of MAR sequences did not identify a unique MAR consensus and 
showed a negative correlation between MARs and evolutionary conserved domains. 
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However, studies in eukaryotic organisms ranging from plants to mammals, clearly 
show that the tethering function of MARs is conserved across different species 
(Eivazova et al., 2007; Ioudinkova et al., 2005; Michalowski et al., 1999; Ostermeier et 
al., 2003). These findings reinforce the view that the interactions of MARs with the 
nuclear matrix is likely to depend on DNA sequence contexts generating distinct 
structures rather than on a primary sequence consensus. 
 
The positions of the experimentally identified MARs in the MHC were compared to 
those predicted by three different MAR prediction programs, namely ChrClass, SIDD 
and MARScan. The general conclusion is that while ChrClass showed high sensitivity, 
outperforming SIDD and MARScan, and might be considered as valuable tool for 
genome-wide studies, each of these computer programs showed reduced specificity. 
Hence, the identification of an increasing number of MAR sequences will be essential 
to develop more accurate MAR prediction algorithms.  
 
The MHC tiling path array was used successfully to identify MARs across the entire 
MHC locus. However, a disadvantage is that MARs are 100-2000 bp and the 2 kb 
resolution of the arrays is not sufficient to define their sequence at the base pair level. A 
limitation of the data analysis strategy is that the stringent threshold used to define 
MARs might have led to an under-representation of the number of MARs across the 
MHC. The threshold of array enrichment to define MARs was set at approximately 4 
standard deviations of the mean on the basis of real-time PCR reactions that were 
carried out to validate the array data. Values of enrichment below such a threshold 
could not be consistently validated with real-time PCR. One reasonable assumption 
might be that the low enrichment of several clones of the MHC tiling path arrays could 
represent background signal due to hybridisation of non-specific DNA sequences. 
Using the relatively stringent threshold of 4 standard deviations, the rate of false 
positives was estimated from the real-time PCR results to approach 0% but the rate of 
false negatives was predicted to be approximately 2%. 
 
Not all previous investigations agree with our findings. For example, the study by 
Shaposhnikov et al. (2007) showed that 98% of the MARs identified in band 16q22.1 in 
HeLa S3 cells are localised within genes (Shaposhnikov et al., 2007). This contrasts 
with our findings indicating that more than 80% of the MARs in the MHC are situated 
outside genes. The same group mapped MARs within the 19q13.12 region and found 
 130 
that only approximately half of the MARs were situated within genes (Chernov et al., 
2002). Here, the differences in MAR distribution observed in several loci are probably 
not due to the different methodologies used to identify MARs but are likely to reflect 
the distinct spatial organisation of different regions of the genome. Given the 
heterogeneity of the human genome it is reasonable to expect the data to differ 
substantially.  
 
Inconsistencies between different studies could also due to the cell or tissue types used, 
or due to the replication and transcription status of a given genomic domain (Heng et 
al., 2004; Ostermeier et al., 2003). Several studies, including one characterising SATB1, 
have shown that MARs can bind to cell type specific matrix proteins suggesting that a 
proportion of MARs are cell type specific (Cai et al., 2006). Other studies have 
indicated that the binding of certain MARs to the nuclear matrix correlates with 
transcription or replication of the loci with which they are associated (Anachkova et al., 
2005; Eivazova et al., 2007; Heng et al., 2004). The type of procedure used to isolate 
MARs might also be responsible for inconsistencies. A comparison of different matrix 
extraction procedures showed that 2 M NaCl led to the isolation of several MARs that 
differed from those isolated using 25 mM LIS and 0.65 M ammonium sulphate (Donev, 
2000). 
 
In conclusion, I have identified MARs across the MHC region of human MRC5 
fibroblasts. This is the first study to map MARs within a 4 Mb locus at a relatively high 
resolution. The frequency and distribution of the MARs as well as their sequence 
composition were determined. Such important insights will help to elucidate the 
relationship between DNA folding and genomic function. 
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5 Genomic anchors in PGF B lymphoblastoid cells and IFN-
γ  induced MRC5 fibroblasts 
 
5.1  Introduction 
 
The relationship between nuclear organisation, chromatin architecture and gene 
expression is not well understood. Several studies indicate that transcription of certain 
loci can be modulated by their re-positioning within the nucleus and by interactions 
with loci on different chromosomes (Kioussis, 2005; Reddy et al., 2008; Spilianakis et 
al., 2005). In addition, certain gene clusters and gene-rich regions have been found to 
loop out of their CT upon transcriptional up-regulation (Chambeyron and Bickmore, 
2004; Volpi et al., 2000; Williams et al., 2002). These studies raise the hypothesis that 
the movement of chromatin toward distinct nuclear microdomains could promote 
transcription and facilitate the co-regulation of functionally related genes (Kumaran et 
al., 2008). In order to test this hypothesis, it is critical to characterise the proteins and 
the DNA sequences that are involved in the re-organisation of chromatin. 
 
The identification of components of the nuclear matrix such as the SATB1 transcription 
factor, RNA and DNA polymerases suggests that transcription and replication occur at 
the nuclear matrix (Ottaviani et al., 2008b). Nuclear myosin, which is found in the 
nuclear matrix, has been found to mediate long-range chromosome movements at 
interphase (Chuang et al., 2006). Topoisomerase II, a major component of the nuclear 
matrix, is able to promote the re-structuring of chromatin (Adachi et al., 1989). The 
nuclear matrix thus not only provides the structural scaffold where key nuclear 
processes are organised, but also may be a major player in chromatin movement. 
 
MARs organise the DNA into loops or folds by mediating the interaction of chromatin 
with the nuclear matrix. The constitutive association of MARs with the nuclear matrix 
has been proposed to maintain the integrity of higher-order chromosome architecture 
(Ottaviani et al., 2008b). The more dynamic transient associations are instead dependent 
on whether a genomic region is being transcribed or replicated (Heng et al., 2004). 
Since only a few MARs have been characterised, their role in genomic function and in 
the context of large-scale chromatin organisation gene expression has yet to be 
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established. Work on the murine Th2 cytokine locus has revealed that activation of gene 
expression is accompanied by a recruitment of MARs to the nuclear matrix (Cai et al., 
2006). Another investigation showed that the recruitment of MARs to the nuclear 
matrix was required for gene repression (Alvarez et al., 2000). Additional small-scale 
studies have suggested that MARs can serve as landing platforms for a wide range of 
regulatory proteins including chromatin remodelling enzymes, splicing factors, 
components of the transcriptional machinery and insulators (Cai et al., 2003; Donev et 
al., 2002; Dunn et al., 2003; Kim et al., 2007; Rajaiya et al., 2006). 
 
In order to gain a more comprehensive understanding of the DNA sequences regulating 
higher-order chromatin structure upon transcriptional regulation, MARs were mapped 
across the MHC in cells exhibiting different levels of expression and large-scale 
chromatin organisation. The cell types used for this study were IFN-γ treated fibroblasts 
and B lymphoblastoid cells, as described previously (Christova et al., 2007; Volpi et al., 
2000), and the findings were compared to those in untreated fibroblasts (Chapter 4). 
Most genes in the MHC class I and III regions are expressed constitutively in all cell 
types (Boehm et al., 1997). In contrast, several MHC class II genes are constitutively 
expressed in IFN-γ induced fibroblasts and B lymphoblastoid cells while are repressed 
in untreated fibroblasts (Boehm et al., 1997; Rohn et al., 1996). 
 
In this chapter, the reconfiguration of MARs upon transcriptional activation is 
described. The mapping and comparison of MARs in the different cell types reveals that 
the uneven distribution of MARs across the MHC is generally maintained from cell to 
cell. MARs are predominantly located in intergenic regions and at or in close proximity 
to the MHC class boundaries, thus subdividing the locus into physical domains. 
However, induction of transcription and extra-chromosomal looping are accompanied 
by a major recruitment of MARs to the nuclear matrix. This recruitment is mainly 
adjacent to differentially expressed genes when they are activated, suggesting that the 
rearrangement of chromatin architecture is closely linked with the regulation of gene 
expression. 
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5.2  Results 
 
5.2.1 Biochemical isolation of matrix attachment regions from PGF and 
IFN-γ  induced MRC5 cells 
 
The biochemical isolation of MARs in PGF and IFN-γ induced MRC5 cells was carried 
out as described in Chapter 4. The optimal incubation time with 2 M NaCl for IFN-γ 
induced MRC5 nuclei was found to be 12 min, as for uninduced MRC5 nuclei, while it 
was 9 min for PGF nuclei (Fig 5.1). In each cell type, optimal incubation times 
produced the largest circular halo structures while incubation times longer than optimal 
produced halo structures of highly variable shapes. 
 
As for uninduced MRC5 cells, the biochemical isolation of MARs was performed 5 
times for each cell line to obtain 5 independent biological replicates. Following 
separation of the MAR and halo fractions using restriction enzymes, more than 70% of 
the DNA was in the halo fraction of all samples (Table 5.1). 
 
The MAR controls, HS3 and rep30 and the non-MAR controls, PRM2 and F were 
interrogated by real-time PCR using the isolated MAR and halo fractions. In both cell 
types, HS3 and rep30 were found to be enriched in the MAR fraction while PRM2 and 
F were enriched in the halo fraction (Fig 5.2). In IFN-γ induced MRC5 cells, the MAR 
fractions contained 76% and 78% respectively of the HS3 and rep30 amplicons, while 
the halo fractions contained 82% and 84% respectively, of the PRM2 and F amplicons. 
In PGF cells, the MAR fractions contained 69% and 73% respectively of the HS3 and 
rep30 amplicons, while the halo fractions contained 69% and 84% respectively, of the 
PRM2 and F amplicons. These data show that the MAR and halo fractionations were 
carried out consistently in all the samples. 
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Figure 5.1 Optimisation of halo extraction time in IFN-γ  induced MRC5 and PFG 
nuclei using 2 M NaCl.  
The size of halo structures at each time point was determined by averaging the distance 
of the perimeter of the halo from the edge of the nuclear matrix in 30 nuclei. The 
optimal incubation time, defined as the minimum incubation time producing the largest 
halo structures, was found to be 12 min for IFN-γ induced MRC5 nuclei and 9 min for 
PGF nuclei. Boxplots show the interquartile range of the data, with the horizontal black 
lines running through each boxplot representing the median values of three independent 
biological experiments. The whiskers extend as far as 1.5 times the interquartile range. 
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Table 5.1 Proportion of DNA in the MAR and halo fractions of IFN-γ  induced 
MRC5 and PFG cells.  
The majority of the DNA was consistently found in the halo fraction of IFN-γ induced 
MRC5 and PGF cells. These proportions were determined by quantifying the amount of 
DNA in the MAR and halo fractions of each sample and assuming 100% when both 
fractions were combined. 
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Figure 5.2 Enrichment of MAR and non-MAR amplicons in MAR and halo 
fractions from IFN-γ induced MRC5 and PGF cells.  
Real-time PCR was performed using matrix and halo DNA samples from five 
biologically independent experiments and primers spanning known MARs (HS3 and 
rep30) and non-MARs (PRM2 and F). Bars represent the mean of five experiments with 
standard deviation. The MAR and non-MAR amplicons were enriched in the MAR and 
halo fractions respectively in samples from (a) IFN-γ induced MRC5 and (b) PGF cells. 
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5.2.2 Hybridisation of matrix attachment regions and halo DNA from  IFN-
γ  induced MRC5 and PGF cells onto MHC tiling path arrays  
 
The MARs in the MHC of PGF and IFN-γ induced MRC5 cells were identified using 
the microarray approach described in the previous chapter. For each cell line two array 
hybridisations were carried out using samples 1 and 2. The Pearson Correlation 
Coefficient, which is common measure of correlation, was calculated between all arrays 
and found to be strongest between duplicates. 
 
The visual examination of the results shows that in PGF and IFN-γ induced MRC5 cells 
the MARs and halo DNA are unevenly distributed across the MHC (Fig 5.3). This 
distribution of MAR and halo DNA across the sub-regions of the MHC is remarkably 
similar to that observed in uninduced MRC5 cells (Chapter 4). In both cell lines the 
class II regions of the MHC is largely associated with the nuclear matrix, the class I 
region has long stretches of halo DNA but still contains a significant proportion of 
MARs while the class III and extended class II regions are mainly constituted of halo 
DNA.  
 
These results show that, although the overall distribution of halo DNA and MARs 
across the MHC of the different cell types appears to be conserved, there are important 
differences. Generally PGF and IFN-γ induced cells have higher enrichments of MARs 
compared to uninduced MRC5 cells. Furthermore, PGF cells have a higher number of 
MARs within the class III region of the MHC and a different distribution of MAR and 
halo DNA within the class I of the MHC compared to IFN-γ induced and uninduced 
MRC5 cells. 
 
Taken together, the graphical representation of the results from the different cell types 
indicate that the halo DNA correlates positively with high GC content, gene-dense and 
highly conserved regions while MARs have high AT content and are located mainly 
within regions of low conservation and gene-content. 
 
 138 
 
 
Figure 5.3 Competitive hybridisation of differentially labelled MAR and halo DNA 
fractions on MHC microarrays using MRC5, IFN-γ  induced MRC5 and PGF cells. 
Positive values represent MAR-enriched DNA while negative values represent halo-
enriched DNA (mean ratios of two independent experiments). GC content, RefSeq gene 
positions, human mRNAs from GeneBank, regions of consevations between 17 
vertebrate species and the repetitive sequences LINE, SINE and LTR across the MHC 
are also shown. 
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5.2.3 Quantitative Real-time PCR analysis of matrix attachment regions 
and halo DNA from IFN-γ  induced MRC5 and PGF cells 
 
In order to validate the array results, thirteen regions across the MHC of IFN-γ induced 
and PGF cells were analysed by quantitative real-time PCR using MAR and halo DNA 
from samples 3,4 and 5.  
 
In IFN-γ induced MRC5 cells, six regions were enriched in halo DNA while the 
remaining seven were MAR-enriched. The thirteen amplicons designed to span the 
selected regions were interrogated using a similar approach to that described in Chapter 
4. According to the microarray data, the six regions situated within HLA-A, HLA-G, 
HLA-E, HLA-C, HLA-DRB5 and TAP1 were enriched in the halo DNA fraction. Real-
time PCR confirmed high enrichment in the halo DNA fraction for all these regions 
which had array ratios equal to or lower than -0.128 (Fig 5.4). The seven regions 
enriched in the MAR fraction based on the microarray data, were situated downstream 
of PRRT1, NOTCH4, ZBTB2, HLA-DPB1, upstream of C6orf10, HLA-B and HLA-C 
and were validated by real-time PCR (Fig 5.5). These regions had array ratios equal to 
or higher than 0.437. 
 
In PGF cells, five regions were enriched in halo DNA while the remaining eight were 
MAR-enriched. The five regions enriched in the halo DNA fraction based on the 
microarray data were situated in the regions overlapping HLA-C, HLA-E, HLA-DRB5, 
TAP1, and HLA-G. Real-time PCR confirmed high enrichment in the halo DNA fraction 
for all these regions, which had array ratios equal to or lower than –0.144 (Fig 5.6). Of 
the eight regions enriched in the MAR fraction based on microarray data, six were 
successfully validated with quantitative real-time PCR (Fig 5.7). These regions located 
downstream of PRRT1, NOTCH4, ZBTB2, upstream of C6orf10, HLA-B and HLA-C 
had array ratios equal to or higher than 0.6 (log2). The remaining two regions upstream 
of HLA-A and downstream of HLA-DPB1, which were enriched in the MAR fraction 
based on array data, could not be validated since they were enriched in the halo fraction 
by real-time PCR (Fig 5.8). The regions upstream of HLA-A and downstream of HLA-
DPB1 had array ratios of 0.319 and 0.127 respectively. This is in agreement with the 
results in uninduced MRC5 cells indicating that loci with low MAR enrichment using 
arrays are enriched in the halo fraction with real-time PCR. 
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Taken together these data confirm that values equal to or higher than 0.4 can be 
successfully validated with real-time PCR analysis. Thus 0.4 can be used as a threshold 
to identify MARs across the MHC of uninduced, IFN-γ induced MRC5 and PGF cells. 
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Figure 5.4 Quantitative real-time PCR analysis of halo-enriched loci in IFN-γ 
induced MRC5 cells.  
Real-time PCR was carried out with primer pairs spanning HLA-G, HLA-DRB5, HLA-
C, TAP1, HLA-E and HLA-A, which were enriched in the halo fraction in the array 
experiments. These loci were confirmed to be highly enriched in the halo fraction. Bars 
represent the mean of three biologically independent experiments, and show the 
standard deviation. 
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Figure 5.5 Quantitative real-time PCR analysis of MAR-enriched loci in IFN-γ  
induced MRC5 cells.  
Real-time PCR was carried out with primer pairs spanning downstream of PRRT1, 
NOTCH4, ZBTB2, HLA-DPB1, upstream of C6orf10, HLA-B and HLA-C, which were 
enriched in the MAR fraction in the array experiments. These loci were confirmed to be 
highly enriched in the MAR fraction. Bars represent the mean of three biologically 
independent experiments, and show the standard deviation. 
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Figure 5.6 Quantitative real-time PCR analysis of halo-enriched loci in PGF cells. 
Real-time PCR was carried out with primer pairs spanning HLA-C, HLA-E, HLA-DRB5, 
TAP1, and HLA-G, which were enriched in the halo fraction in the results array 
experiments. These loci were confirmed to be highly enriched in the halo fraction. Bars 
represent the mean of three biologically independent experiments, and show the 
standard deviation. 
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Figure 5.7 Quantitative real-time PCR analysis of loci showing high MAR 
enrichment in PGF cells.  
Real-time PCR was carried out with primer pairs spanning downstream of PRRT1, 
NOTCH4, ZBTB2, upstream of C6orf10, HLA-B and HLA-C, which showed high 
enrichment in the MAR fraction in the array experiments. These loci were confirmed to 
be highly enriched in the MAR fraction. Bars represent the mean of three biologically 
independent experiments, and show the standard deviation. 
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Figure 5.8 Quantitative real-time PCR analysis of loci showing low MAR 
enrichment in PGF cells.  
Real-time PCR was carried out with primer pairs spanning upstream of HLA-A and 
downstream of HLA-DPB1, which showed low enrichment in the MAR fraction in the 
array experiments. Real-time PCR indicated that these regions showed low enrichment 
in the halo fraction. Bars represent the mean of three experiments, and show the 
standard deviation. 
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5.2.4 Position of matrix attachment regions across the MHC of IFN-γ  
treated MRC5 and PGF cells 
 
Work by Volpi et al. (2000), showed that that giant chromatin loops containing the 
entire MHC extend outwards from the territory of chromosome 6 with higher frequency 
in B cells and IFN-γ induced fibroblasts induced than in uninduced fibroblasts. In that 
study AHB cells were used to represent B cells. Here we confirmed that large-scale 
looping of the MHC is also observed with high frequency in PGF B lymphoblastoid 
cells (Fig 5.9). 
 
To determine whether the change in large-scale chromatin organisation and expression 
of MHC genes are accompanied by a rearrangement of genomic anchors, we identified 
MARs across the MHC in IFN-γ treated fibroblast and in PGF B lymphoblastoid cells 
using the MHC tiling path array as previously described in (Fig 5.10). An interactive 
map of MARs can be obtained by uploading tables in Appendices II-IV into the UCSC 
Human Genome Browser (http://genome.ucsc.edu/cgi-bin/hgGateway), May 2004 
assembly and a detailed profile of MARs is shown in Fig 5.11. 
 
The overall distribution of MARs in the MHC is highly conserved in fibroblast and B 
lymphoblastoid cells. In all cells studied, over 90% of the MARs identified are located 
within the classical class I and class II regions while the remaining 10% of MARs are 
contained in the class III and extended class II regions of the MHC.  
 
There are, however, important differences between the MAR profiles of the different 
cell lines. A striking increase in the number of MARs was found in IFN-γ induced 
MRC5 and PGF cells compared to untreated fibroblasts. This increase in the number of 
MARs is mainly concentrated within the classical class I and class II regions.  
 
In IFN-γ treated fibroblasts and B lymphoblastoid cells, MARs were identified on 
average every 17 and 15 kb respectively, which is approximately twice the frequency of 
that in untreated fibroblasts. In IFN-γ induced MRC5 cells, 221 MARs were identified 
and were subdivided as follows: 111 in the class I, 8 in the class III, 96 in the class II 
and 6 in the extended class II region of the MHC. The class I, III, II and extended class 
II regions have one MAR every 16, 120, 9, and 52 kb respectively. In PGF cells, 261 
MARs were identified and were subdivided as follows: 115 in the class I, 20 in the class 
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III, 121 in the class II and 5 in the extended class II region of the MHC. The class I, III, 
II and extended class II regions have one MAR every 16, 40, 7 and 72 kb respectively. 
 
Of the 221 MARs detected in the MHC of IFN-γ treated fibroblasts, 192 are intergenic 
whereas 29 contain intragenic regions. In B lymphoblastoid cells of the 261 MARs 
identified, 205 are located intergenically while 56 contain intragenic DNA.  
 
As observed in uninduced MRC5 cells, in IFN-γ induced MRC5 and PGF cells MARs 
have been identified at the boundaries separating class I from class III , class III from 
the class II region and class II from the extended class II region (Fig 5.12) as well as in 
regions flanking genes such as HLA-A, HLA-C, HLA-G, HLA-F, HLA-B and HLA-
DQB1. 
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Figure 5.9 Cytological visualisation of giant external chromatin loops carrying the 
MHC region in relation to the chromosome 6 territory. 
(a) FISH image showing the HLA-DRA gene (red) located within the chromosome 6 
territory (green). (b) Only a low basal level of external chromatin loops carrying the 
MHC of 10% (N = 313) was present in control MRC5 cells. IFN-γ induction of external 
chromatin loops in MRC5 cells, frequency of giant loop formation increased to 27% (N 
= 325). (c) PGF cells show a high basal level of external chromatin loops, 39% (N = 
344). N - number of CTs analysed. 
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Figure 5.10 MARs in the MHC of MRC5, IFN-γ induced MRC5 and PGF cells. 
The mean value for two array hybridisations was calculated for each fragment 
represented in the MHC tiling path array. Regions enriched in the MAR fraction with 
mean ratios equal to or higher than 0.4 (log2) were plotted on the UCSC genome 
browser (http://genome.ucsc.edu/) and represented on the top row by black vertical 
lines. The number of MARs in each region is shown above the data plots. 
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Figure 5.11 (5 pages) Detailed profile of MARs across the MHC of MRC5, IFN-γ 
induced MRC5 and PGF cells.  
MARs are shown relative to Refseq genes from the UCSC web browser 
(http://genome.ucsc.edu/) in MRC5, IFN-γ induced MRC5 and PGF cells. 
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Figure 5.11 (continued). 
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Figure 5.11 (continued). 
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Figure 5.11 (continued). 
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Figure 5.11 (continued). 
 
 155 
 
Figure 5.12 Distribution of MARs at MHC class boundaries in MRC5, IFN-γ 
induced MRC5 and PGF cells.  
The boundaries separating A) class I from class III, B) class III from class II, C) class II 
from the extended class II are highlighted in grey. MRC5, IFN-γ induced MRC5 and 
PGF cells are shown in the top, middle and bottom row respectively. 
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5.2.5 Sequence analysis of matrix attachment regions in IFN-γ  induced 
MRC5 and PGF cells  
 
Different genomic properties including conservation, AT content, gene and repetitive 
sequences density of MARs and non-MARs across the MHC of IFN-γ induced 
fibroblasts and B lymphoblastoid cells were analysed as described for uninduced 
fibroblasts. 
 
The average AT content of MARs in IFN-γ induced fibroblasts and B lymphoblastoid 
cells is 60% and 58% respectively while of halo DNA is 52% and 53% respectively. In 
general, the MARs identified in IFN-γ induced fibroblasts and B lymphoblastoid cells 
have a higher AT content than non-MARs (P-value of 0.003 for IFN-γ induced 
fibroblasts and 0.002 for and B lymphoblastoid cells). However there are a number of 
MARs that are GC-rich and non-MARs that are AT-rich. 
 
Intragenic sequences constitute more than 40% of non-MARs in both cell types and 
16% and 22% of MARs in IFN-γ induced MRC5 and PGF cells respectively (P-value of 
0.001 for IFN-γ induced fibroblasts and 0.004 for B lymphoblastoid cells). The Pearson 
Product Moment Correlation was determined to study the relatiosnhip between gene 
density and the positions of MARs. The correlation (r) values are consistently negative 
for all cell types (r-value of -0.23 for uninduced MRC5, -0.32 for IFN-γ induced MRC5 
and -0.37 for PGF cells) suggesting that MARs are mainly located in gene-poor regions. 
The relationship between gene density and the positions of MARs can be visualised in 
figure 5.13. 
 
The assessment of the conservation of MARs and non-MARs shows that non-MARs are 
generally more conserved than MARs. However the degree of conservation of these 
sequences varies substantially between the different cell types. The non-MARs in IFN-γ 
induced MRC5 cells are three times more conserved than MARs (P-value < 0.003) 
while the non-MARs in PGF cells are less than twice more conserved than MARs (P-
value < 0.005). 
 
In IFN-γ induced fibroblasts the average content of repetitive sequences of MARs and 
non-MARs is 58% and 38% respectively (P value of 0). In PGF cells the average 
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content of repetitive sequences of MARs and non-MARs is 48% and 43% respectively 
(P-value < 0.007). In both cell types, LINEs are over-represented by more than twofold 
among MARs relative to their overall abundance in non-MARs (P-value of 0) while the 
SINE content is approximately two times higher in MARs compared to non-MARs (P-
value < 0.005). MARs and non-MARs of PGF cells do not differ significantly in 
relation to the LTR content (P-value of 1). This contrasts to IFN-γ induced MRC5 cells, 
in which LTRs are over-represented by approximately three-fold in MARs relative to 
their overall abundance in non-MARs (P-value < 0.005). 
 
The sequence properties of MARs and non-MARs in IFN-γ induced MRC5 and PGF 
cells are similar to those in untreated MRC5 cells. In summary, compared with non-
MARs, MARs are generally AT-rich, enriched in repetitive sequences, depleted of 
intragenic sequences and show a lower degree of conservation. 
 
 
Figure 5.13 Correlation of MARs and gene density in MRC5, IFN-γ induced 
MRC5 and PGF cells. 
Gene and MAR density were binned in 100 kb windows that were slid by 10 kb for 
each point. The trendlines were plotted based on two points moving average. In general, 
the different cell types show a negative correlation between MAR and gene density in 
all cell types. 
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5.2.6 Classification of matrix attachment regions 
 
To gain a better insight into the roles of MARs in the MHC, we compared their 
positions in the three different cell types. This comparative analysis identified three 
main categories of MARs: structural, cell specific and transcription-dependent. The 
positions of the MARs in each category are shown in tables in Appendices V-X.  
 
MARs constitutively attached to the nuclear matrix in all cell types account for 17% of 
all MARs (Fig 5.14a). These anchors are defined as structural MARs since their 
tethering function is preserved regardless of the cell type and transcriptional status of 
the MHC locus. The majority of the structural MARs identified are situated within the 
class I region of the MHC. 
 
Approximately 45% of MARs are cell type specific. They are further classified into 
fibroblast specific, which include MARs present in both untreated and treated 
fibroblasts (Fig 5.14b), and B lymphoblastoid specific (Fig 5.14c). Most cell type 
specific MARs are equally distributed within the class I and class II regions of the 
MHC. 
 
Transcription-dependent MARs are DNA sequences that transiently associate to the 
nuclear matrix depending on the transcriptional status of the MHC. They include MARs 
in untreated fibroblasts that are released from the nuclear matrix in IFN-γ treated 
fibroblasts (Fig 5.14d), MARs recruited to the nuclear matrix in response to IFN-γ 
treatment (Fig 5.14e) and MARs recruited to the nuclear matrix in both B 
lymphoblastoid cells and IFN-γ treated fibroblasts (Fig 5.14f). These groups of MARs 
together constitute 34% of all MARs identified and are predominantly located within 
the class I and II regions of the MHC.  
 
The remaining 4% of MARs were present in both B lymphoblastoid cells and untreated 
fibroblasts. To determine whether these MARs are cell specific or transcriptional 
dependent, it is necessary to characterise MARs across the MHC of other cell lines. 
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Figure 5.14 Distribution of structural, cell specific and transcription-dependent 
MARs across the MHC.  
Shown are (a) structural MARs, (b) MRC5-specific MARs, (c) PGF-specific MARs, 
(d) MARs of untreated MRC5 cells, (e) MARs of IFN-γ treated MRC5 cells and (f) 
MARs of both IFN-γ treated MRC5 and PGF cells. 
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5.2.7 Distribution of matrix attachment regions relative to differentially 
and non-differentially expressed genes 
 
The relationship between gene expression and MARs was further investigated by 
examining the positions of MARs in relation to differentially and non-differentially 
expressed genes. 
 
Microarrays were used to compare expression of MHC genes of untreated fibroblasts 
with IFN-γ treated fibroblasts and B lymphoblastoid cells (Fig 5.15). A significant 
proportion of class II genes and a few class I genes are up-regulated genes in IFN-γ 
treated fibroblasts and B lymphoblastoid cells. The expression of the class III and 
extended class II genes in fibroblasts does not differ following IFN-γ treatment, while a 
proportion of class III genes are up-regulated in B lymphoblastoid cells relative to 
untreated fibroblasts. As expected, most of the differentially expressed genes code for 
classical class I and class II molecules (Table 5.2). 
 
The distances of MARs from differentially and non-differentially expressed genes in 
fibroblasts and B lymphoblastoid cells were calculated to determine how changes in 
gene expression affect MAR distribution (Fig 5.16). The results show that in both IFN-γ 
treated fibroblasts and B lymphoblastoid cells the average distance between MARs and 
differentially expressed genes was over two times shorter than the distance between 
MARs and non-differentially expressed genes (Fig 5.17). A Mann-Whitney test showed 
that the distribution was significant with p-values of 0.003 and 0.009, respectively. The 
average distance between MARs and non-differentially expressed genes in IFN-γ 
induced fibroblasts is 26 kb, while between MARs and differentially expressed genes, 
the average distance is 12 kb. This trend is observed for several genes of critical 
immunological importance including HLA-C, HLA-DPA1, HLA-DPB1, and HLA-DRB1 
genes. 
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Figure 5.15 Comparison of gene expression levels in the MHC of MRC5, IFN-γ 
induced MRC5 and PGF cells.  
a) The red line represents the log2 expression ratios of IFN-γ induced MRC5/MRC5 
ratios and the blue line represents the ratios of PGF/MRC5. (b) Distribution of MARs in 
MRC5, IFN- γ treated MRC5 and PGF cells. 
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 IFN-γ treated MRC5  PGF 
Class I HLA-F Class I HLA-F 
 HLA-E  VARS2 
 HLA-C  HLA-B 
 HLA-B  HCP5 
 MICB Class III LTA 
Class III C4  TNF 
Class II HLA-DRA  LTB 
 TAP2  AIF1 
 PSMB8  NEU1 
 TAP1  GPSM3 
 PSMB9 Class II HLA-DRA 
 HLA-DMB  HLA-DRB1 
 HLA-DMA  HLA-DQA1 
 HLA-DPA1  HLA-DOB 
   PSMB8 
   TAP1 
   PSMB9 
   HLA-DMB 
   HLA-DMA 
   HLA-DPA1 
   HLA-DPB1 
  Ext. Class II SLC39A7 
   HSD17B8 
 
Table 5.2 Differentially expressed genes in IFN-γ treated MRC5 and PGF cells.  
Genes included show at least a two-fold change in up-regulation of expression 
compared to untreated MRC5 cells. 
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Figure 5.16 Distance of MARs from MHC genes in IFN-γ treated MRC5 and PGF 
cells.  
The genomic position of each gene (x-axis) is plotted against its distance from the 
closest MAR (y-axis). The black and red dots represent non-differentially and 
differentially expressed genes respectively. 
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Figure 5.17 Distances of MARs to differentially and non-differentially expressed 
genes in IFN-γ MRC5 and PGF cells.  
Boxplots show the interquartile range of the data, with the horizontal black lines 
running through each boxplot represent the median values. The whiskers extend as far 
as 1.5 times the interquartile range. Any values that lie beyond the whiskers are plotted 
as dots. A Mann-Whitney test showed that the differences between the distributions of 
differentially and non-differentially expressed genes were statistically significant for 
both cell types (p-values of 0.003 and 0.009, respectively). 
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5.2.8 Comparison between matrix attachment regions identified 
experimentally and in silico in IFN-γ  induced MRC5 and PGF cells 
 
The performance of three MAR prediction programmes SIDD, ChrClass and MARScan 
was assessed as described for untreated MRC5 cells. 
 
The number of MARs predicted by all programmes is higher than that of experimentally 
identified MARs in IFN-γ induced MRC5 and PGF cells. It is important to note that 
SIDD, ChrClass and MARScan give extremely different distributions of MARs across 
the MHC locus. This is to be expected since each of these software programmes 
recognises different sequence motifs associated with MARs (described in Chapter 4).  
 
Tables 5.3 and 5.4 show the number of predictions of experimentally defined MARs 
and not matching experimentally defined MARs in the two cell types. As seen in 
untreated MRC5 cells the number of false positives is significantly high, in both IFN-γ 
induced MRC5 and PGF cells. The number of true positives for ChrClass was 
approximately more than 2.5 times greater than SIDD and 3.5 times higher than 
MARScan. The number of false positive for ChrClass was slightly lower than SIDD and 
about 2.5 times higher than MARScan. 
 
In agreement with the results from uninduced MRC5 cells, ChrClass outperformed 
SIDD and MARScan in both IFN-γ induced MRC5 and PGF cells. ChrClass had the 
highest sensitivity and specificity while SIDD and MARScan had the lowest specificity 
and sensitivity respectively.  
 
In IFN-γ induced MRC5 cells, 15 MARs detected with the MHC microarrays were not 
predicted by any of the selected programs while in PGF that number was 17. As seen in 
the previous chapter, this suggests that additional sequence motifs associated with 
MARs should be incorporated into novel software programmes to improve their 
predicting power. These sequences could include specific classes of repetitive 
sequences such as LINEs since they are over-represented among MARs of the MHC 
relative to their abundance in non-MARs. 
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 ChrClass SIDD MARScan 
Total Predicted 617 543 187 
True Positive 191 75 55 
False Positive 426 468 132 
False Negative 18 71 69 
Specificity 0.31 0.14 0.29 
Sensitivity 0.86 0.34 0.25 
 
Table 5.3 Comparison between different MAR predicting algorithms in IFN-γ 
treated cells. 
 
 
 
 ChrClass SIDD MARScan 
Total Predicted 617 543 187 
True Positive 236 77 47 
False Positive 381 476 140 
False Negative 41 33 90 
Specificity 0.38 0.14 0.25 
Sensitivity 0.90 0.30 0.18 
 
Table 5.4 Comparison between different MAR predicting algorithms in PGF cells.  
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5.3  Discussion 
 
In order to examine the relationship between chromatin folding and gene expression, 
MARs were mapped in cells exhibiting differential expression of the MHC. By 
comparing the position of MARs in uninduced fibroblasts, IFN-γ induced fibroblasts 
and B lymphoblastoid cells, activation of the MHC was found to be accompanied by 
dynamic interactions between chromatin and the nuclear matrix. The vast recruitment of 
MARs to the nuclear matrix upon up-regulation of the MHC suggests that MARs play a 
role in transcriptional regulation of MHC genes.  
 
As determined in uninduced fibroblasts, MARs in IFN-γ induced fibroblasts and B 
lymphoblastoid cells, MARs were found to be rich in AT and repetitive sequences, 
furthermore they correlate negatively with gene density. Despite the overall differences 
in MHC expression between uninduced, IFN-γ induced and B lymphoblastoid cells, 
MARs were mainly positioned within the MHC class I and class II regions. In all cell 
types examined, MARs predominantly occupy intergenic regions closely flanking 
several class I and class II genes and near MHC boundaries suggesting that MARs have 
an insulator function. This proposed role for MARs is further supported by recent 
findings showing that MARs shield transgenes from the effects of the neighbouring host 
chromatin domains (Girod et al., 2007; Halweg et al., 2005). It remains to be 
established whether MARs act as boundary elements by topologically constraining the 
DNA into loops or by forming a physical barrier that blocks interactions between 
promoter and unrelated enhancers.  
 
Upon transcriptional up-regulation of MHC genes with IFN-γ, loop DNA adjacent to 
genes is recruited to the nuclear matrix. The number of MARs in IFN-γ induced 
fibroblasts is approximately two times greater than untreated fibroblasts and their 
average position is two times closer to differentially expressed MHC genes. The 
recruited MARs, mostly situated intergenically within the classical class I and II 
regions, reduce the average loop size across the MHC locus of IFN-γ induced 
fibroblasts. A similar pattern of anchoring and average loop size is seen in B 
lymphoblastoid cells, which constitutively express MHC genes that are up-regulated in 
IFN-γ induced fibroblasts. This association between transcriptional activation and 
recruitment of MARs has been previously reported at the murine Th2 cytokine locus 
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containing the co-ordinately regulated Il4, Il3 and Il5 genes within a gene cluster of 120 
kb (Cai et al., 2006).  
 
To gain a better understanding of MAR function in the MHC, the MARs of the different 
cell types were classified into three groups: structural, cell type specific and 
transcription-dependent (Heng et al., 2004; Heng et al., 2001; Shaposhnikov et al., 
2007). Structural MARs are constitutively bound to the nuclear matrix in all cell types 
regardless of the transcriptional status of the MHC locus (Heng et al., 2004; Heng et al., 
2001). MARs that bind to the nuclear matrix in all cell types could be critical in 
maintaining the higher-order chromatin structure of the MHC. Cell type specific MARs 
could reflect interactions between chromatin and cell type specific nuclear matrix 
proteins (Jackson et al., 1992). Studies on SATB1 have revealed that the binding of cell 
type specific nuclear matrix proteins at MARs is essential for tissue-specific regulation 
of gene expression (Cai et al., 2006; Galande et al., 2007). Therefore this group of 
MARs could interact with cell type specific matrix proteins, which are important for the 
distinct MHC expression profiles of fibroblasts and B lymphoblastoid cells. 
Transcription-dependent MARs are recruited to or released from the nuclear matrix 
based on the transcriptional status of a given genomic region (Heng et al., 2004). Most 
MARs of this group are recruited to the nuclear matrix upon activation of the MHC and 
may associate with a sub-class of MAR-binding proteins functioning as transcriptional 
activators of MHC genes. 
 
These permanent and transient chromatin-matrix interactions should be examined in the 
context of previous findings showing that constitutively high gene expression or the 
induction of expression of certain genomic domains are accompanied by a higher-order 
re-structuring of chromatin (Brown et al., 2006; Chambeyron and Bickmore, 2004; 
Mahy et al., 2002; Volpi et al., 2000; Williams et al., 2002). In IFN-γ treated fibroblasts, 
the MHC emanates out of its CT forming giant chromatin loops with an increased 
frequency compared to untreated fibroblasts (Volpi et al., 2000). Here, FISH analysis 
revealed that the number of giant chromatin loops in B lymphoblastoid cells is largely 
equivalent to that seen in IFN-γ treated fibroblasts. Recent work by Christova et al. 
(2007) has shown that the formation of these giant loops is accompanied by chromatin 
decondensation, which probably provides a more ‘open’ chromatin environment 
(Christova et al., 2007). Decondensed chromatin could thus facilitate chromatin-matrix 
interactions by increasing accessibility for nuclear matrix proteins and transcription 
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machinery (Hart and Laemmli, 1998; Kimura et al., 1999). Since several components of 
transcription factories associate with the nuclear matrix, it is tempting to speculate that 
dynamic matrix-MAR interactions localise genes close to transcription factories 
optimising their regulation (Ottaviani et al., 2008b). Furthermore, giant chromatin loops 
may place the MHC in distinct nuclear microenvironments containing specific matrix 
proteins as well as transcription factors required for the expression of MHC genes. 
Taken together these findings indicate that there is an intimate relationship between 
gene expression, higher-order chromatin structure and the association of MARs with the 
nuclear matrix (Fig 5.18).  
 
The role of MARs upon MHC induction could be explored in the future by interfering 
with their function and analysing the impact on regulation of gene expression. However, 
this approach cannot be used at present due to the lack of selective MAR-targeting 
agents to disrupt the binding of MARs with the nuclear matrix. A different strategy to 
analyse the structural and functional role of MARs includes the isolation and 
characterisation of MAR-binding proteins (Donev et al., 2002). If unknown, the 
function of these proteins could be analysed using approaches such as gene silencing. A 
similar strategy has been successfully applied to characterise the matrix protein SATB1 
and the function of its MAR target sequences (Cai et al., 2003; Cai et al., 2006). 
Additional studies would also be required to understand whether MAR recruitment is an 
important early step in transcriptional activation of the MHC. This question can be 
addressed by time-course experiments to determine the kinetics of MAR recruitment to 
the nuclear matrix during IFN-γ activation.  
  
The feasibility of large-scale MAR prediction was evaluated by comparing the positions 
of experimentally identified MARs in IFN-γ induced fibroblasts and B lymphoblastoid 
cells with those predicted by three MAR-prediction software programmes: ChrClass, 
SIDD and MARScan. As observed for uninduced fibroblasts in the previous chapter, 
ChrClass was found to have the best predicting power as measured by sensitivity and 
specificity. All the programmes used predicted a high number of false positives and 
therefore cannot yet substitute experimental verification. These findings show, however, 
that ChrClass could be a useful start where no experimental data is available. As seen, 
the binding of MARs to the nuclear matrix can be constitutive and transient, cell type 
specific and transcriptional dependent. The description of the sequence of these 
different MAR groups at the base pair level and the characterisation of target sites of 
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MAR-binding proteins will be essential for the development of improved MAR-
predicting software. 
 
The comparison between the position of MARs with CIITA binding sites and 
acetylated regions described in Chapter 3 did not reveal significant correlations. 
However, it is possible that such correlations were not detected since different cell 
types were used in these experiments. 
 
In summary these results have shown that activation of MHC genes is accompanied by 
a massive re-organisation of chromatin architecture. The mapping of MARs in IFN-γ 
induced fibroblasts and B lymphoblastoid cells, and the comparison with those 
identified in uninduced fibroblasts has indicated that MARs are recruited to the nuclear 
matrix upon transcriptional up-regulation. MARs are formed adjacent to differentially 
expressed genes when the genes are activated suggesting that there is an intimate 
relationship between higher-order genome architecture and regulation of gene 
expression. This work thus provides a substantial framework for subsequent studies on 
DNA-protein interactions that are responsible for both the structural integrity of 
chromosomes and genomic function. 
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Figure 5.18 Model showing dynamic changes in chromatin organisation of the 
MHC locus upon transcriptional up-regulation.   
In cells that are not expressing MHC class II genes, such as uninduced fibroblasts, the 
4Mb MHC locus (red) is positioned within the chromosome 6 territory anchored by 
constitutive MARs (yellow) to nuclear matrix proteins (dark green), forming stable 
chromatin loops. Upon up-regulation of gene expression the entire MHC locus adopts a 
more ‘open’, decondensed chromatin structure, represented by the thinning and 
lengthening of the chromatin line, and the entire MHC region is repositioned outside of 
the CT. IFN-γ-dependent MARs (light blue) are recruited to the nuclear matrix, folding 
chromatin into smaller loops, and facilitating the interaction of chromatin and 
transcription factors (light green). Many IFN-γ-dependent MARs are positioned 
immediately adjacent to genes. The constitutive MARs remain attached to nuclear 
matrix proteins following transcriptional up-regulation and some may have an 
insulatory function. 
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6 Summary and Discussion 
 
In this thesis, I have examined the relationship between genomic anchoring and gene 
expression in the MHC, a large human locus containing clusters of co-ordinately 
regulated genes. Using a novel tiling path array of the MHC, I have shown that MARs 
are unevenly distributed across the MHC region. They are mainly situated within 
intergenic domains and closely flank several genes, including those involved in antigen 
processing and presentation, as well as the boundaries defining the MHC sub-regions. 
Although a unique consensus was not identified, MARs have a high AT and repeat 
sequence content. Analysis of cell types with different expression profiles suggests that 
transcriptional up-regulation of the MHC is accompanied by a significant recruitment of 
MARs to the nuclear matrix.  Of particular interest, certain MARs are formed close to 
transcriptionally up-regulated genes upon MHC activation, while others are 
permanently associated with the nuclear matrix in all cell types. Collectively, these 
findings suggest that the rearrangement of chromatin architecture to form new loop 
domains may be an integral component of gene activation. 
 
6.1 Higher-order chromatin structure 
 
What does the map of MARs across the MHC in different cell types tell us about 
chromatin architecture, and how compatible is it with the models described in Chapter 
1? To address these questions, one should consider the spatial arrangement of MARs in 
relation to the proposed chromatin loop domain. The common view is that MARs are 
located at the bases of the chromatin loop structures. However, each MAR may not 
identify the base of a separate loop, since consecutive, closely juxtaposed MARs may 
together be positioned at the base of a loop by their common attachment to a particular 
set of nuclear matrix proteins. Certain MARs may be located along a loop rather than 
exclusively at the base, and furthermore, one cannot exclude a role for MARs in 
anchoring chromatin folds, rather than loops. 
 
With respect to the MHC, MARs identified within a 300 kb region of the class I region 
have been shown by a chromatin ligation assay, to be present at the bases of loops, with 
each pair of MARs that form a loop structure being in close spatial proximity in vivo 
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(Kumar et al., 2007a).  In contrast, 3C analysis of the Ifng locus indicates that certain 
MARs are associated with a linear, rather than looped, chromatin conformation, 
indicating that not all MARs mediate the organisation of chromatin into loop structures 
(Eivazova et al., 2007). The methodology used in this thesis to isolate the nuclear 
matrix is identical to that shown to extract proteins with both structural functions, such 
as lamins, and no known structural functions, such as general transcription factors 
(Noma et al., 2006). Certain MARs in the MHC might thus only have a regulatory 
function and be located away from the bases of the loop structures. Analysis of the 
three-dimensional chromatin architecture using 3C analysis needs to be performed to 
determine which MARs mediate loop formation and which have a regulatory function. 
 
The findings from the present study should be examined in light of the different models 
of higher-order chromatin structure. The MLS model postulates that successive bases of 
chromatin loops are held together by ‘loop base springs’ (Munkel et al., 1999). 
However, as the existence of a proteinaceous nuclear scaffold tethering the chromatin is 
not excluded, the MARs of the MHC could mediate the organisation of the MHC into 
rosette-like structures containing chromatin loops. If all the MARs are located at the 
bases of the loop structures, the MHC class I and II regions would be organised into 
smaller chromatin loops (~15 kb) compared to those of the MHC class III and the 
extended class II regions (~80 kb). In contrast, if certain MARs of the MHC class I and 
II regions were located away from the bases of the loop structures, the sizes of the 
chromatin loops could be similar across the MHC sub-regions.  
 
The RW/GL model predicts the formation of chromatin loops in the order of several Mb 
attached to a proteinaceous nuclear scaffold. According to this model, the MHC should 
only contain very few MARs and not the large number that were identified 
experimentally in all three cell types. Although this model might not be suitable to 
interpret our results, smaller chromatin loops might still be formed within the relatively 
large loops and allow for the existence of a higher number of MARs (Sachs et al., 
1995).  
 
The chromonema fibre model does not appear to agree with our findings since it favours 
the formation of chromatin folds maintained by chromatin interactions. However, this 
model can accommodate a nuclear matrix mediating the tethering of the chromatin folds 
(Belmont and Bruce, 1994). In this instance, MARs would organise the MHC class I 
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and II regions into more tightly folded chromatin compared to the MHC class III and 
extended class II regions. 
 
6.2  Relationship to giant chromatin loops 
 
Within the nucleus, chromatin exists in open and closed configurations. Certain 
genomic regions are subject to dynamic changes in conformation, according to their 
transcriptional status and other parameters. None of the models described above provide 
information on how the different levels of chromatin condensation are established or 
how they are altered upon interaction with regulatory nuclear machineries.  
 
The formation of giant chromatin loops carrying the MHC upon transcriptional 
activation has been described earlier (Volpi et al., 2000). It might be expected that the 
release of a chromatin loop away from the chromosome territory would be achieved 
through release of MARs upon transcriptional activation. Rather, what is seen is the 
maintenance of virtually all existing MARs, together with the formation of additional 
MARs indicating new sites of anchoring to the nuclear matrix. This observation could 
reflect the biological and physical properties of the nuclear matrix. If nuclear matrix 
components move within the nucleus they might facilitate the formation of giant 
chromatin loops through their interaction with MARs. This is in agreement with well-
established findings that many proteins in the nucleus are highly mobile and generate a 
dynamic, architectural framework, where nuclear processes take place. Immediately 
after treatment of cells with IFN-γ and activation of the JAK-STAT pathway, 
phosphorylated STAT1 moves rapidly into the nucleus. As the giant chromatin loops 
appear within minutes, and only form if STAT1 is present (Christova et al., 2007), one 
could speculate that STAT1 may be involved in MAR-matrix interactions that generate 
large-scale reconfiguration of chromatin architecture. 
 
MARs are likely to mediate the tethering of the local chromatin loops across the MHC, 
however, whether these genomic sequences are also involved in the formation of the 
giant chromatin loops remains to be established. The average size of the giant chromatin 
loops is in the order of several Mb (Volpi et al., 2000), while the average distance 
between MARs in the MHC is approximately several kb. The formation of additional 
MARs upon activation of the MHC could indicate the formation of new chromatin 
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loops, as observed in the mouse Th2 cytokine locus (Cai et al., 2006). However, this is 
difficult to reconcile with the observed decondensation of the MHC that accompanies 
its transcriptional up-regulation (Christova et al., 2007). It is more likely that the overall 
decondensation of the locus increases access of MARs, which are located a distance 
away from loop bases, to nuclear matrix proteins. Thus, the associations of these MARs 
with the nuclear matrix would not result in the formation of additional chromatin loops. 
Another possibility is that different MARs might be responsible for different levels of 
chromatin compaction so that the release of a few selected MARs might still lead to 
chromatin decondensation despite an overall recruitment of MARs. The data are thus 
consistent, firstly, with a complex hierarchy of DNA folding to achieve effective 
packaging of the MHC, and secondly, with activation of MHC genes being associated 
with conformational changes occurring at multiple levels. 
 
6.3  Insights into the nature of the nuclear matrix 
 
As this thesis concerns the investigation of MARs, it is appropriate to evaluate whether 
the nuclear matrix is a true nuclear entity and analyse what the data reveal about the 
composition and properties of the nuclear matrix. 
 
The extraction of soluble histone and non-histone proteins with high-salt buffers can 
form artifactual protein complexes since the negatively charged polyanions of the 
buffers interact with the cationic sites of proteins (Pederson, 2000). This process may 
disrupt both pre-existing DNA-protein interactions and protein-protein interactions and 
lead to the formation of new aggregates. This limitation of the methodology has to be 
taken into account when considering recent findings proteins SATB1, topoisomerase II 
and condensin, which are found in the matrix fraction of the nucleus following 
treatment with 2 M NaCl buffer (Maeshima and Laemmli, 2003; Seo et al., 2005). All 
three proteins are important in chromatin architecture. SATB1 has a ‘cage-like’ network 
distribution pattern in interphase nuclei (Cai et al., 2003; Cai et al., 2006). 
Topoisomerase II and condensin form two juxtaposed or coiled chain structures along 
the longitudinal axis of metaphase chromosomes (Kireeva et al., 2004; Maeshima and 
Laemmli, 2003). These findings strongly suggest that components of the nuclear matrix 
form complex structures in nuclei in vivo. However, additional components might 
simply co-precipitate in the matrix fraction as a result of the high-salt treatment and thus 
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might not actually participate in the maintenance of chromosomal structure. In order to 
distinguish the proteins of the nuclear matrix from the artifactual ones, more 
components need to be characterised and studied using techniques such as ChIP and in 
vivo imaging. 
 
The presence of both constitutive and dynamic MARs in the MHC is likely to reflect 
the heterogeneous composition of the nuclear matrix, which is constituted not only of 
structural proteins but also of factors involved in transcription. The nuclear matrix 
contains a few structural components including SATB1 and lamins, which can self-
assemble to form complex higher-order nuclear structures extending throughout the 
nuclear interior (Cai et al., 2006; Dechat et al., 2008). Most nuclear matrix components, 
including chromatin remodelling enzymes and general transcription factors, have a 
diffuse distribution in the nucleus of living cells (Bettinger et al., 2004; Noma et al., 
2006; Reyes et al., 1997). The nuclear matrix thus does not appear to be a continuous 
structural framework but rather is a collection of different proteins that mediate high-
order chromosome structure and regulate gene expression in response to transcriptional 
up-regulation. 
 
6.4  The architecture of the nucleus 
 
An understanding of chromatin architecture has to incorporate the surrounding nuclear 
environment. The Inter-Chromatin Domain (ICD) model describes the nucleus as 
having compartmentalised chromatin domains separated by a network of chromatin-free 
space (Cremer and Cremer, 2001). This view of the nucleus is derived from 
microscopic imaging of the CTs and ICD. Experiments showing that approximately 
90% of DNA, corresponding to about 50% of the nuclear mass, can be removed by 
extraction whilst preserving the structure of the ICD, suggest that the nuclear matrix 
could be situated within the channels of the ICD (Jackson, 2003). This hypothesis is 
further supported by the findings that both the ICD and the nuclear matrix are 
implicated in transcription and replication and are associated with nuclear components 
such as PML and Cajal bodies, which have a role in mRNA maturation and RNP 
assembly (Cremer et al., 2004; Gribbon et al., 2002; Zhong et al., 2000). 
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The definition of the ICD as the chromatin-free compartment separating CTs and 
chromatin domains is still controversial. Intermingling between CTs indicates that the 
ICD might not be preferentially distributed at the borders of CTs (Branco and Pombo, 
2006). In addition, experiments showing that large macromolecules are able to diffuse 
within condensed chromatin suggest that the ICD might ramify in between fine 
chromatin domains (Cremer and Cremer, 2001; Verschure et al., 2003). These data 
indicate that rather than simply being compartmentalised into chromatin and chromatin-
free domains, the nucleus is divided into different compartments characterised by 
variable volumes of chromatin-free space. Since it is highly condensed, heterochromatin 
contains less chromatin-free space than euchromatin, however, chromatin-free space is 
found throughout both domains. This network of chromatin-free space might be filled 
with different molecules including components of the nuclear matrix proteins, which are 
able to organise chromosomal architecture through their interactions with MARs. 
 
In order to understand the different elements responsible for the compartmentalisation 
of the nucleus it is also necessary to explore the forces generated by molecular 
crowding, which are strong in the nucleus due to the high macromolecule concentration 
(in the range of 100 mg/ml) (Hancock, 2004b). These forces vastly increase the 
association constants of intermolecular interactions and might play a role in the 
assembly and function of distinct nuclear compartments including PML bodies and 
nucleoli (Hancock, 2004b). There is experimental evidence showing that these 
compartments disassembled with dispersion of their molecular components when nuclei 
expand in volume in hypotonic buffer and reassembled when the nuclear volume returns 
to normal in physiological buffers (Hancock, 2004a). 
 
6.5  Genomic features of matrix attachment regions 
 
The average AT content of MARs in all cell types analysed here is equal to or higher 
than 58% while that of non-MAR DNA is equal to or lower than 53%. MARs are 
therefore relatively AT-rich, confirming the results of previous small-scale 
investigations (Purbowasito et al., 2004; Shaposhnikov et al., 2007). These findings 
could have important practical implications since they suggest that drugs such as 
bizelesin, which bind selectively to AT-rich regions, could exhibit their cytotoxicity by 
interfering with the function of MARs (as discussed in Chapter 1). However, MARs 
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with low AT content have also been found indicating that high AT content alone is not 
sufficient for interaction of a genomic sequence with the nuclear matrix. 
 
MARs are relatively rich in repetitive elements since the average content of repetitive 
sequences of MARs is equal to or higher than 49% while that of non-MAR DNA is 
equal to or lower than 43%. A positive correlation between MARs and repetitive 
elements was indicated previously in studies of several genomic regions including the 
human serpin gene cluster and a 1 Mb imprinted domain on mouse chromosome 7 
(Purbowasito et al., 2004; Rollini et al., 1999). Further sequence analysis revealed that 
LINEs are the predominant class of repetitive sequences in the MARs in the MHC, and 
are consistently over-represented relative to their overall abundance in non-MAR DNA. 
This indicates that LINEs might contribute to the binding of DNA to the nuclear matrix 
and thus play a significant role in chromatin architecture. 
 
In all cell types studied here, intragenic sequences constitute approximately 40% of 
non-MAR DNA and 20% for MARs. In addition, MARs show a negative correlation 
with gene density. The preferential localisation of MARs within intergenic sequences as 
well as their proximity to MHC genes and class boundaries suggest that they might 
function as boundary elements. This is also supported by previous transgene 
experiments revealing that MARs are able to shield genes from positioning effects 
(Girod et al., 2007; Halweg et al., 2005). Although the details need to be established, 
this insulatory function might arise from the ability of MARs of forming topologically 
constrained looped structures which protect the intervening DNA from the influence of 
chromatin outside the loop. 
 
Another feature of MARs observed consistently in all three cell types is that they are 
approximately two times less conserved than non-MAR DNA. No unique sequence 
consensus was identified for MARs, suggesting that their conserved function across 
different species is not dictated by an evolutionary conserved primary sequence but 
rather by diverse DNA motifs generating distinct higher-order chromatin structures. A 
similar finding was shown for methylated sites on histones, which were found to be 
functionally conserved between the human and mouse genomes at orthologous sites 
even when their underlying sequence was not highly conserved (Bernstein et al., 2005).  
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The absence of a unique consensus characterising MARs has led to difficulties in 
predicting the position of MARs using in silico approaches. The performance of the 
computer programmes SIDD, ChrClass and MARScan was assessed in this thesis using 
experimental data from the three cell types. These programmes are based on different 
sets of DNA motifs associated with MARs, thus, it is not surprising that their 
predictions across the MHC overlap only partially. Although the performance of each 
programme was found to vary in the three cell types, Chrclass outperformed SIDD and 
MARScan since it had the highest sensitivity and specificity. In each cell type, a 
significant number of MARs were detected experimentally that were not predicted by 
any of the selected programmes. The positive and negative correlations between MARs 
and the genomic features analysed, which include AT content, repetitive sequences and 
gene density, should be incorporated into these programmes to improve their predicting 
power. 
 
6.6 The structural and functional relationship between matrix 
attachment regions and the MHC 
 
The efficient up-regulation of expression of MHC genes upon specific stimulatory 
signals regulates antigen presentation to T cells and ultimately determines the 
effectiveness of the immune response. The recruitment of genomic anchors near 
differentially expressed MHC genes accompanies their transcriptional activation, 
indicating that they could be critical for the regulation of the MHC locus. 
 
The MHC class I and II regions contain a larger number of MARs and are therefore 
more topologically constrained than the class III and the extended class II regions. Since 
the class I and II regions have significantly higher AT and repetitive element content as 
well as higher gene density than the class III and extended class II regions, the uneven 
distribution of MARs might be due to the distinct genomic features of the MHC classes. 
The similar MAR distribution between the class I and class II regions might also reflect 
their similar evolution. The organisation and sequence of the genes contained in these 
classes suggest that they are derived from a common ancestor (Kasahara et al., 1995; 
Klein and Sato, 1998). In contrast, most of the class III genes and extended class II 
genes are not functionally or evolutionarily related to one another (Sultmann et al., 
2000). 
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The organisation of chromatin into repeating local loops tethered to the nuclear scaffold 
might define distinct chromatin domains and constitute the basic structural unit of 
chromatin for regulating DNA transcription and replication (Bode et al., 1995; Heng et 
al., 2001; Nickerson et al., 1995). Furthermore, if the MHC sub-regions are organised in 
a rosette-like conformation as proposed by the MLS model, several MARs could be 
tethered at the centre of each rosette and multiple loops could share the same nuclear 
microenvironment facilitating the co-ordinate regulation of the MHC genes contained 
within the class I and II regions (Munkel et al., 1999). 
 
One of the most striking features of the human genome is its subdivision into G- and R-
bands (as discussed in Chapter 1). In the MHC, the class II region replicates late and it 
is highly AT-rich (Tenzen et al., 1997). We would therefore expect the MHC class II 
region to correspond to a G-band. Does the MAR distribution provide insights into the 
banding phenomenon? According to Saitoh and Laemmli (1994), G- and R-bands arise 
from the differential compaction of MARs along metaphase chromosomes (Saitoh and 
Laemmli, 1994). They showed that G bands correspond to regions where MARs are 
more tightly coiled than R-bands. A similar pattern might also exist in interphase 
chromosomes as our findings suggest that the MHC class II contains a significant 
higher number of MARs than the adjacent sub-regions and might thus be subjected to 
higher structural constraints. 
 
Previous small-scale studies on different organisms have indicated that dynamic 
recruitment of MARs to the nuclear matrix regulates the expression of genes involved 
in cellular differentiation and disease development as well as additional nuclear 
processes including DNA replication and mitosis (discussed in Chapter 1). The 
expression of several MHC proteins, including HLA class I molecules, is low in 
pluripotent human embryonic stem cells but shows a significant increase during 
differentiation (Drukker and Benvenisty, 2004; Drukker et al., 2002). In order to 
improve our understanding of the molecular mechanisms regulating MHC gene 
expression during cellular differentiation, the MHC tiling path arrays could be used to 
map the MARs in cells at different developmental stages. The identification of MARs in 
cells exhibiting abnormal MHC gene expression could determine whether MARs 
contribute to the diseases associated with this locus. In preparation for mitosis, 
chromatin starts undergoing profound conformational changes to reach the extreme 
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degree of compaction observed in metaphase chromosomes. The isolation of MARs 
from metaphase nuclei and their localisation across the MHC could reveal whether the 
rearrangement of MARs is also involved in the formation of metaphase chromosomes. 
In addition to consolidating the findings of the present study, these experiments will 
provide a broader view of the relationships between structure and function that underlie 
chromosome biology. 
 
6.7  Final Remarks 
 
Our knowledge of how the MHC functions in the context of the nucleus has been 
enhanced by the findings that distinct genomic sites of the MHC interact with proteins 
of the nuclear matrix. These MARs are likely to regulate the expression of the MHC 
locus by dynamically organising chromatin in three-dimensional space. The 
identification of CIITA-binding sites and histone acetylated regions across the MHC 
emphasises that this critical region of the genome is regulated at multiple levels. The 
characterisation of cis-regulatory elements, regulatory proteins and epigenetic 
modifications as well as their co-ordination and compartmentalisation into distinct 
nuclear microenvironments will allow us to gain a more comprehensive view of 
genomic function and identify truly novel targets for therapy. 
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Appendices 
 
Appendix I - Position of clones constituted entirely of repetitive sequences 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Start position End position 
29857045 29859021 
29859685 29861731 
29952327 29954750 
29954618 29957153 
30007795 30009507 
30071694 30074112 
30123120 30125633 
30157712 30159479 
30159325 30162190 
30254297 30256821 
30324946 30327580 
30326343 30328780 
30353431 30355824 
30355557 30357404 
30356186 30358959 
30358915 30361227 
30360627 30363086 
30373125 30373916 
30461074 30463679 
30505856 30508413 
30507610 30510119 
30548127 30550788 
30550719 30553560 
30553123 30554913 
30598279 30600699 
30624293 30626447 
31044408 31046885 
31102983 31105539 
31176621 31179067 
31258475 31261419 
31282010 31284107 
31309154 31310921 
31331246 31333604 
31333527 31335887 
31397092 31399917 
31399278 31403895 
31405420 31408180 
31407745 31410625 
31410312 31412594 
31481894 31483829 
31482771 31485215 
31505209 31507825 
31507238 31509555 
31509279 31511644 
31578226 31580534 
31929098 31930771 
32061007 32063565 
32063457 32066073 
32333324 32335035 
32334902 32337196 
32347172 32349492 
32357072 32359919 
32531595 32534000 
32552075 32554386 
32570284 32572093 
32637066 32640334 
32637942 32640486 
32750587 32752380 
32751956 32754798 
32803977 32805579 
32879848 32882714 
32946350 32948854 
33065138 33067726 
 205 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
33099436 33102017 
33125489 33127433 
33128270 33130623 
33130078 33132394 
33171878 33174286 
33174199 33176819 
33196915 33199698 
33208179 33210083 
33211780 33213487 
33213814 33215866 
33423446 33426238 
33541330 33543791 
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Appendix II - Position of MARs of uninduced MRC5 cells and their array  
                        enrichment 
 
Start position End position Matrix enrichment (log2) 
29802604 29804427 0.408556898 
29811013 29813380 0.560802711 
29840342 29842808 0.536847791 
29849827 29852415 0.454672441 
29872823 29875035 0.461270083 
29882039 29884543 0.608527194 
29884167 29886552 0.927214351 
29894385 29896949 0.415990851 
29933548 29935949 0.405509686 
29937894 29939594 0.89732932 
29960874 29962955 0.531348184 
29975451 29978299 0.454830111 
29982740 29984644 1.606179952 
29996470 29998921 0.475552781 
30036629 30039288 0.447158433 
30046908 30048715 0.691269293 
30062253 30064589 0.411414968 
30065589 30067967 0.534589265 
30101121 30103717 0.487064175 
30103986 30106521 0.484163181 
30129527 30132152 0.411419205 
30131866 30134499 0.524926594 
30134479 30136131 0.628146834 
30146157 30148833 0.413190429 
30168959 30171414 0.418168319 
30200798 30203110 0.429058999 
30223796 30226544 0.753265219 
30226106 30228443 0.813896405 
30231506 30234359 0.45203356 
30238940 30240972 1.103889025 
30249896 30252535 0.500941774 
30252097 30254580 0.719450528 
30304335 30306759 0.551212328 
30341155 30343559 0.540194347 
30343050 30345405 0.657699355 
30377836 30380380 0.81314185 
30389144 30392634 0.412102625 
30391810 30393924 0.568857432 
30421568 30424503 0.463906481 
30428243 30430343 0.614378646 
30442776 30445345 0.49071704 
30455483 30457800 0.998706823 
30459362 30461425 0.552074532 
30472435 30474725 0.434562973 
30482335 30484495 0.408831062 
30501127 30503780 0.596996587 
30507610 30510119 0.73442487 
30509530 30512280 0.860153585 
30516686 30519460 0.479511852 
30610759 30613495 0.421833521 
30698815 30701782 0.488345733 
30731648 30734384 0.753858118 
30767990 30770760 0.740066525 
30772906 30775852 0.49751423 
31056157 31059172 0.851972976 
31092038 31094660 0.551624383 
31321337 31323848 0.452281196 
31323764 31326217 0.621960824 
31365145 31367681 0.491564421 
31367358 31369739 0.43577134 
31389893 31392559 0.428661609 
31415829 31418487 0.419018763 
31425276 31427539 0.422257018 
31511491 31514354 0.540576928 
31865033 31867206 0.825494445 
31955316 31957399 0.802678454 
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31975147 31977228 0.559284364 
31980740 31983206 0.575024791 
32220043 32222067 0.702016342 
32364646 32367027 0.411144569 
32387922 32390488 0.452297001 
32390209 32393140 0.663247501 
32395956 32398655 0.750176571 
32409735 32412419 0.689602651 
32425489 32427795 0.564261938 
32430334 32433086 0.453128227 
32434975 32437634 0.410066859 
32449154 32450929 0.432421388 
32471036 32473567 0.470043067 
32498517 32501144 0.524899088 
32505710 32507577 0.661459906 
32509557 32512401 0.429390024 
32511421 32513544 0.932602283 
32526778 32528509 0.503215151 
32539196 32541992 0.584627644 
32561821 32564747 0.431994573 
32566224 32568770 0.55458087 
32583051 32585482 0.478776537 
32619337 32622559 0.401899149 
32622631 32625110 0.513908404 
32651630 32653632 0.499003012 
32686431 32689080 0.767205538 
32691590 32694583 0.461439144 
32705613 32708110 0.735658383 
32761722 32764350 0.482341379 
32769075 32771517 0.565704136 
32780871 32783266 0.41115026 
32787740 32790461 0.412398176 
32794482 32797049 0.43454104 
32796793 32799124 0.617260724 
32857226 32859895 0.501158919 
32870242 32872810 0.548254335 
32875022 32877556 0.428879357 
32877232 32879913 0.455350541 
32904298 32906120 0.55790393 
32931156 32933975 0.417799295 
33025410 33027740 0.43507822 
33027231 33028946 0.558000713 
33067567 33070137 0.5299079 
33104021 33106350 0.445969608 
33117354 33120123 0.561697932 
33176769 33178915 0.404808889 
33217907 33219670 0.457952348 
33227950 33230409 0.460856046 
33283836 33286387 3.975215717 
33292021 33293767 0.426293697 
33501985 33503886 0.59069723 
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Appendix III - Position of MARs of IFN-γ induced MRC5 cells and their array   
                          enrichment 
 
Start position End position Matrix enrichment (log2) 
29772399 29775033 1.049801067 
29781700 29784102 0.591308658 
29792469 29798300 0.522471833 
29811013 29813380 0.420064147 
29840342 29842808 0.641989126 
29849827 29852415 0.704240122 
29854767 29857057 0.552058507 
29872823 29875035 0.54336622 
29882039 29884543 0.834133308 
29884167 29886552 1.133676991 
29896602 29899084 0.441221525 
29917144 29919923 0.50772475 
29931599 29934065 0.529999226 
29933548 29935949 0.910566307 
29935654 29938224 0.74470164 
29937894 29939594 0.441422054 
29949751 29952328 0.463249917 
29956443 29958865 0.617680963 
29960874 29962955 1.158341109 
29975451 29978299 0.50409617 
29977965 29979873 0.425804085 
29993954 29996553 0.644487391 
29996470 29998921 0.58506104 
30036629 30039288 0.442040222 
30062253 30064589 0.541396708 
30065589 30067967 0.844153915 
30096934 30100100 0.447535682 
30101121 30103717 0.639791775 
30103986 30106521 0.665963702 
30127345 30129803 0.493341502 
30168959 30171414 0.516361315 
30203030 30205314 0.50502874 
30207839 30210162 0.604713047 
30223796 30226544 0.762099579 
30226106 30228443 1.771074308 
30231506 30234359 0.722487581 
30238940 30240972 2.140226418 
30249896 30252535 0.641808161 
30252097 30254580 0.68684891 
30256578 30258948 0.418002505 
30269344 30271071 0.461621459 
30301929 30304620 1.081822769 
30306687 30309185 0.415578249 
30309105 30311651 0.574531723 
30322904 30325267 0.43606955 
30328752 30331413 0.550448473 
30331401 30333872 0.606252271 
30341155 30343559 0.655637831 
30345571 30347925 0.545263234 
30347804 30350169 0.46135727 
30389144 30392634 0.594588791 
30391810 30393924 0.754115027 
30406289 30409007 1.121396851 
30411277 30413752 0.542471092 
30424262 30426665 0.513809249 
30433512 30435982 0.469998703 
30435458 30437915 0.559598092 
30442776 30445345 0.458286542 
30450571 30453097 0.515079905 
30453257 30455963 1.092588766 
30455483 30457800 1.266178864 
30459362 30461425 0.757938884 
30463598 30466352 0.45280234 
30472435 30474725 0.590706527 
30474644 30477030 0.488176961 
30482335 30484495 0.522910204 
 209 
30484481 30486798 0.495980716 
30498694 30501279 0.582779522 
30501127 30503780 0.956521698 
30503512 30505932 0.52845754 
30509530 30512280 0.818405019 
30512150 30514491 0.595409879 
30516686 30519460 0.583966874 
30532105 30534885 0.433526001 
30546495 30548204 0.800496996 
30608279 30610773 0.426602843 
30687802 30690256 0.717735973 
30698815 30701782 0.441636431 
30767990 30770760 0.925658748 
30950261 30953164 0.403764536 
31054143 31056020 0.421592821 
31056157 31059172 0.554921445 
31147190 31149630 0.412134893 
31208146 31210054 0.587538815 
31256049 31258433 0.512333365 
31306864 31309399 0.449128931 
31321337 31323848 0.83287629 
31323764 31326217 0.769802675 
31349918 31352712 0.425241291 
31365145 31367681 1.001499443 
31367358 31369739 1.052325164 
31377505 31380155 0.549970869 
31387943 31390679 0.90454688 
31389893 31392559 1.020292464 
31392265 31394713 0.546338622 
31403562 31405377 0.446565181 
31413230 31416000 0.914900848 
31415829 31418487 0.668498238 
31421730 31424152 0.414236451 
31423462 31425292 0.493809738 
31425276 31427539 0.418474252 
31433998 31436656 0.545090692 
31435990 31438961 0.436673775 
31472505 31475307 0.455900346 
31498765 31501407 0.401680246 
31511491 31514354 0.77212005 
31517732 31520447 0.742048175 
31522428 31524251 0.589933091 
31555714 31557747 0.415611255 
31562288 31564901 0.407069889 
31567390 31569981 0.403397752 
31602298 31604502 0.617155371 
31784795 31786680 0.40183233 
31955316 31957399 0.494678105 
31980740 31983206 0.613123821 
31990195 31993322 0.531821297 
32220043 32222067 0.727509267 
32323976 32326426 0.638889147 
32330237 32333661 0.405145132 
32337055 32339933 0.65203743 
32352121 32354558 0.40422516 
32354408 32357209 0.432501891 
32359755 32362494 0.443665253 
32364646 32367027 0.611222219 
32379696 32381542 0.401916558 
32383418 32386054 0.406333698 
32387922 32390488 0.6774036 
32390209 32393140 0.428043767 
32395956 32398655 1.597834078 
32398586 32401154 0.891748454 
32402691 32405190 0.447497692 
32404753 32407328 0.458058934 
32409735 32412419 0.864437415 
32425489 32427795 0.772856453 
32434975 32437634 0.419542132 
32439560 32442112 0.523744186 
32449154 32450929 0.73579992 
 210 
32453538 32456020 0.519284458 
32471036 32473567 0.647072857 
32491122 32493607 0.447654425 
32501095 32503289 0.454018427 
32509557 32512401 0.587227372 
32511421 32513544 2.50762754 
32518443 32520782 0.544699667 
32526778 32528509 0.664975997 
32536608 32539324 0.616132169 
32539196 32541992 1.027431171 
32541661 32544149 0.401677674 
32543851 32546046 0.461342381 
32561821 32564747 0.793174255 
32566224 32568770 0.478428081 
32577343 32579881 0.430770385 
32583051 32585482 0.493821162 
32598134 32600400 0.412373568 
32613182 32615215 0.456789805 
32644074 32646662 1.030594313 
32646521 32649544 0.501180242 
32651630 32653632 0.448923754 
32663263 32666061 0.404139716 
32673701 32676631 0.414046656 
32686431 32689080 0.866036275 
32689045 32691474 1.184147147 
32691590 32694583 0.559257989 
32694444 32697209 0.46287668 
32696991 32699506 0.547303174 
32705613 32708110 0.738285211 
32710133 32712269 0.423524638 
32722734 32725314 0.495529479 
32724504 32727177 0.490469236 
32743165 32746083 0.404463712 
32745804 32748726 0.430081816 
32754319 32756817 0.580936359 
32761722 32764350 0.754099217 
32766998 32769591 0.615316648 
32769075 32771517 0.719787252 
32786130 32788393 0.686275865 
32787740 32790461 0.927442836 
32794482 32797049 0.50394299 
32796793 32799124 0.62237831 
32799001 32801669 1.4187691 
32808098 32810522 0.598241428 
32810462 32813136 0.420570067 
32825193 32827718 0.586511952 
32827724 32830188 0.515317133 
32829829 32831757 0.461188079 
32843585 32846054 0.418084091 
32847268 32850579 0.692887483 
32857226 32859895 0.778559184 
32868718 32871367 0.539393651 
32870242 32872810 0.479746347 
32872192 32874816 0.437635 
32875022 32877556 1.017812107 
32877232 32879913 0.717756672 
32931156 32933975 0.540953045 
32941867 32944276 0.499969951 
32962761 32965294 0.449659401 
32974464 32976746 0.460148697 
32975782 32978196 0.438711003 
32977812 32980308 0.676242898 
32980467 32982978 0.768576279 
32992393 32994837 0.557045226 
33022966 33025488 0.501840271 
33025410 33027740 0.914369565 
33067567 33070137 0.915400066 
33090674 33093215 0.613554929 
33104021 33106350 0.752821178 
33115900 33118153 0.658419785 
33117354 33120123 0.551879791 
 211 
33121204 33123602 0.51283286 
33123473 33125541 0.510379312 
33133928 33138288 0.720228682 
33138219 33141006 0.520126602 
33142984 33145436 0.408756126 
33176769 33178915 0.572146644 
33192620 33193912 0.486828122 
33210173 33212682 0.515207685 
33227950 33230409 0.545032793 
33320016 33322458 0.61226308 
33462560 33465285 0.559465849 
33501985 33503886 0.663283564 
33529999 33532371 0.559354425 
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Appendix IV - Position of MARs of PGF cells and their array enrichment 
 
Start position End position Matrix enrichment (log2) 
29739385 29741249 0.482147191 
29755213 29757127 0.432167475 
29849827 29852415 1.110277457 
29861411 29863644 0.405538158 
29894385 29896949 0.487401914 
29896602 29899084 0.502859211 
29929108 29931705 0.574111984 
29937894 29939594 2.526421952 
30023644 30025314 1.775267442 
30053351 30055956 0.693329948 
30065589 30067967 1.039362864 
30101121 30103717 0.581704641 
30103986 30106521 0.98209088 
30106463 30109071 0.519614908 
30108625 30111062 0.841034798 
30110866 30113454 1.729229932 
30113400 30115997 0.439612457 
30118308 30120829 0.801492862 
30123120 30125633 0.883641409 
30125000 30127465 0.805619325 
30127345 30129803 1.064832248 
30129527 30132152 1.99585852 
30131866 30134499 2.207236754 
30134479 30136131 2.387396226 
30152988 30155591 0.988586241 
30155515 30157551 0.529730025 
30200798 30203110 0.470841255 
30219223 30221767 0.533182358 
30231506 30234359 3.319040001 
30249896 30252535 0.464204585 
30252097 30254580 0.443791026 
30314787 30317588 0.501078915 
30341155 30343559 0.479846912 
30345571 30347925 1.205872764 
30347804 30350169 0.864868628 
30350008 30351777 0.799927299 
30363052 30365623 0.886622078 
30365212 30368158 0.652169791 
30368063 30370782 0.676448044 
30368214 30370831 0.622433822 
30377836 30380380 0.658218406 
30380190 30382789 0.542408668 
30391810 30393924 0.899687284 
30448175 30450582 0.476275354 
30463598 30466352 0.468579875 
30474644 30477030 0.732587325 
30482335 30484495 1.876325603 
30489386 30491682 0.416035621 
30498694 30501279 0.69955459 
30501127 30503780 0.758140163 
30503512 30505932 0.481793655 
30509530 30512280 0.74238899 
30555778 30557696 0.812807873 
30557295 30559029 0.670945263 
30562566 30564894 0.403426484 
30568353 30570872 0.903176347 
30583516 30586461 0.763093791 
30600787 30603165 0.711956124 
30610759 30613495 0.417564988 
30677499 30679491 0.993747688 
30689948 30692394 1.071166292 
30691343 30693991 1.058426869 
30698815 30701782 2.012782126 
30701596 30704062 0.744320899 
30711444 30713962 0.683121345 
30714444 30716453 0.405939453 
30756515 30758800 0.508400578 
30767990 30770760 0.54222195 
30772906 30775852 0.53441826 
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30825368 30827875 0.533282644 
30827954 30830159 0.982094296 
30834737 30837454 0.488754857 
30901287 30903649 0.4370775 
30903401 30906093 0.850043797 
30923216 30925575 0.40814842 
30991536 30994461 0.653581056 
31018945 31021138 0.446628494 
31021804 31024362 1.027783576 
31023710 31026101 0.96905714 
31024896 31027536 0.915876174 
31026926 31029099 0.79052907 
31028955 31031073 0.741360261 
31030830 31033294 0.453431798 
31039751 31042033 1.470046109 
31049352 31051490 0.479301224 
31051409 31054038 1.143856913 
31054143 31056020 0.903290745 
31056157 31059172 2.389286257 
31061209 31064176 0.719780599 
31098259 31100652 0.770924003 
31100296 31102131 0.550215769 
31105233 31107465 0.62682859 
31110005 31112753 0.594295352 
31174122 31176523 0.431525983 
31256049 31258433 0.473060356 
31323764 31326217 0.587113883 
31352523 31355086 0.42361182 
31369850 31372247 0.794692668 
31373910 31376551 0.433074209 
31376096 31377899 0.992805918 
31403562 31405377 0.50653476 
31413230 31416000 0.524884214 
31435990 31438961 0.600006049 
31438478 31440903 0.488539995 
31442467 31444925 0.71193306 
31444860 31447238 1.130968695 
31451728 31454419 1.28228359 
31454436 31456982 0.403756867 
31485229 31487901 0.419517344 
31490983 31493112 1.13447987 
31511491 31514354 0.415125969 
31522428 31524251 0.510902871 
31558217 31560371 0.401852481 
31575231 31578232 0.417827056 
31588415 31591252 0.53639594 
31621456 31623166 0.756629863 
31662312 31665020 1.237122769 
31676093 31678464 0.690785896 
31678683 31681025 0.575932467 
31687714 31690387 0.490032589 
31689689 31692751 0.664720512 
31796596 31799113 0.439280284 
31838392 31840676 0.789680799 
31938977 31941560 0.407787394 
31945923 31948419 0.427803588 
31955316 31957399 0.714972748 
31963191 31965805 0.496633778 
31980740 31983206 0.638547938 
32193954 32196840 0.446889343 
32220043 32222067 1.041134424 
32246419 32248999 0.433639482 
32248564 32250364 0.488978232 
32249781 32252103 0.457409351 
32323976 32326426 0.62996533 
32327905 32330164 0.441934589 
32339897 32342653 0.402688603 
32359755 32362494 0.470886614 
32372351 32375042 0.479955291 
32376862 32379701 0.476129427 
32386043 32387227 1.506569425 
32393119 32395967 0.406674242 
 214 
 
 
32411660 32414241 1.849664636 
32414203 32416787 0.919980551 
32416697 32418805 0.423529254 
32418544 32420769 0.545012326 
32423326 32425860 1.26078944 
32432791 32435294 0.961228297 
32434975 32437634 0.730141176 
32439560 32442112 0.591598327 
32446941 32449572 0.489568258 
32453538 32456020 0.686435565 
32467000 32470237 0.423336688 
32483778 32485594 0.502526401 
32496153 32498835 0.562715912 
32498517 32501144 0.791099009 
32505710 32507577 2.094044123 
32524176 32526297 0.409230532 
32526778 32528509 0.682785027 
32536608 32539324 0.464144547 
32543851 32546046 0.616745224 
32566224 32568770 0.773844701 
32577343 32579881 0.491508336 
32577611 32579425 0.554686048 
32583051 32585482 0.688380975 
32585496 32588059 0.489706196 
32587814 32590389 0.433742848 
32613182 32615215 0.409983107 
32619337 32622559 1.002131183 
32626531 32628342 0.885650144 
32629755 32631649 0.471231818 
32649832 32652328 1.777332919 
32653939 32656323 0.483995856 
32657249 32658112 0.469473531 
32668459 32673858 0.540204285 
32678591 32681243 0.662968739 
32680961 32683760 0.553234079 
32710133 32712269 0.670335726 
32714274 32717018 1.377067649 
32716744 32719125 0.693679936 
32718336 32721027 0.463576216 
32720216 32722920 0.836576859 
32722734 32725314 0.622251611 
32724504 32727177 0.452963123 
32743165 32746083 0.524197086 
32759416 32762298 2.056098071 
32761722 32764350 0.431556292 
32766998 32769591 0.645115482 
32769075 32771517 1.12835019 
32771813 32774032 3.031142095 
32773440 32776301 0.499332172 
32776173 32778703 3.341811971 
32778597 32781168 1.112091941 
32786130 32788393 1.279673698 
32787740 32790461 1.534303387 
32794482 32797049 1.04283508 
32796793 32799124 0.505040719 
32801443 32804134 0.597150639 
32805771 32808229 1.192730415 
32808098 32810522 0.793411988 
32810462 32813136 0.52587137 
32812745 32815129 0.531638095 
32827724 32830188 0.640426903 
32843585 32846054 0.409749519 
32847268 32850579 0.608774574 
32850451 32852327 1.587074053 
32857226 32859895 0.609320612 
32859507 32861730 2.525040351 
32861678 32864080 1.060303875 
32877232 32879913 0.540065293 
32890054 32892994 0.556003338 
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Appendix V - Position of MARs common to all cell types 
 
Start position End position 
29849827 29852415 
29937894 29939594 
30065589 30067967 
30101121 30103717 
30103986 30106521 
30231506 30234359 
30249896 30252535 
30341155 30343559 
30391810 30393924 
30482335 30484495 
30501127 30503780 
30509530 30512280 
30698815 30701782 
30767990 30770760 
31056157 31059172 
31323764 31326217 
31511491 31514354 
31955316 31957399 
31980740 31983206 
32220043 32222067 
32434975 32437634 
32526778 32528509 
32566224 32568770 
32583051 32585482 
32761722 32764350 
32769075 32771517 
32787740 32790461 
32794482 32797049 
32796793 32799124 
32857226 32859895 
32877232 32879913 
33117354 33120123 
33501985 33503886 
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Appendix VI - Position of MARs in the MHC of both IFN-γ induced and   
                          uninduced MRC5 cells 
 
Start position End position 
29811013 29813380 
29840342 29842808 
29872823 29875035 
29882039 29884543 
29884167 29886552 
29933548 29935949 
29960874 29962955 
29975451 29978299 
29996470 29998921 
30036629 30039288 
30062253 30064589 
30168959 30171414 
30223796 30226544 
30226106 30228443 
30238940 30240972 
30389144 30392634 
30442776 30445345 
30455483 30457800 
30459362 30461425 
30472435 30474725 
30516686 30519460 
31321337 31323848 
31365145 31367681 
31367358 31369739 
31389893 31392559 
31415829 31418487 
31425276 31427539 
32364646 32367027 
32387922 32390488 
32390209 32393140 
32395956 32398655 
32409735 32412419 
32425489 32427795 
32449154 32450929 
32471036 32473567 
32509557 32512401 
32511421 32513544 
32539196 32541992 
32561821 32564747 
32651630 32653632 
32395956 32398655 
32686431 32689080 
32691590 32694583 
32705613 32708110 
32875022 32877556 
32931156 32933975 
33025410 33027740 
33067567 33070137 
33104021 33106350 
33176769 33178915 
33227950 33230409 
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Appendix VII - Position of MARs of PGF cells only 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Start position End position 
29739385 29741249 
29755213 29757127 
29861411 29863644 
29929108 29931705 
30023644 30025314 
30053351 30055956 
30106463 30109071 
30108625 30111062 
30110866 30113454 
30113400 30115997 
30118308 30120829 
30125000 30127465 
30152988 30155591 
30155515 30157551 
30219223 30221767 
30314787 30317588 
30350008 30351777 
30363052 30365623 
30365212 30368158 
30368063 30370782 
30368214 30370831 
30380190 30382789 
30448175 30450582 
30489386 30491682 
30555778 30557696 
30557295 30559029 
30562566 30564894 
30583516 30586461 
30600787 30603165 
30677499 30679491 
30689948 30692394 
30691343 30693991 
30701596 30704062 
30711444 30713962 
30714444 30716453 
30756515 30758800 
30825368 30827875 
30827954 30830159 
30834737 30837454 
30901287 30903649 
30903401 30906093 
30923216 30925575 
30991536 30994461 
31018945 31021138 
31021804 31024362 
31023710 31026101 
31024896 31027536 
31026926 31029099 
31028955 31031073 
31030830 31033294 
31039751 31042033 
31049352 31051490 
31051409 31054038 
31054143 31056020 
31061209 31064176 
31098259 31100652 
31100296 31102131 
31105233 31107465 
31110005 31112753 
31174122 31176523 
31352523 31355086 
31369850 31372247 
31373910 31376551 
31376096 31377899 
31438478 31440903 
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31442467 31444925 
31444860 31447238 
31451728 31454419 
31454436 31456982 
31485229 31487901 
31490983 31493112 
31558217 31560371 
31575231 31578232 
31588415 31591252 
31621456 31623166 
31662312 31665020 
31676093 31678464 
31678683 31681025 
31687714 31690387 
31689689 31692751 
31796596 31799113 
31838392 31840676 
31938977 31941560 
31945923 31948419 
31963191 31965805 
32193954 32196840 
32246419 32248999 
32248564 32250364 
32249781 32252103 
32327905 32330164 
32339897 32342653 
32372351 32375042 
32376862 32379701 
32386043 32387227 
32393119 32395967 
32411660 32414241 
32414203 32416787 
32416697 32418805 
32418544 32420769 
32423326 32425860 
32432791 32435294 
32446941 32449572 
32467000 32470237 
32483778 32485594 
32496153 32498835 
32524176 32526297 
32577611 32579425 
32585496 32588059 
32587814 32590389 
32626531 32628342 
32629755 32631649 
32653939 32656323 
32657249 32658112 
32668459 32673858 
32678591 32681243 
32680961 32683760 
32714274 32717018 
32716744 32719125 
32718336 32721027 
32720216 32722920 
32759416 32762298 
32771813 32774032 
32773440 32776301 
32776173 32778703 
32778597 32781168 
32801443 32804134 
32805771 32808229 
32812745 32815129 
32850451 32852327 
32859507 32861730 
32861678 32864080 
32890054 32892994 
32892523 32894937 
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32894483 32897025 
32896974 32899399 
32906204 32908888 
32944237 32946032 
32948866 32951226 
32951208 32953571 
32964422 32967273 
32967276 32969811 
32968550 32971099 
32970390 32972719 
32972559 32975260 
32987255 32990019 
32989946 32992530 
32997141 32999893 
32999284 33001846 
33003704 33006056 
33006053 33008988 
33008444 33010878 
33010869 33013520 
33034370 33036962 
33037346 33039646 
33039760 33042545 
33049800 33052268 
33086287 33088714 
33092818 33095473 
33097613 33099941 
33106390 33108236 
33109482 33111869 
33112049 33114719 
33113667 33116173 
33144119 33146299 
33146226 33148958 
33148418 33151260 
33150708 33153101 
33162178 33164006 
33219995 33222707 
33538830 33541653 
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Appendix VIII - Position of MARs of uninduced MRC5 cells 
 
Start position End position 
29802604 29804427 
29894385 29896949 
29982740 29984644 
30046908 30048715 
30129527 30132152 
30131866 30134499 
30134479 30136131 
30146157 30148833 
30200798 30203110 
30304335 30306759 
30343050 30345405 
30377836 30380380 
30421568 30424503 
30428243 30430343 
30610759 30613495 
30731648 30734384 
30772906 30775852 
31092038 31094660 
31865033 31867206 
31975147 31977228 
32430334 32433086 
32498517 32501144 
32505710 32507577 
32619337 32622559 
32622631 32625110 
32780871 32783266 
32904298 32906120 
33027231 33028946 
33217907 33219670 
33283836 33286387 
33292021 33293767 
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Appendix IX - Position of MARs of IFN-γ induced MRC5 only 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Start position End position 
29772399 29775033 
29781700 29784102 
29792469 29798300 
29854767 29857057 
29917144 29919923 
29931599 29934065 
29935654 29938224 
29949751 29952328 
29956443 29958865 
29977965 29979873 
29993954 29996553 
30096934 30100100 
30203030 30205314 
30207839 30210162 
30256578 30258948 
30269344 30271071 
30306687 30309185 
30309105 30311651 
30322904 30325267 
30328752 30331413 
30331401 30333872 
30406289 30409007 
30411277 30413752 
30424262 30426665 
30433512 30435982 
30435458 30437915 
30450571 30453097 
30453257 30455963 
30484481 30486798 
30512150 30514491 
30532105 30534885 
30546495 30548204 
30608279 30610773 
30687802 30690256 
30950261 30953164 
31147190 31149630 
31208146 31210054 
31306864 31309399 
31349918 31352712 
31377505 31380155 
31387943 31390679 
31392265 31394713 
31421730 31424152 
31423462 31425292 
31433998 31436656 
31472505 31475307 
31498765 31501407 
31517732 31520447 
31562288 31564901 
31567390 31569981 
31602298 31604502 
31784795 31786680 
31990195 31993322 
32330237 32333661 
32337055 32339933 
32352121 32354558 
32354408 32357209 
32379696 32381542 
32383418 32386054 
32398586 32401154 
32402691 32405190 
32404753 32407328 
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32491122 32493607 
32501095 32503289 
32518443 32520782 
32541661 32544149 
32598134 32600400 
32644074 32646662 
32646521 32649544 
32663263 32666061 
32673701 32676631 
32689045 32691474 
32694444 32697209 
32696991 32699506 
32745804 32748726 
32754319 32756817 
32799001 32801669 
32825193 32827718 
32829829 32831757 
32868718 32871367 
32872192 32874816 
32962761 32965294 
32974464 32976746 
32975782 32978196 
32980467 32982978 
33022966 33025488 
33090674 33093215 
33115900 33118153 
33121204 33123602 
33123473 33125541 
33142984 33145436 
33192620 33193912 
33210173 33212682 
33320016 33322458 
33462560 33465285 
33529999 33532371 
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Appendix X - Position of MARs of both IFN-γ  induced MRC5 and PGF cells 
 
Start position End position 
29896602 29899084 
30127345 30129803 
30345571 30347925 
30347804 30350169 
30463598 30466352 
30474644 30477030 
30498694 30501279 
30503512 30505932 
31054143 31056020 
31256049 31258433 
31403562 31405377 
31413230 31416000 
31435990 31438961 
31522428 31524251 
32323976 32326426 
32359755 32362494 
32439560 32442112 
32453538 32456020 
32536608 32539324 
32543851 32546046 
32577343 32579881 
32613182 32615215 
32710133 32712269 
32722734 32725314 
32724504 32727177 
32743165 32746083 
32766998 32769591 
32786130 32788393 
32808098 32810522 
32810462 32813136 
32827724 32830188 
32843585 32846054 
32847268 32850579 
32941867 32944276 
32977812 32980308 
32992393 32994837 
33133928 33138288 
33138219 33141006 
 
